
<html lang="en"     class="pb-page"  data-request-id="8404e9b3-24ba-4db0-a176-dd5241fc60be"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm300452p;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-11;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling" /></meta><meta name="dc.Creator" content="Huifen  Chen" /></meta><meta name="dc.Creator" content="Bryan K.  Chan" /></meta><meta name="dc.Creator" content="Jason  Drummond" /></meta><meta name="dc.Creator" content="Anthony A.  Estrada" /></meta><meta name="dc.Creator" content="Janet  Gunzner-Toste" /></meta><meta name="dc.Creator" content="Xingrong  Liu" /></meta><meta name="dc.Creator" content="Yichin  Liu" /></meta><meta name="dc.Creator" content="John  Moffat" /></meta><meta name="dc.Creator" content="Daniel  Shore" /></meta><meta name="dc.Creator" content="Zachary K.  Sweeney" /></meta><meta name="dc.Creator" content="Thuy  Tran" /></meta><meta name="dc.Creator" content="Shumei  Wang" /></meta><meta name="dc.Creator" content="Guiling  Zhao" /></meta><meta name="dc.Creator" content="Haitao  Zhu" /></meta><meta name="dc.Creator" content="Daniel J.  Burdick" /></meta><meta name="dc.Description" content="Mutations in the genetic sequence of leucine-rich repeat kinase 2 (LRRK2) have been linked to increased LRRK2 activity and risk for the development of Parkinson’s disease (PD). Potent and selective..." /></meta><meta name="Description" content="Mutations in the genetic sequence of leucine-rich repeat kinase 2 (LRRK2) have been linked to increased LRRK2 activity and risk for the development of Parkinson’s disease (PD). Potent and selective..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 1, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm300452p" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm300452p" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm300452p" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm300452p" /></link>
        
    
    

<title>Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm300452p" /></meta><meta property="og:title" content="Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0003.jpeg" /></meta><meta property="og:description" content="Mutations in the genetic sequence of leucine-rich repeat kinase 2 (LRRK2) have been linked to increased LRRK2 activity and risk for the development of Parkinson’s disease (PD). Potent and selective small molecules capable of inhibiting the kinase activity of LRRK2 will be important tools for establishing a link between the kinase activity of LRRK2 and PD. In the absence of LRRK2 kinase domain crystal structures, a LRRK2 homology model was developed that provided robust guidance in the hit-to-lead optimization of small molecule LRRK2 inhibitors. Through a combination of molecular modeling, sequence analysis, and matched molecular pair (MMP) activity cliff analysis, a potent and selective lead inhibitor was discovered. The selectivity of this compound could be understood using the LRRK2 homology model, and application of this learning to a series of 2,4-diaminopyrimidine inhibitors in a scaffold hopping exercise led to the identification of highly potent and selective LRRK2 inhibitors that were also brain penetrable." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm300452p"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm300452p">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm300452p&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm300452p&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm300452p&amp;href=/doi/10.1021/jm300452p" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 5536-5545</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm3004587" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm3004762" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huifen++Chen">Huifen Chen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryan+K.++Chan">Bryan K. Chan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason++Drummond">Jason Drummond</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+A.++Estrada">Anthony A. Estrada</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Janet++Gunzner-Toste">Janet Gunzner-Toste</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xingrong++Liu">Xingrong Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yichin++Liu">Yichin Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Moffat">John Moffat</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Shore">Daniel Shore</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zachary+K.++Sweeney">Zachary K. Sweeney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thuy++Tran">Thuy Tran</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shumei++Wang">Shumei Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guiling++Zhao">Guiling Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haitao++Zhu">Haitao Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+J.++Burdick">Daniel J. Burdick</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1.0"><span class="aff-text"><sup>†</sup>Discovery Chemistry Department, <sup>‡</sup>Biochemical and Cellular Pharmacology Department, <sup>§</sup>Drug Metabolism and Pharmacokinetics Department, and <sup>∥</sup>Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="corresp-info"><strong>*</strong>For H.C. and D.J.B.: phone, 650-225-1000; fax, 650-467-5155; e-mail, <a href="/cdn-cgi/l/email-protection#395a515c5717514c505f5c57795e5c575c175a5654"><span class="__cf_email__" data-cfemail="32515a575c1c5a475b54575c7255575c571c515d5f">[email protected]</span></a> (H.C.) and <a href="/cdn-cgi/l/email-protection#f89a8d8a9c919b93d69c9996b89f9d969dd69b9795"><span class="__cf_email__" data-cfemail="1a786f687e737971347e7b745a7d7f747f34797577">[email protected]</span></a> (D.J.B).</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm300452p&amp;href=/doi/10.1021%2Fjm300452p" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 5536–5545</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 16, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 March 2012</li><li><span class="item_label"><b>Published</b> online</span>1 June 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 June 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm300452p" title="DOI URL">https://doi.org/10.1021/jm300452p</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5536%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHuifen%2BChen%252C%2BBryan%2BK.%2BChan%252C%2BJason%2BDrummond%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D11%26contentID%3Djm300452p%26title%3DDiscovery%2Bof%2BSelective%2BLRRK2%2BInhibitors%2BGuided%2Bby%2BComputational%2BAnalysis%2Band%2BMolecular%2BModeling%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5545%26publicationDate%3DJune%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm300452p"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3886</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">57</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm300452p" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Huifen&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;K. Chan&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;Drummond&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;A. Estrada&quot;},{&quot;first_name&quot;:&quot;Janet&quot;,&quot;last_name&quot;:&quot;Gunzner-Toste&quot;},{&quot;first_name&quot;:&quot;Xingrong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Yichin&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Moffat&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Shore&quot;},{&quot;first_name&quot;:&quot;Zachary&quot;,&quot;last_name&quot;:&quot;K. Sweeney&quot;},{&quot;first_name&quot;:&quot;Thuy&quot;,&quot;last_name&quot;:&quot;Tran&quot;},{&quot;first_name&quot;:&quot;Shumei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Guiling&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Haitao&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;J. Burdick&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;5536-5545&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm300452p&quot;},&quot;abstract&quot;:&quot;Mutations in the genetic sequence of leucine-rich repeat kinase 2 (LRRK2) have been linked to increased LRRK2 activity and risk for the development of Parkinson’s disease (PD). Potent and selective small molecules capable of inhibiting the kinase activity of LRRK2 will be important tools for establishing a link between the kinase activity of LRRK2 and PD. In the absence of LRRK2 kinase domain crystal structures, a LRRK2 homology model was developed that provided robust guidance in the hit-to-lead optimization of small molecule LRRK2 inhibitors. Through a combination of molecular modeling, sequence analysis, and matched molecular pair (MMP) activity cliff analysis, a potent and selective lead inhibitor was discovered. The selectivity of this compound could be understood using the LRRK2 homology model, and application of this learning to a series of 2,4-diaminopyrimidine inhibitors in a scaffold hopping exercise led to the identification of highly potent and selective LRRK2 inhibitors that were also brain penet&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300452p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300452p" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300452p&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300452p" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm300452p&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300452p" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm300452p&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm300452p&amp;href=/doi/10.1021/jm300452p" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm300452p" /></input><a href="/doi/pdf/10.1021/jm300452p" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm300452p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm300452p%26sid%3Dliteratum%253Aachs%26pmid%3D22591441%26genre%3Darticle%26aulast%3DChen%26date%3D2012%26atitle%3DDiscovery%2Bof%2BSelective%2BLRRK2%2BInhibitors%2BGuided%2Bby%2BComputational%2BAnalysis%2Band%2BMolecular%2BModeling%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D11%26spage%3D5536%26epage%3D5545%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291654" title="Homology">Homology</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jmcmar.2012.55.issue-11/production/jmcmar.2012.55.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300452p&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Mutations in the genetic sequence of leucine-rich repeat kinase 2 (LRRK2) have been linked to increased LRRK2 activity and risk for the development of Parkinson’s disease (PD). Potent and selective small molecules capable of inhibiting the kinase activity of LRRK2 will be important tools for establishing a link between the kinase activity of LRRK2 and PD. In the absence of LRRK2 kinase domain crystal structures, a LRRK2 homology model was developed that provided robust guidance in the hit-to-lead optimization of small molecule LRRK2 inhibitors. Through a combination of molecular modeling, sequence analysis, and matched molecular pair (MMP) activity cliff analysis, a potent and selective lead inhibitor was discovered. The selectivity of this compound could be understood using the LRRK2 homology model, and application of this learning to a series of 2,4-diaminopyrimidine inhibitors in a scaffold hopping exercise led to the identification of highly potent and selective LRRK2 inhibitors that were also brain penetrable.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>⊥</span> Author Present Address</h4><p class="last">Novartis Institutes for Biomedical Research (NIBR), 4560 Horton Street, Emeryville, CA 94608-2916.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Parkinson’s disease (PD) is a multisystem neurodegenerative disorder that is clinically characterized primarily by tremors, rigidity, and bradykinesia.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The current standard of care for PD patients is limited to symptomatic treatment, which only provides temporary attenuation of motor symptoms and does not affect the progression of neurodegeneration. There is, therefore, a strong demand for disease modifying or neuroprotective therapies. One of the more attractive targets for disease modification was identified in 2004 when genetic variations in the LRRK2 gene were linked to familial PD.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> In particular, the specific G2019S mutation of LRRK2 has been associated with both familial and idiopathic PD.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> The LRRK2 gene encodes a large protein with multiple domains, including a kinase domain.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> The detailed physiological function and effectors of the LRRK2 kinase are largely unknown and remain to be determined.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Importantly, the G2019S mutation in the kinase domain is a dominant mutation that has been shown to increase LRRK2 kinase activity in vitro, suggesting that the kinase activity of LRRK2 is involved in Parkinson’s disease pathophysiogenesis.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11-14)</a> Indeed, recent studies with nonspecific LRRK2 small molecule inhibitors have suggested that inhibition of LRRK2 activity might ameliorate neurodegenerative phenotypes in <i>C. elegans</i> and <i>Drosophila</i> Parkinson’s disease models and mouse models of LRRK2.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> However, because of the lack of general kinase selectivity of compounds used in the efficacy studies, the biological effects of LRRK2 kinase inhibition remain to be elucidated.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p last">A few selective inhibitors of LRRK2 kinase activity such as LRRK2-IN-1<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and CZC-25146<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> have been described recently. However, they do not appear to have sufficient CNS exposure to be used in mammalian models of PD. A potent ALK/LRRK2 kinase inhibitor, TAE684, was recently reported to achieve significant brain exposure in mouse but did not inhibit LRRK2 phosphorylation in the brain.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The development of selective and brain penetrable LRRK2 inhibitors therefore remains a critical need for the LRRK2 field.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In this contribution, we describe our initial efforts to use structure-based design and computational approaches to identify useful LRRK2 chemical probes starting from a high-throughput screening effort.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52335" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52335" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A high-throughput screening campaign using G2019S LRRK2 protein<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> yielded a number of interesting small molecule inhibitor scaffolds, including triazolopyridines and diaminopyrimidines represented by compounds <b>1</b> and <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). The triazolopyridine compounds were highly potent and had physical properties consistent with CNS penetration,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> while the aminopyrimidine inhibitors had excellent ligand efficiency (LE).<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> It is well-known, however, that the diaminopyrimidine motif is particularly well-represented in the kinase inhibition literature<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and the potential selectivity of these compounds was a concern. We therefore focused our initial computer-aided design efforts on the development of models and approaches that would allow us to improve the selectivity of compounds such as <b>1</b> and <b>2</b>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of high-throughput screening hits <b>1</b> and <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300452p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Homology Modeling and ATP-Binding Site Analysis</h3><div class="NLM_p">Use of crystal structure information is critical to the success of a structure-based drug design (SBDD) effort. However, the structure of the kinase domain of LRRK2 has not yet been reported.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Therefore, construction of a LRRK2 homology model<a onclick="showRef(event, 'ref7 ref10 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref7 ref10 ref28 ref29 ref30">(7, 10, 28-30)</a> using known kinase structures as templates was initiated. The most crucial elements for building a homology model are the choice of structural templates and sequence alignment.<a onclick="showRef(event, 'ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33">(31-33)</a> The choice of template can be influenced by numerous factors including sequence identity and functional relevance to the target protein, structural quality, and purpose of the model. Since our goal was to use the homology model for SBDD, we had to be even more prudent with the selection of structural templates in order to generate a model that would allow the docking of most LRRK2 inhibitors.</div><div class="NLM_p">Two approaches were employed to identify appropriate structural templates. The first approach relied on using kinase domain (KD) crystal structures of proteins that have a high degree of sequence homology with the KD of LRRK2.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Using Psi-Blast,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> a panel of human protein kinases with the highest KD sequence identity to LRRK2 was identified (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), although none of the kinases have sequence identity to LRRK2 greater than 32%. Several homology models were built with MLK1, TIE2, and TAK1 protein structures as templates using MOE (Chemical Computing Group, Inc.).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The models built with these templates were useful for elucidating general features of the ATP binding site, such as hinge residues, gatekeeper, and other residues that could participate in ATP and/or inhibitor binding. However, none of them proved robust enough to provide reasonable docking poses for all of the top priority chemical classes found in the screening campaign.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Multiple Sequence Alignment of ATP-Binding Site Residues<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> of LRRK2 and Selected Kinases</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0006.gif" alt="" id="GRAPHIC-d2241e409-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Residue numbers are based on Swiss-Prot nomenclature.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Cells colored in red have identical amino acids as in LRRK2.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Gatekeeper residue.</p></div></div><div></div></div><div class="NLM_p">The second approach for template selection was to search for kinases that exhibited similar inhibition profiles as LRRK2 for a given set of inhibitors. Analysis of the internal biochemical activity profiles of LRRK2 inhibitors found in the screening campaign revealed a surprising correlation between LRRK2 and JAK3 and a weaker correlation with JAK2. These data suggested that JAK3 crystal structures could be good structural templates for building LRRK2 homology models. However, because of the paucity of available high quality JAK3 crystal structures, JAK2 cocrystal structures were used. The final LRRK2 model (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A) was constructed from an unpublished in-house JAK2 cocrystal structure similar to a published structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JY9">3JY9</a>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The JAK2 structure was chosen based on its very high resolution (1.7 Å) and open ATP-binding site, which would allow the docking of many diverse compounds without introducing steric clashes. Similar to other protein kinases, the LRRK2 KD consists of a smaller N-terminal lobe and a larger C-terminal lobe connected by the hinge. According to the model, the N-terminal domain consists mostly of β sheets and an α helix, while the C-terminal domain consists of mostly α helices. The ATP-binding site is situated at the interface of the two lobes. The gatekeeper, Met1947, and catalytic residues, Lys1906 and Glu1920, line the back wall of the ATP-binding site, while residues Glu1948, Leu1949, and Ala1950 form the side wall along the kinase hinge (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). The side chains of amino acids Phe1883, Leu1885, Val1893, and Ala1904 form the ceiling of the ATP site, and those of Ile1933, Gly1953, Ser1954, and Leu2001 form the floor. At the opening of ATP-binding site, the side chains of Arg1957 and His1998 partially close in on the sugar moiety of ATP. The binding pocket is relatively closed and flat along the hinge and becomes more open near the solvent exposed region as well as the sugar and phosphate binding region. The ATP-binding pocket is largely hydrophobic with the exception of the hinge backbone hydrogen bond donor/acceptors, back pocket Lys1906 and Glu1920, and the front pocket Arg1957 side chain.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) LRRK2 kinase domain homology model with the N-terminal domain on top and C-terminal domain at bottom. The solvent accessible surface of the ATP-binding site is colored in pink, while the cartoon defining the protein backbone is colored in green. (B) LRRK2 ATP-binding site in complex with ATP (colored in yellow) looking down through the N-terminal domain. Side chains of binding site residues are shown as sticks and colored in green. Side chains of the four key selectivity residues (Phe1883, Leu1949, Ser1954, and Arg1957) are colored in magenta. The alternative conformations of Arg1957 and Gln1961 are shown in cyan. Hydrogen bond interactions between ATP and LRRK2 are shown as yellow dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300452p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To investigate the validity of the LRRK2 model for structure-based design purposes, extensive docking studies on a diverse set of LRRK2 inhibitors, including those reported in the literature<a onclick="showRef(event, 'ref29 ref38'); return false;" href="javascript:void(0);" class="ref ref29 ref38">(29, 38)</a> and those found in the high-throughput screen, were initiated. Reasonable docking models could be generated for most of the LRRK2 inhibitors either by using the automatic docking program Glide (Schrödinger, Inc.)<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> or by manually docking inhibitors in the LRRK2 homology model. The side chain conformations of Arg1957 and Gln1961 prevented the docking of some inhibitors, so a second LRRK2 model was generated by moving these mobile side chains out of the inhibitor binding site (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). These two models were used in lieu of a crystal structure to guide our design efforts.</div><div class="NLM_p">Identification of molecular basis that determines kinase selectivity<a onclick="showRef(event, 'ref40 ref41 ref42 ref43 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43 ref44 ref45">(40-45)</a> is an important aspect of kinase drug discovery research because of the highly conserved kinase domain structures and ATP binding sites across the human kinome.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> LRRK2 KD has low sequence identity to other protein kinases and even its closest related family member, LRRK1,<a onclick="showRef(event, 'ref28 ref47'); return false;" href="javascript:void(0);" class="ref ref28 ref47">(28, 47)</a> has a KD sequence identity of only 32% (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The ATP-binding site of LRRK2, however, is more conserved and has much higher sequence identity to other protein kinases. In an effort to identify protein residues that could impart kinase selectivity, a detailed binding site sequence analysis was performed (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Out of the 19 binding site residues whose side chains could potentially interact with ATP-competitive inhibitors, six are conserved in over 400 kinases, five are conserved in 200–300 kinases, and eight are conserved in less than 150 kinases. To identify residues with the highest likelihood to confer selectivity against other kinases, we analyzed the relative locations, accessibility, and properties of the eight least conserved residues and narrowed the list down to four residues: Phe1883, Leu1949, Ser1954, and Arg1957.</div><div class="NLM_p last">Phe1883 is removed from the ATP-binding site and at the interface of the solvent exposed region. This residue is something other than phenylalanine in over 350 kinases and could perhaps be contacted by inhibitors with larger groups. Leu1949 presents the most attractive selectivity handle because of its proximity to the hinge binding moiety and its shorter side chain relative to the dominant Phe or Tyr side chains in approximately 290 other kinases.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a> The smaller Leu side chain creates a small cavity in LRRK2 that is not present in most other kinases and could be exploited to improve kinase selectivity. Similarly, there are over 230 kinases with a side chain larger than Ser1954, and of those, 200 have either a Glu or Asp side chain. Arg1957 provides another residue to target for selectivity with approximately 200 kinases containing a negatively charged Asp or Glu side chain. We hypothesized that targeting one or more of these four residues was a good strategy<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> to achieve general kinase selectivity and potency of the small molecule inhibitors.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Identification of Selectivity Hotspot through Matched-Pair Analysis</h3><div class="NLM_p">The triazolopyridine hit <b>1</b> was an attractive starting point for further optimization owing to its good LRRK2 potency (<i>K</i><sub>i</sub> = 20 nM) and high ligand efficiency (LE = 0.42); however, it was found to inhibit JAK2 with a <i>K</i><sub>i</sub> of 3 nM. To evaluate whether JAK2 selectivity could be achieved in this series, a substructure search of our internal compound library using the unsubstituted version of <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, R<sub>1</sub>–R<sub>5</sub> = H) was performed. One-hundred compounds containing the substructure were tested in a JAK2 inhibition assay, and the data were analyzed using MMP<a onclick="showRef(event, 'ref51 ref52 ref53 ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53 ref54 ref55 ref56">(51-56)</a> to uncover structural features associated with significantly reduced JAK2 potency.</div><div class="NLM_p">For the matched-pair analysis, a Tanimoto similarity coefficient of 0.94 was used as a cutoff to identify closely related pairs. The cutoff JAK2 <i>K</i><sub>i</sub> for being considered inactive was 250 nM. Out of the 100 tested compounds, 320 compound pairs were identified that met the chemical space similarity criteria. For a pair to be considered to have an activity cliff, the biological activity ratio had to be at least 2 orders of magnitude. Only four pairs met the activity ratio criteria as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Three of the four pairs (A, B, and C) involved a replacement of the hydroxyl (R<sub>4</sub>) with a hydrogen, methyl, or methyl sulfone, all of which led to a significant loss of JAK2 activity. The last pair (D, compounds <b>1</b> and <b>8</b>) was not substituted in the same manner as the other three pairs. An additional methyl group on the aniline (R<sub>2</sub>) portion of compound <b>8</b> greatly reduced the activity of the inhibitor against JAK2 in comparison to compound <b>1</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Matched-Pair Activity Cliffs Identified from the Triazolopyridine JAK2 Activity Cliff Analysis</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0013.gif" alt="" id="GRAPHIC-d2241e557-autogenerated" /></img><div></div></div><div class="NLM_p">Compound <b>1</b> was docked to the ATP-binding site of the LRRK2 homology model. Models of this compound in the ATP-binding site of LRRK2 and JAK2 are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A and Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B. Several key interactions could account for the excellent LRRK2 and JAK2 potency of <b>1</b>. The 2-aminotriazole core binds to the adenine site and forms a pair of strong hydrogen bonds to the hinge backbone in addition to numerous hydrophobic interactions with residues above and below the core. The 3,5-dimethyl-4-phenol moiety binds in the mostly hydrophilic back pocket, with the hydroxyl accepting one hydrogen bond from the conserved catalytic Lys1906 while donating one to the conserved Glu1920 in helix C of LRRK2 (residues Lys882 and Glu898 of JAK2). The phenol ring also makes hydrophobic interactions with gatekeeper Met1947 in LRRK2 and Met929 in JAK2. The unsubstituted aniline ring binds to a hydrophobic channel that leads to the solvent exposed region of the ATP site in both proteins. On the basis of this binding mode, replacement of the 4-hydroxyl of the phenol would be difficult, since it acts as both a donor and acceptor to two highly conserved catalytic residues. All three matched-pair compounds <b>4</b>, <b>6</b>, and <b>7</b> involved replacement of this hydroxyl which resulted in significant loss in JAK2 potency. As this subpocket of LRRK2 is nearly identical to that of JAK2, a similar loss in LRRK2 potency would be expected to occur.</div><div class="NLM_p">The loss in activity in the last matched pair (D), does not involve a hydroxyl replacement but rather an addition of a methyl to the aniline portion of the molecule. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B, the unsubstituted aniline of compound <b>1</b> fits tightly against the JAK2 protein surface formed by the hinge and side chain of Tyr931. An ortho-methyl substitution on the phenyl ring could clash with Tyr931 and cause a significant drop in JAK2 potency. This observation is consistent with the 135-fold drop in JAK2 activity seen in compound <b>8</b>. An inspection of the LRRK2 protein surface (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A) indicates that the methyl of compound <b>8</b> might fit well in the pocket created by the smaller side chain of Leu1949 in LRRK2, a key selectivity residue that was suggested by the ATP binding site analysis. Indeed, compound <b>8</b> was 2-fold more potent (<i>K</i><sub>i</sub> ≈ 10 nM) than compound <b>1</b> in the LRRK2 binding assay, indicating that the pocket formed by Leu1949 can provide a selectivity handle.</div><div class="NLM_p">In an effort to confirm that JAK2 selectivity is a good indicator of overall kinase selectivity in this series, compound <b>8</b> was tested against an Invitrogen panel of 63 kinases (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information Table 1">Supporting Information Table 1</a>). Consistent with the hypothesis, compound <b>8</b> was very selective and only inhibited one kinase (Abl) in addition to wild-type and mutant G2019S LRRK2 at greater than 50% inhibition at 1 μM. These data strongly support the proposed binding mode and the hypothesis that general kinase selectivity can be achieved in this series by introducing small groups in the vicinity of the Leu1949 side chain. However, optimization of the triazolopyridine scaffold was not pursued because of difficulties in maintaining potency and good physicochemical properties while replacing the 3,5-dimethyl-4-hydroxyphenyl moiety.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Docking model of compound <b>1</b> (green) in LRRK2 binding site. Key hydrogen bonds are shown in yellow dashed lines. Solvent accessible surface is shown in pink. (B) Docking model of compound <b>1</b> in JAK2. (C) Overlay of compound <b>1</b> (green) and <b>8</b> (magenta) docking models in LRRK2 (colored in white with L1949 in green). The side chain of Y931 of JAK2 is also shown and colored in cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300452p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Optimization of the Diaminopyrimidines</h3><div class="NLM_p">The diaminopyrimidine series identified in the HTS campaign (<b>2</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) had excellent biochemical potency and ligand efficiency. The physicochemical properties also represented reasonable starting points for a series designed to cross the blood–brain barrier. However, for this scaffold to advance as a lead series, significant improvement of the selectivity profile was needed.</div><div class="NLM_p">The suggested binding mode of compound <b>2</b> in the LRRK2 homology model is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A. The 2,4-diaminopyrimidine core binds to the adenine site and interacts with the kinase hinge through a pair of hydrogen bonds to the backbone amide NH and carbonyl oxygen of Ala1950. According to our model, the C5 chlorine forms favorable van der Waals interactions with the Met1947 gatekeeper side chain, and the C4 N-methyl fills a hydrophobic cavity. The carbonyl oxygen of the amide group forms a weak hydrogen bond with the guanidinium side chain of Arg1957, with nonideal hydrogen bond geometry. The aniline ring binds in a flat hydrophobic cleft along the hinge near the opening of the ATP-binding site with the 4-morpholinoamide group pointing toward the side chain of Phe1883.</div><div class="NLM_p">On the basis of the docking model, we hypothesized the following: (1) the front pocket morpholino amide could possibly be removed without a significant impact on LRRK2 potency; (2) compound <b>2</b> might be a nonselective kinase inhibitor, since it binds to the same hinge region as compound <b>1</b> and does not access the Leu1949 selectivity pocket; (3) the selectivity of this class of compounds could be significantly improved by ortho-substitution on the aniline ring. Compound <b>2</b> was tested in the JAK2 assay and found to be a potent inhibitor of JAK2 kinase activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The truncated compound <b>9</b> was also tested in both the LRRK2 and JAK2 binding assays (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Loss of the morpholino amide resulted in a 2-fold loss in potency against LRRK2 and a 9-fold loss in potency against JAK2. These data suggested that the molecular weight and TPSA of this series could be significantly reduced and that this series could lead to the discovery of compounds with properties consistent with CNS penetration.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Docking model of compound <b>2</b> (green) in LRRK2 binding site. (B) Overlay of docking models of compound <b>11</b> (magenta) and <b>15</b> (green) in LRRK2 binding site. Intermolecular hydrogen bonds are shown as dashed yellow lines, while the solvent accessible surface is shown in pink. Leu1949 is shown in light green sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300452p&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Using knowledge of structure–selectivity relationships gained from the triazolopyridines, a methyl group was installed in the ortho position of the aniline moiety in the truncated series (compound <b>10</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Although there was a slight loss in potency against LRRK2, significant selectivity against JAK2 was achieved. It appeared from the homology model that the pocket near Leu1949 was small and that large groups, such as a phenyl, would not fit. Small substituents were tolerated to varying degrees (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The methyl (<b>10</b>) and Br (<b>12</b>) substitutions caused a 2- to 3-fold drop in LRRK2 potency, while the methoxy (<b>11</b>) and difluoromethoxy (<b>13</b>) groups led to slight improvement in LRRK2 potency. More importantly, all of the ortho-substituted compounds, <b>10</b>–<b>13</b>, achieved greater than 97-fold selectivity over JAK2 in comparison to the unsubstituted compound <b>9</b>. These same trends were observed when the same ortho-substitutions were incorporated into the original HTS hit (<b>14</b>–<b>16</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). First, the morpholinoamide analogues had the same potency rank order seen with the truncated analogues. The slight loss in activity seen with compound <b>9</b> was regained with the addition of the morpholinoamide. Second, the compounds were very selective against JAK2, with the methoxy substituent achieving over 1000-fold selectivity against JAK2. This result supports the idea that the methoxy group fits favorably in the pocket near Leu1949.</div><div class="NLM_p">To further confirm that filling the Leu1949 pocket maintained selectivity against JAK2, several substitutions were made at the C5 position of the pyrimidine core (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). As predicted by the binding mode of compound <b>2</b>, R<sub>1</sub> can modulate the LRRK2 biochemical potency (<b>17</b>–<b>20</b>) through van der Waals interactions, conformational preference, and electronic effects, without having any obvious impact on JAK2 activity. Replacement with the smaller and more electronegative fluorine (<b>18</b>) reduced LRRK2 activity by 24-fold and substitution with a nitrile (<b>20</b>) by 4-fold. Interestingly, replacement with a bromine (<b>17</b>) or CF<sub>3</sub> (<b>19</b>) increased potency by 3-fold. Compound <b>15</b> was tested against a panel of 63 kinases at Invitrogen (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information Table 1">Supporting Information Table 1</a>). As shown previously with compound <b>8</b>, compound <b>15</b> inhibits only wild-type and G2019S mutant LRRK2 at greater than 50% inhibition at 1 μM and it does not inhibit Abl. This result further validated the hypothesis that installation of substituents in the small selectivity pocket near Leu1949 could impart general kinase selectivity.</div><div class="NLM_p">As there is a critical need for a potent, selective, and brain penetrable LRRK2 tool compound, the ability of compound <b>15</b> to cross the blood–brain barrier in rodents was assessed based on its favorable physicochemical properties (cLogP, TPSA, and CNS MPO score of 1.9, 88 Å<sup>2</sup>, and 5.4, respectively). <b>15</b> was evaluated in wild-type (FVB) and P-gp/BCRP knockout mice<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57, 58)</a> following a 1 mg/kg intravenous injection. The total brain to plasma AUC ratios and the unbound brain to unbound plasma AUC ratios were 1.4 and 0.61, respectively, in wild-type and 2.9 and 1.3, respectively, in P-gp/Bcrp knockout mice. The half-life (<i>T</i><sub>1/2</sub>) was 0.23 h. At 1 h following 30 mg/kg intraperitoneal injection in wild-type mouse, the total and unbound plasma concentrations of compound <b>15</b> were 8.4 and 1.1 μM, respectively, and the total and unbound brain concentrations were 6.2 and 0.37 μM, respectively. While these data suggest that P-gp and/or Bcrp slightly restrict the brain penetration in mice for <b>15</b>, it clearly demonstrates that this compound achieves desirable brain penetration for use as a tool compound in animal models of PD.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. LRRK2 Activity and JAK2 Selectivity of Ortho-Substituted Front Pocket Phenyl Diaminopyrimidines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0011.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>K</i><sub>i</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">LRRK2</th><th class="colsep0 rowsep0" align="center" char=".">JAK2</th><th class="colsep0 rowsep0" align="center" char=".">JAK2/LRRK2 index</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">0.064</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.020</td><td class="colsep0 rowsep0" align="char" char=".">>3.2</td><td class="colsep0 rowsep0" align="char" char=".">>160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">>3.2</td><td class="colsep0 rowsep0" align="char" char=".">>533</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char=".">0.033</td><td class="colsep0 rowsep0" align="char" char=".">>3.2</td><td class="colsep0 rowsep0" align="char" char=".">>97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">OCHF<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char=".">>3.2</td><td class="colsep0 rowsep0" align="char" char=".">>457</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. LRRK2 Activity and JAK2 Selectivity of Ortho-Substituted Front Pocket Phenyl Morpholinoamide Diaminopyrimidines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0001.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>K</i><sub>i</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char=".">LRRK2</th><th class="colsep0 rowsep0" align="center" char=".">JAK2</th><th class="colsep0 rowsep0" align="center" char=".">JAK2/LRRK2 index</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char=".">>3.2</td><td class="colsep0 rowsep0" align="char" char=".">>457</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">>3.2</td><td class="colsep0 rowsep0" align="char" char=".">>1067</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char=".">0.013</td><td class="colsep0 rowsep0" align="char" char=".">>3.2</td><td class="colsep0 rowsep0" align="char" char=".">>246</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">>3000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.071</td><td class="colsep0 rowsep0" align="char" char=".">>3.2</td><td class="colsep0 rowsep0" align="char" char=".">>45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">>3.2</td><td class="colsep0 rowsep0" align="char" char=".">>3200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.013</td><td class="colsep0 rowsep0" align="char" char=".">>3.2</td><td class="colsep0 rowsep0" align="char" char=".">>246</td></tr></tbody></table></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Chemistry</h3><div class="NLM_p">The target compounds were synthesized as depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Commercially available 2,4-dichloropyrimidines were reacted with 8 M methylamine in ethanol at room temperature to produce intermediates <b>26</b>–<b>30</b>. 2,5-Dichloro-<i>N</i>-methylpyrimidin-4-amine <b>27</b> and appropriately substituted anilines were suspended in <i>n</i>-butanol and subjected to microwave irradiation to yield products <b>9</b>–<b>13</b>.</div><div class="NLM_p">The appropriately substituted 4-aminobenzoic acids were coupled to morpholine using standard amide bond chemistry to generate intermediates <b>31</b>–<b>34</b>. These intermediates were then coupled to the proper 2-chloropyrimidine, <b>26</b>–<b>30</b>, via acid catalyzed S<sub>N</sub>Ar to yield products <b>2</b> and <b>14</b>–<b>20</b>.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300452p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 8 M methylamine in ethanol, methanol; (b) Ar-NH<sub>2</sub>, <i>n</i>-butanol; (c) TFA, 2-methoxyethanol.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58852" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58852" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In the absence of LRRK2 KD crystal structures, we relied on homology modeling as a viable way to provide a 3D LRRK2 model that can be used for structure-based design. The choice of structural templates proved to be critical to yield a model robust for structure-based design. We found that structures with the highest sequence identity to LRRK2 (e.g., MLK1, Tie2, Braf) were not the best choice for homology modeling owing to factors such as paucity of high resolution cocomplex structures, partially hindered binding sites or conformational states not represented in target protein. What proved particularly useful was the analysis of available selectivity data, which revealed an unexpected correlation between inhibition of JAK3/2 and LRRK2. This result led to the choice of JAK2 as a structural template for modeling despite relatively low sequence identity (26%) between LRRK2 and JAK2. The particular choice of JAK2 structure can also have an impact on the robustness of the homology model. We chose a high resolution JAK2 structure with an open ATP-binding site, which proved very useful for docking a diverse set of LRRK2 small molecule inhibitors. The LRRK2 homology models have been used in conjunction with binding site sequence analysis and MMP activity cliff analysis to identify residues that can potentially impart general kinase selectivity. One such residue is Leu1949, which is mostly a Phe or Tyr in other protein kinases. By incorporation of small substituents on an otherwise nonselective kinase inhibitor to reach the small selectivity pocket created by Leu1949 in LRRK2, broad kinase selectivity can be achieved. Through molecular modeling guided medicinal chemistry efforts, the nonselective 2,4-diaminopyridine hit <b>2</b> was optimized into a promising lead series and compounds in this series are being used to probe the link between LRRK2 kinase activity and Parkinson’s disease. Details of this work are forthcoming.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77344" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77344" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General Methods</h3><div class="NLM_p last">All solvents and reagents were used as obtained from the commercial vendors. Intermediates were purified on a Teledyne ISCO CombiFlash system using prepacked silica gel columns using appropriate gradients of ethyl acetate and heptane unless otherwise noted. All final products were purified by preparative reverse phase HPLC using appropriate gradients of acetonitrile and water with 0.05% formic acid as the counterion. All tested compounds were determined to be >95% pure by high-performance liquid chromatography under the following conditions: system, Agilent 1200 series HPLC instrument equipped with an Agilent 6140 quadrapole mass spectrometer; column, Agilent C18 (2.1 mm × 30 mm, 1.8 μm); flow rate 0.4 mL/min; mobile phase A, deionized water; mobile phase B, 0.05% trifluoroacetic acid in acetonitrile; gradient, 3% B (0–0.5 min), 3–95% B (0.5–7.0 min), 95% B (7.0–7.5 min), 3% B (7.5–7.6 min). Purity was calculated as a percentage of total areas at 254 nm. <sup>1</sup>H NMR spectra were recorded using a Bruker Avance III 400 MHz or Bruker Avance III 500 MHz spectrometer. Chemical shifts are in parts per million (δ) referenced to Me<sub>4</sub>Si (0.00 ppm). Liquid chromatography electrospray mass spectra were recorded using a Sciex 150EX LC–MS system with a Shimadzu LC10AD liquid chromatograph.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 2-Chloro-5-fluoro-<i>N</i>-methylpyrimidin-4-amine (<b>26</b>)</h3><div class="NLM_p">Methylamine (8 M in ethanol, 15 mL, 120 mmol) was added to 5-fluoro-2,4-dichloropyrimidine (<b>21</b>, 9.0 g, 53.9 mmol) in methanol (40 mL). The mixture was stirred at room temperature and then concentrated under reduced pressure. The residue was purified by silica gel chromatography using a methanol/dichloromethane gradient of 1–10% over 35 min to give pure 2-chloro-5-fluoro-<i>N</i>-methylpyrimidin-4-amine (<b>26</b>, 6.77 g, 77.7%) as an off white solid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 8.14 (s, 1H), 8.04 (d, <i>J</i> = 3.5 Hz, 1H), 2.85 (d, <i>J</i> = 4.6 Hz, 3H); ESMS <i>m</i>/<i>z</i> 162.6 (M + 1).</div><div class="NLM_p last">In a similar fashion, the following intermediates were synthesized from the appropriate starting materials using the procedure for <b>26</b>.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 2,5-Dichloro-<i>N</i>-methylpyrimidin-4-amine (<b>27</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO) δ 8.13 (s, 1H), 2.87 (d, <i>J</i> = 4.6 Hz, 4H); ESMS <i>m</i>/<i>z</i> 178.9 (M + 1).</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 2-Chloro-4-(methylamino)pyrimidine-5-carbonitrile (<b>28</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.31 (s, 1H), 5.74 (s, 1H), 3.34 (d, <i>J</i> = 5 Hz, 3H); ESMS <i>m</i>/<i>z</i> 171.7 (M + 1).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-Chloro-<i>N</i>-methyl-5-(trifluoromethyl)pyrimidin-4-amine (<b>29</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.37 (s, 1H), 7.91 (s, 1H), 2.90 (d, <i>J</i> = 4.5 Hz, 3H); ESMS <i>m</i>/<i>z</i> 212.1 (M + 1).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 5-Bromo-2-chloro-<i>N</i>-methylpyrimidin-4-amine (<b>30</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.21 (s, 1H), 7.71 (s, 1H), 2.86 (d, <i>J</i> = 4.6 Hz, 4H); ESMS <i>m</i>/<i>z</i> 224.0 (M + 1).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 5-Chloro-<i>N</i><sup>4</sup>-methyl-<i>N</i><sup>2</sup>-phenylpyrimidine-2,4-diamine (<b>9</b>)</h3><div class="NLM_p">2,5-Dichloro-<i>N</i>-methylpyrimidin-4-amine (<b>27</b>, 0.06 g, 0.337 mmol), aniline (0.063 g, 0.674 mmol), and <i>n</i>-butanol (0.8 mL) were placed in a 10 mL CEM microwave vial. The vial was capped and irradiated in a CEM microwave reactor for 20 min at 150 °C followed by concentration under reduced pressure. The residue was purified by preparative reverse phase HPLC to give 5-chloro-<i>N</i><sup>4</sup>-methyl-<i>N</i><sup>2</sup>-phenylpyrimidine-2,4-diamine (<b>9</b>, 0.0076 g, 9.6%) as an off white solid: <sup>1</sup>H NMR (500 MHz, DMSO) δ 9.14 (s, 1H), 7.91 (s, 1H), 7.75 (d, <i>J</i> = 7.7 Hz, 2H), 7.30–7.19 (m, 2H), 7.13 (d, <i>J</i> = 3.9 Hz, 1H), 6.89 (t, <i>J</i> = 7.3 Hz, 1H), 2.92 (d, <i>J</i> = 4.6 Hz, 3H); ESMS <i>m</i>/<i>z</i> 235.0 (M + 1).</div><div class="NLM_p last">In a similar fashion, the following compounds were synthesized from the appropriate starting materials using the procedure for <b>9</b>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 5-Chloro-<i>N</i><sup>4</sup>-methyl-<i>N</i><sup>2</sup>-<i>o</i>-tolylpyrimidine-2,4-diamine (<b>10</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.20 (s, 1H), 7.80 (s, 1H), 7.56 (d, <i>J</i> = 7.9 Hz, 1H), 7.19–7.07 (m, 2H), 7.07–6.92 (m, 2H), 2.81 (d, <i>J</i> = 4.6 Hz, 3H), 2.21 (s, 3H); ESMS <i>m</i>/<i>z</i> 249.1 (M + 1).</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 5-Chloro-<i>N</i><sup>2</sup>-(2-methoxyphenyl)-<i>N</i><sup>4</sup>-methylpyrimidine-2,4-diamine (<b>11</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.30 (dd, <i>J</i> = 7.4, 2.0 Hz, 1H), 7.92 (s, 1H), 7.56 (s, 1H), 7.22 (d, <i>J</i> = 4.2 Hz, 1H), 7.04–6.97 (m, 1H), 6.93 (dd, <i>J</i> = 9.4, 3.8 Hz, 2H), 3.86 (s, 3H), 2.90 (d, <i>J</i> = 4.6 Hz, 3H); ESMS <i>m</i>/<i>z</i> 265.0 (M + 1).</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i><sup>2</sup>-(2-Bromophenyl)-5-chloro-<i>N</i><sup>4</sup>-methylpyrimidine-2,4-diamine (<b>12</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.08–7.97 (m, 2H), 7.89 (s, 1H), 7.62 (d, <i>J</i> = 8.0 Hz, 1H), 7.35 (t, <i>J</i> = 7.7 Hz, 1H), 7.22 (d, <i>J</i> = 4.3 Hz, 1H), 7.00 (t, <i>J</i> = 7.6 Hz, 1H), 2.85 (d, <i>J</i> = 4.6 Hz, 3H); ESMS <i>m</i>/<i>z</i> 314.9 (M + 1).</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 5-Chloro-<i>N</i><sup>2</sup>-(2-(difluoromethoxy)phenyl)-<i>N</i><sup>4</sup>-methylpyrimidine-2,4-diamine (<b>13</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.17–8.12 (m, 1H), 7.95 (s, 1H), 7.90 (s, 1H), 7.27–7.17 (m, 3H), 7.14 (t, <i>J</i> = 74 Hz, 1H), 7.09–7.02 (m, 1H), 2.87 (d, <i>J</i> = 4.6 Hz, 3H); ESMS <i>m</i>/<i>z</i> 301.0 (M + 1).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (4-Amino-3-methoxyphenyl)(morpholino)methanone (<b>33</b>)</h3><div class="NLM_p">4-Amino-3-methoxybenzoic acid (0.50 g, 2.99 mmol), <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride (1.43 g, 7.48 mmol), 1-hydroxybenzotriazole (0.606 g, 4.49 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (1.56 mL, 8.97 mmol), morpholine (2.608 mL, 29.9 mmol), and <i>N</i>,<i>N</i>-dimethylformamide (15 mL) were combined and stirred for 18 h at room temperature. The mixture was concentrated under reduced pressure and the residue partitioned between ethyl acetate (50 mL) and water (50 mL). The aqueous layer was extracted with ethyl acetate (30 mL), and the combined organic extracts were washed with saturated sodium chloride (30 mL), dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The residue was purified by silica gel chromatography using an ethyl acetate/heptane gradient of 0–100% over 15 min to give (4-amino-3-methoxyphenyl)(morpholino)methanone (<b>33</b>, 0.505 g, 71.4%) as a glassy solid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 6.85 (s, 1H), 6.80 (d, <i>J</i> = 8.0 Hz, 1H), 6.61 (d, <i>J</i> = 8.0 Hz, 1H), 5.12 (s, 2H), 3.77 (s, 3H), 3.57 (d, <i>J</i> = 4.2 Hz, 4H), 3.50 (d, <i>J</i> = 4.4 Hz, 4H); ESMS <i>m</i>/<i>z</i> 237.2 (M + 1).</div><div class="NLM_p last">In a similar fashion, the following intermediates were synthesized from the appropriate starting materials using the procedure for <b>33</b>.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (4-Aminophenyl)(morpholino)methanone (<b>31</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 7.13 (d, <i>J</i> = 8.3 Hz, 2H), 6.54 (d, <i>J</i> = 8.3 Hz, 2H), 5.49 (s, 2H), 3.57 (d, <i>J</i> = 4.5 Hz, 4H), 3.48 (d, <i>J</i> = 4.7 Hz, 4H); ESMS <i>m</i>/<i>z</i> 207.2 (M + 1).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (4-Amino-3-methylphenyl)(morpholino)methanone (<b>32</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 7.03 (s, 1H), 7.00 (d, <i>J</i> = 8.2 Hz, 1H), 6.58 (d, <i>J</i> = 8.1 Hz, 1H), 5.26 (s, 2H), 3.56 (d, <i>J</i> = 4.1 Hz, 4H), 3.48 (d, <i>J</i> = 4.2 Hz, 4H), 2.05 (s, 3H); ESMS <i>m</i>/<i>z</i> 221.3 (M + 1).</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (4-Amino-3-bromophenyl)(morpholino)methanone (<b>34</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 7.44 (s, 1H), 7.17 (d, <i>J</i> = 8.3 Hz, 1H), 6.80 (d, <i>J</i> = 8.3 Hz, 1H), 5.76 (s, 2H), 3.58 (d, <i>J</i> = 4.2 Hz, 4H), 3.50 (d, <i>J</i> = 4.0 Hz, 4H); ESMS <i>m</i>/<i>z</i> 285.1 (M + 1).</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (4-(5-Chloro-4-(methylamino)pyrimidin-2-ylamino)phenyl)(morpholino)methanone (<b>2</b>)</h3><div class="NLM_p">2,5-Dichloro-<i>N</i>-methylpyrimidin-4-amine (<b>27</b> 0.10 g, 0.562 mmol), (4-aminophenyl)(morpholino)methanone (<b>33</b>, 0.348 g, 1.69 mmol), trifluoroacetic acid (0.1 mL, 1.35 mmol), and 2-methoxyethanol (2 mL) were combined and heated for 18 h 125 °C. The mixture was concentrated under reduced pressure and the residue was purified by preparative reverse phase HPLC to give (4-(5-chloro-4-(methylamino)pyrimidin-2-ylamino)phenyl)(morpholino)methanone (<b>2</b>, 0.051 g, 25.8%) as an off white solid: <sup>1</sup>H NMR (400 MHz, DMSO) δ 9.46 (s, 1H), 7.95 (s, 1H), 7.83 (d, <i>J</i> = 8.6 Hz, 2H), 7.32 (d, <i>J</i> = 8.6 Hz, 2H), 7.25 (d, <i>J</i> = 4.6 Hz, 1H), 3.67–3.40 (m, 8H), 2.94 (t, <i>J</i> = 7.0 Hz, 3H); ESMS <i>m</i>/<i>z</i> 348.1 (M + 1).</div><div class="NLM_p last">In a similar fashion, the following compounds were synthesized from the appropriate starting materials using the procedure for <b>2</b>.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (4-(5-Chloro-4-(methylamino)pyrimidin-2-ylamino)-3-methylphenyl)(morpholino)methanone (<b>14</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.32 (s, 1H), 7.86 (s, 1H), 7.76 (d, <i>J</i> = 8.2 Hz, 1H), 7.23 (s, 1H), 7.19 (d, <i>J</i> = 8.3 Hz, 1H), 7.13 (d, <i>J</i> = 4.5 Hz, 1H), 3.54 (d, <i>J</i> = 38.0 Hz, 8H), 2.84 (d, <i>J</i> = 4.6 Hz, 3H), 2.26 (s, 3H); ESMS <i>m</i>/<i>z</i> 362.1 (M + 1).</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (4-(5-Chloro-4-(methylamino)pyrimidin-2-ylamino)-3-methoxyphenyl)(morpholino)methanone (<b>15</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.41 (d, <i>J</i> = 8.2 Hz, 1H), 7.96 (s, 1H), 7.68 (s, 1H), 7.32 (d, <i>J</i> = 4.1 Hz, 1H), 7.05 (s, 1H), 7.01 (d, <i>J</i> = 8.2 Hz, 1H), 3.90 (s, 3H), 3.56 (d, <i>J</i> = 34.5 Hz, 8H), 2.90 (t, <i>J</i> = 7.3 Hz, 3H); ESMS <i>m</i>/<i>z</i> 378.1 (M + 1).</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (3-Bromo-4-(5-chloro-4-(methylamino)pyrimidin-2-ylamino)phenyl)(morpholino)methanone (<b>16</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.21 (d, <i>J</i> = 8.5 Hz, 1H), 8.06 (s, 1H), 7.94 (s, 1H), 7.67 (d, <i>J</i> = 1.6 Hz, 1H), 7.41 (d, <i>J</i> = 8.5 Hz, 1H), 7.32 (d, <i>J</i> = 4.4 Hz, 1H), 3.55 (d, <i>J</i> = 41.3 Hz, 8H), 2.88 (d, <i>J</i> = 4.6 Hz, 3H); ESMS <i>m</i>/<i>z</i> 428.0 (M + 1).</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (4-(5-Bromo-4-(methylamino)pyrimidin-2-ylamino)-3-methoxyphenyl)(morpholino)methanone (<b>17</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.40 (d, <i>J</i> = 8.3 Hz, 1H), 8.04 (s, 1H), 7.68 (s, 1H), 7.14 (d, <i>J</i> = 4.6 Hz, 1H), 7.05 (d, <i>J</i> = 1.6 Hz, 1H), 7.01 (dd, <i>J</i> = 8.3, 1.6 Hz, 1H), 3.90 (s, 3H), 3.56 (d, <i>J</i> = 34.6 Hz, 8H), 2.90 (d, <i>J</i> = 4.6 Hz, 3H); ESMS <i>m</i>/<i>z</i> 422.0 (M + 1).</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (4-(5-Fluoro-4-(methylamino)pyrimidin-2-ylamino)-3-methoxyphenyl)(morpholino)methanone (<b>18</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.46 (d, <i>J</i> = 8.3 Hz, 1H), 7.89 (d, <i>J</i> = 3.6 Hz, 1H), 7.56 (d, <i>J</i> = 5.5 Hz, 2H), 7.04 (s, 1H), 7.00 (d, <i>J</i> = 8.3 Hz, 1H), 3.90 (s, 3H), 3.58 (d, <i>J</i> = 19.4 Hz, 4H), 3.52 (s, 3H), 2.90 (t, <i>J</i> = 7.7 Hz, 3H); ESMS <i>m</i>/<i>z</i> 362.1 (M + 1).</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (3-Methoxy-4-(4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)phenyl)(morpholino)methanone (<b>19</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.31 (d, <i>J</i> = 8.2 Hz, 1H), 8.19 (s, 1H), 8.07 (s, 1H), 7.21 (d, <i>J</i> = 4.3 Hz, 1H), 7.07 (s, 1H), 7.02 (d, <i>J</i> = 8.2 Hz, 1H), 3.90 (s, 3H), 3.56 (d, <i>J</i> = 37.1 Hz, 9H), 2.92 (d, <i>J</i> = 4.3 Hz, 3H); ESMS <i>m</i>/<i>z</i> 412.1 (M + 1).</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-(2-Bromo-4-(morpholine-4-carbonyl)phenylamino)-4-(methylamino)pyrimidine-5-carbonitrile (<b>20</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO) δ 8.33 (d, <i>J</i> = 5.9 Hz, 2H), 8.18 (d, <i>J</i> = 8.2 Hz, 1H), 7.76 (d, <i>J</i> = 4.3 Hz, 1H), 7.08 (d, <i>J</i> = 1.5 Hz, 1H), 7.04–6.97 (m, 1H), 3.88 (s, 3H), 3.56 (d, <i>J</i> = 37.1 Hz, 8H), 2.88 (d, <i>J</i> = 4.5 Hz, 3H); ESMS <i>m</i>/<i>z</i> 369.1 (M + 1).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Microfluidic Capillary Electrophoresis Assay</h3><div class="NLM_p last">LRRK2 reactions were carried out in a final volume of 10 μL per well in a 384-well microplate. A standard enzymatic mixture, for which the reaction was initiated by the addition of 5 μL of 2× ATP to 5 μL of 2× enzyme, contained 10 nM G2019S, 1 μM FAM-LRRKtide (5FAM-GAGRLGRDKYKTLRQIRQ-CONH<sub>2</sub>), 130 μM ATP, 25 mM Tris, pH 8.0, 5 mM MgCl<sub>2</sub>, 0.01% Triton X-100, 2 mM DTT, 5 mM β-glycerophosphate, 5 mM NaF,100 μM Na<sub>3</sub>VO<sub>4</sub>, and 1× protease inhibitor cocktail (Calbiochem). After incubation for 120 min at ambient temperature, the product and substrate in each reaction were separated using a 12-sipper microfluidic chip (Caliper Life Sciences, Hopkinton, MA) run on a Caliper LC3000 (Caliper Life Sciences, Hopkinton, MA). The separation of product and substrate was optimized by choosing voltages and pressure using Caliper’s optimizer software (Hopkinton, MA). The separation buffer contained 100 mM HEPES, pH 7.2, 0.015% Brij-35, 0.1% coating reagent 3, 10 mM EDTA, and 5% DMSO. The separation conditions used a downstream voltage of −500 V, an upstream voltage of −2350 V, and a screening pressure of −1.4 psi. The product and substrate fluorescence was excited at 488 nm and detected at 530 nm. Substrate conversion was calculated from the electrophoregram using HTS Well Analyzer software (Caliper Life Sciences, Hopkinton, MA).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Brain Penetration Protocol</h3><div class="NLM_p last">For the brain penetration studies, plasma and brain tissues were collected at 5 min and 1 h following the intravenous injection of compound <b>15</b> at 1 mg/kg in wild-type (FVB) and P-gp/Bcrp knockout mice (<i>n</i> = 3). The concentrations in the plasma and brain samples were determined by LC–MS/MS after sample treatment. The area under the curve (AUC) from time zero to 1 h was calculated using the trapezoidal rule. The mouse plasma and brain tissue binding were determined using equilibrium dialysis.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Molecular Modeling</h3><div class="NLM_p last">Homology models of LRRK2 were constructed using the modeling program MOE, version 2009.10 (Chemical Computing Group, Montreal),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and AMBER99<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> force field. The human LRRK2 sequence was retrieved from Swiss-Prot<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and aligned to template structure sequences using ClustalW<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> followed by manual fine-tuning of residues adjacent to loop regions, insertions, and deletions. The models were further refined with bound ligand using the Macromodel utility implemented in Maestro and OPLS2005 force field (Schrödinger, Inc., New York, NY).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Inhibitor docking studies were carried out using docking program Glide SP with one hydrogen bond constraint to the carbonyl oxygen of hinge residue Ala1950. The docking poses were evaluated based on a combination of criteria including the Glide docking score (cutoff = −6), favorable intermolecular interactions with the hinge and other parts of the ATP-binding pocket, low strain energy of the bound ligand (<i>E</i><sub>strain</sub> < 2 kcal/mol), etc.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Activity Cliff Analysis</h3><div class="NLM_p last">Activity cliff analysis was carried out using a Pipeline Pilot protocol (Accelrys Inc.)<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> that computes pairwise Tanimoto similarities and activity changes between all pairs of compounds. The Tanimoto similarities were calculated using extended connectivity fingerprints configured with counts (ECFC_2).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Only pairs that met a similarity cutoff of 0.94 were analyzed for activity cliffs.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41"><a href="/doi/suppl/10.1021/jm300452p">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Table 1 listing Invitrogen kinase selectivity profiling data. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300452p/suppl_file/jm300452p_si_001.pdf">jm300452p_si_001.pdf (82.34 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm300452p" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huifen Chen</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry Department, ‡Biochemical and Cellular Pharmacology Department, §Drug Metabolism and Pharmacokinetics
Department, and ∥Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f09398959ede98859996959eb097959e95de939f9dd09285829499939bde94919eb097959e95de939f9d"><span class="__cf_email__" data-cfemail="99faf1fcf7b7f1ecf0fffcf7d9fefcf7fcb7faf6f4">[email protected]</span> <span class="__cf_email__" data-cfemail="cba9beb9afa2a8a0e5afaaa58bacaea5aee5a8a4a6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel J. Burdick</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry Department, ‡Biochemical and Cellular Pharmacology Department, §Drug Metabolism and Pharmacokinetics
Department, and ∥Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#90f3f8f5febef8e5f9f6f5fed0f7f5fef5bef3fffdb0f2e5e2f4f9f3fbbef4f1fed0f7f5fef5bef3fffd"><span class="__cf_email__" data-cfemail="34575c515a1a5c415d52515a7453515a511a575b59">[email protected]</span> <span class="__cf_email__" data-cfemail="dcbea9aeb8b5bfb7f2b8bdb29cbbb9b2b9f2bfb3b1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan K. Chan</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry Department, ‡Biochemical and Cellular Pharmacology Department, §Drug Metabolism and Pharmacokinetics
Department, and ∥Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason Drummond</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry Department, ‡Biochemical and Cellular Pharmacology Department, §Drug Metabolism and Pharmacokinetics
Department, and ∥Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony A. Estrada</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry Department, ‡Biochemical and Cellular Pharmacology Department, §Drug Metabolism and Pharmacokinetics
Department, and ∥Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janet Gunzner-Toste</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry Department, ‡Biochemical and Cellular Pharmacology Department, §Drug Metabolism and Pharmacokinetics
Department, and ∥Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xingrong Liu</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry Department, ‡Biochemical and Cellular Pharmacology Department, §Drug Metabolism and Pharmacokinetics
Department, and ∥Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yichin Liu</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry Department, ‡Biochemical and Cellular Pharmacology Department, §Drug Metabolism and Pharmacokinetics
Department, and ∥Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Moffat</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry Department, ‡Biochemical and Cellular Pharmacology Department, §Drug Metabolism and Pharmacokinetics
Department, and ∥Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Shore</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry Department, ‡Biochemical and Cellular Pharmacology Department, §Drug Metabolism and Pharmacokinetics
Department, and ∥Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zachary K. Sweeney</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry Department, ‡Biochemical and Cellular Pharmacology Department, §Drug Metabolism and Pharmacokinetics
Department, and ∥Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thuy Tran</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry Department, ‡Biochemical and Cellular Pharmacology Department, §Drug Metabolism and Pharmacokinetics
Department, and ∥Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shumei Wang</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry Department, ‡Biochemical and Cellular Pharmacology Department, §Drug Metabolism and Pharmacokinetics
Department, and ∥Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guiling Zhao</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry Department, ‡Biochemical and Cellular Pharmacology Department, §Drug Metabolism and Pharmacokinetics
Department, and ∥Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haitao Zhu</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry Department, ‡Biochemical and Cellular Pharmacology Department, §Drug Metabolism and Pharmacokinetics
Department, and ∥Neuroscience Department, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2241e2015-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Drs. Nicholas Skelton and Steven Magnuson for critical reading of the manuscript and helpful discussions. We also thank the analytical, bioanalytical, NMR, pharmacokinetic, and biopharmacology colleagues for their assistance with compound purification and testing.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i43" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i43"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i44" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i44"> Abbreviations Used</h2><tr><td class="NLM_term">LRRK2</td><td class="NLM_def"><p class="first last">leucine-rich repeat kinase 2</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">JAK2</td><td class="NLM_def"><p class="first last">Janus kinase 2</p></td></tr><tr><td class="NLM_term">JAK3</td><td class="NLM_def"><p class="first last">Janus kinase 3</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matched molecular pair</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">KD</td><td class="NLM_def"><p class="first last">kinase domain</p></td></tr><tr><td class="NLM_term">SBDD</td><td class="NLM_def"><p class="first last">structure-based drug design</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71202" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71202" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 62 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_contrib-group">Lees, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revesz, T.</span><span> </span><span class="NLM_article-title">Parkinson’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">2055</span><span class="NLM_x">–</span> <span class="NLM_lpage">2066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2009&pages=2055-2066&author=A.+J.+Leesauthor=J.+Hardyauthor=T.+Revesz&title=Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DA.%2BJ.%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DRevesz%26aufirst%3DT.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2009%26volume%3D373%26spage%3D2055%26epage%3D2066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span>Erratum in  <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">684</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Erratum+in+Lancet+2009%2C+374%2C+684."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DLancet%26date%3D2009%26volume%3D374%26spage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Zimprich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincoln, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachergus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulihan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoessl, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patenge, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbajal, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieregge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asmus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Myhsok, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meitinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wszolek, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span> </span><span class="NLM_article-title">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1016%2Fj.neuron.2004.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=15541309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=601-607&author=A.+Zimprichauthor=S.+Biskupauthor=P.+Leitnerauthor=P.+Lichtnerauthor=M.+Farrerauthor=S.+Lincolnauthor=J.+Kachergusauthor=M.+Hulihanauthor=R.+J.+Uittiauthor=D.+B.+Calneauthor=A.+J.+Stoesslauthor=R.+F.+Pfeifferauthor=N.+Patengeauthor=I.+C.+Carbajalauthor=P.+Viereggeauthor=F.+Asmusauthor=B.+Muller-Myhsokauthor=D.+W.+Dicksonauthor=T.+Meitingerauthor=T.+M.+Stromauthor=Z.+K.+Wszolekauthor=T.+Gasser&title=Mutations+in+LRRK2+cause+autosomal-dominant+parkinsonism+with+pleomorphic+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span></div><div class="casAuthors">Zimprich, Alexander; Biskup, Saskia; Leitner, Petra; Lichtner, Peter; Farrer, Matthew; Lincoln, Sarah; Kachergus, Jennifer; Hulihan, Mary; Uitti, Ryan J.; Calne, Donald B.; Stoessl, A. Jon; Pfeiffer, Ronald F.; Patenge, Nadja; Carbajal, Iria Carballo; Vieregge, Peter; Asmus, Friedrich; Mueller-Myhsok, Bertram; Dickson, Dennis W.; Meitinger, Thomas; Strom, Tim M.; Wszolek, Zbigniew K.; Gasser, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have previously linked families with autosomaldominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8).  By high-resoln. recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2).  It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains.  Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies.  These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathol., and progressive supranuclear palsy-like pathol.  Clin. diagnoses of Parkinsonism with dementia or amyotrophy or both, with their assocd. pathologies, are also noted.  Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders assocd. with parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9aK6wacZJhbVg90H21EOLACvtfcHk0lgk1QQu9qPdRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL&md5=9ae4c87ce3172e29829e317d94b5cdaa</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2004.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2004.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DZimprich%26aufirst%3DA.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DLeitner%26aufirst%3DP.%26aulast%3DLichtner%26aufirst%3DP.%26aulast%3DFarrer%26aufirst%3DM.%26aulast%3DLincoln%26aufirst%3DS.%26aulast%3DKachergus%26aufirst%3DJ.%26aulast%3DHulihan%26aufirst%3DM.%26aulast%3DUitti%26aufirst%3DR.%2BJ.%26aulast%3DCalne%26aufirst%3DD.%2BB.%26aulast%3DStoessl%26aufirst%3DA.%2BJ.%26aulast%3DPfeiffer%26aufirst%3DR.%2BF.%26aulast%3DPatenge%26aufirst%3DN.%26aulast%3DCarbajal%26aufirst%3DI.%2BC.%26aulast%3DVieregge%26aufirst%3DP.%26aulast%3DAsmus%26aufirst%3DF.%26aulast%3DMuller-Myhsok%26aufirst%3DB.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DStrom%26aufirst%3DT.%2BM.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DGasser%26aufirst%3DT.%26atitle%3DMutations%2520in%2520LRRK2%2520cause%2520autosomal-dominant%2520parkinsonism%2520with%2520pleomorphic%2520pathology%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D601%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Paisan-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilks, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez de Munain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparicio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrera, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Silva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marti-Masso, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Tur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A. B.</span><span> </span><span class="NLM_article-title">Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=595-600&author=C.+Paisan-Ruizauthor=S.+Jainauthor=E.+W.+Evansauthor=W.+P.+Gilksauthor=J.+Simonauthor=M.+van+der+Brugauthor=A.+Lopez+de+Munainauthor=S.+Aparicioauthor=A.+M.+Gilauthor=N.+Khanauthor=J.+Johnsonauthor=J.+R.+Martinezauthor=D.+Nichollauthor=I.+M.+Carreraauthor=A.+S.+Penaauthor=R.+de+Silvaauthor=A.+Leesauthor=J.+F.+Marti-Massoauthor=J.+Perez-Turauthor=N.+W.+Woodauthor=A.+B.+Singleton&title=Cloning+of+the+gene+containing+mutations+that+cause+PARK8-linked+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaisan-Ruiz%26aufirst%3DC.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DEvans%26aufirst%3DE.%2BW.%26aulast%3DGilks%26aufirst%3DW.%2BP.%26aulast%3DSimon%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%26aulast%3DLopez%2Bde%2BMunain%26aufirst%3DA.%26aulast%3DAparicio%26aufirst%3DS.%26aulast%3DGil%26aufirst%3DA.%2BM.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DJ.%2BR.%26aulast%3DNicholl%26aufirst%3DD.%26aulast%3DCarrera%26aufirst%3DI.%2BM.%26aulast%3DPena%26aufirst%3DA.%2BS.%26aulast%3Dde%2BSilva%26aufirst%3DR.%26aulast%3DLees%26aufirst%3DA.%26aulast%3DMarti-Masso%26aufirst%3DJ.%2BF.%26aulast%3DPerez-Tur%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DN.%2BW.%26aulast%3DSingleton%26aufirst%3DA.%2BB.%26atitle%3DCloning%2520of%2520the%2520gene%2520containing%2520mutations%2520that%2520cause%2520PARK8-linked%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D595%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Dachsel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span> </span><span class="NLM_article-title">LRRK2 and Parkinson disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1001%2Farchneurol.2010.79" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=20457952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A280%3ADC%252BC3czisFOrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=542-547&author=J.+C.+Dachselauthor=M.+J.+Farrer&title=LRRK2+and+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 and Parkinson disease</span></div><div class="casAuthors">Dachsel Justus C; Farrer Matthew J</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">542-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  To review the molecular genetics and functional biology of leucine-rich repeat kinase 2 (LRRK2) in parkinsonism and to summarize the opportunities and challenges to develop interventions for Parkinson disease (PD) based on this genetic insight.  DATA SOURCES:  Publications cited are focused on LRRK2 biology between 2004 and March 2009.  STUDY SELECTION:  Literature selected was based on original contributions, seminal observations, and thoughtful reviews.  DATA EXTRACTION:  Unless stated otherwise, data was primarily abstracted from peer-reviewed literature appearing on PubMed.  DATA SYNTHESIS:  Genetic mutations that predispose PD are diagnostically useful in early or atypical presentations.  The molecular pathways identified suggest therapeutic interventions for Lrrk2 and idiopathic PD and the rationale and opportunity to develop physiologically relevant biomarkers and experimental models with which to test them.  CONCLUSIONS:  Both affected and asymptomatic LRRK2 carriers now provide the opportunity to define the natural history of PD.  This includes the frequency, penetrance, and rate of motor symptoms, nonmotor comorbidities, and their associated biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3dH7Qk4jbtZPlX7E30qdzfW6udTcc2ebeY_vlvDY82rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czisFOrsQ%253D%253D&md5=7f08a3bbe3fc77c7d9bac287a1ff5316</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2010.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2010.79%26sid%3Dliteratum%253Aachs%26aulast%3DDachsel%26aufirst%3DJ.%2BC.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26atitle%3DLRRK2%2520and%2520Parkinson%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2010%26volume%3D67%26spage%3D542%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Satake, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakabayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuta, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsunoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obata, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakoda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, T.</span><span> </span><span class="NLM_article-title">Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1038%2Fng.485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=19915576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1303-1307&author=W.+Satakeauthor=Y.+Nakabayashiauthor=I.+Mizutaauthor=Y.+Hirotaauthor=C.+Itoauthor=M.+Kuboauthor=T.+Kawaguchiauthor=T.+Tsunodaauthor=M.+Watanabeauthor=A.+Takedaauthor=H.+Tomiyamaauthor=K.+Nakashimaauthor=K.+Hasegawaauthor=F.+Obataauthor=T.+Yoshikawaauthor=H.+Kawakamiauthor=S.+Sakodaauthor=M.+Yamamotoauthor=N.+Hattoriauthor=M.+Murataauthor=Y.+Nakamuraauthor=T.+Toda&title=Genome-wide+association+study+identifies+common+variants+at+four+loci+as+genetic+risk+factors+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease</span></div><div class="casAuthors">Satake, Wataru; Nakabayashi, Yuko; Mizuta, Ikuko; Hirota, Yushi; Ito, Chiyomi; Kubo, Michiaki; Kawaguchi, Takahisa; Tsunoda, Tatsuhiko; Watanabe, Masahiko; Takeda, Atsushi; Tomiyama, Hiroyuki; Nakashima, Kenji; Hasegawa, Kazuko; Obata, Fumiya; Yoshikawa, Takeo; Kawakami, Hideshi; Sakoda, Saburo; Yamamoto, Mitsutoshi; Hattori, Nobutaka; Murata, Miho; Nakamura, Yusuke; Toda, Tatsushi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1303-1307</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To identify susceptibility variants for Parkinson's disease (PD), we performed a genome-wide assocn. study (GWAS) and two replication studies in a total of 2,011 cases and 18,381 controls from Japan.  We identified a new susceptibility locus on 1q32 (P = 1.52 × 10-12) and designated this as PARK16, and we also identified BST1 on 4p15 as a second new risk locus (P = 3.94 × 10-9).  We also detected strong assocns. at SNCA on 4q22 (P = 7.35 × 10-17) and LRRK2 on 12q12 (P = 2.72 × 10-8), both of which are implicated in autosomal dominant forms of parkinsonism.  By comparing results of a GWAS performed on individuals of European ancestry, we identified PARK16, SNCA and LRRK2 as shared risk loci for PD and BST1 and MAPT as loci showing population differences.  Our results identify two new PD susceptibility loci, show involvement of autosomal dominant parkinsonism loci in typical PD and suggest that population differences contribute to genetic heterogeneity in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiCdi72L_e27Vg90H21EOLACvtfcHk0lidGf8h5-9QAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsb7O&md5=46e665390ca8166d83a4688d4f581cf5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fng.485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.485%26sid%3Dliteratum%253Aachs%26aulast%3DSatake%26aufirst%3DW.%26aulast%3DNakabayashi%26aufirst%3DY.%26aulast%3DMizuta%26aufirst%3DI.%26aulast%3DHirota%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DC.%26aulast%3DKubo%26aufirst%3DM.%26aulast%3DKawaguchi%26aufirst%3DT.%26aulast%3DTsunoda%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DTomiyama%26aufirst%3DH.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DObata%26aufirst%3DF.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DKawakami%26aufirst%3DH.%26aulast%3DSakoda%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DToda%26aufirst%3DT.%26atitle%3DGenome-wide%2520association%2520study%2520identifies%2520common%2520variants%2520at%2520four%2520loci%2520as%2520genetic%2520risk%2520factors%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Genet.%26date%3D2009%26volume%3D41%26spage%3D1303%26epage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Simón-Sánchez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bras, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paisan-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krüger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federoff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalls, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Illig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gieger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houlden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okun, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racette, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foote, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynor, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arepalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonozi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwinn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanock, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schatzkin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenbeck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuschl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riess, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span> </span><span class="NLM_article-title">Genome-wide association study reveals genetic risk underlying Parkinson’s disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1308</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1038%2Fng.487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=19915575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1308-1312&author=J.+Sim%C3%B3n-S%C3%A1nchezauthor=C.+Schulteauthor=J.+M.+Brasauthor=M.+Sharmaauthor=J.+R.+Gibbsauthor=D.+Bergauthor=C.+Paisan-Ruizauthor=P.+Lichtnerauthor=S.+W.+Scholzauthor=D.+G.+Hernandezauthor=R.+Kr%C3%BCgerauthor=M.+Federoffauthor=C.+Kleinauthor=A.+Goateauthor=J.+Perlmutterauthor=M.+Boninauthor=M.+A.+Nallsauthor=T.+Illigauthor=C.+Giegerauthor=H.+Houldenauthor=M.+Steffensauthor=M.+S.+Okunauthor=B.+A.+Racetteauthor=M.+R.+Cooksonauthor=K.+D.+Footeauthor=H.+H.+Fernandezauthor=B.+J.+Traynorauthor=S.+Schreiberauthor=S.+Arepalliauthor=R.+Zonoziauthor=K.+Gwinnauthor=M.+van+der+Brugauthor=G.+Lopezauthor=S.+J.+Chanockauthor=A.+Schatzkinauthor=Y.+Parkauthor=A.+Hollenbeckauthor=J.+Gaoauthor=X.+Huangauthor=N.+W.+Woodauthor=D.+Lorenzauthor=G.+Deuschlauthor=H.+Chenauthor=O.+Riessauthor=J.+A.+Hardyauthor=A.+B.+Singletonauthor=T.+Gasser&title=Genome-wide+association+study+reveals+genetic+risk+underlying+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide association study reveals genetic risk underlying Parkinson's disease</span></div><div class="casAuthors">Simon-Sanchez, Javier; Schulte, Claudia; Bras, Jose M.; Sharma, Manu; Gibbs, J. Raphael; Berg, Daniela; Paisan-Ruiz, Coro; Lichtner, Peter; Scholz, Sonja W.; Hernandez, Dena G.; Krueger, Rejko; Federoff, Monica; Klein, Christine; Goate, Alison; Perlmutter, Joel; Bonin, Michael; Nalls, Michael A.; Illig, Thomas; Gieger, Christian; Houlden, Henry; Steffens, Michael; Okun, Michael S.; Racette, Brad A.; Cookson, Mark R.; Foote, Kelly D.; Fernandez, Hubert H.; Traynor, Bryan J.; Schreiber, Stefan; Arepalli, Sampath; Zonozi, Ryan; Gwinn, Katrina; van der Brug, Marcel; Lopez, Grisel; Chanock, Stephen J.; Schatzkin, Arthur; Park, Yikyung; Hollenbeck, Albert; Gao, Jianjun; Huang, Xuemei; Wood, Nick W.; Lorenz, Delia; Deuschl, Guenther; Chen, Honglei; Riess, Olaf; Hardy, John A.; Singleton, Andrew B.; Gasser, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1308-1312</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We performed a genome-wide assocn. study (GWAS) in 1713 individuals of European ancestry with Parkinson's disease (PD) and 3978 controls.  After replication in 3361 cases and 4573 controls, we obsd. two strong assocn. signals, one in the gene encoding α-synuclein (SNCA; rs2736990, OR = 1.23, P = 2.24 × 10-16) and another at the MAPT locus (rs393152, OR = 0.77, P = 1.95 × 10-16).  We exchanged data with colleagues performing a GWAS in Japanese PD cases.  Assocn. to PD at SNCA was replicated in the Japanese GWAS, confirming this as a major risk locus across populations.  We replicated the effect of a new locus detected in the Japanese cohort (PARK16, rs823128, OR = 0.66, P = 7.29 × 10-8) and provide supporting evidence that common variation around LRRK2 modulates risk for PD (rs1491923, OR = 1.14, P = 1.55 × 10-5).  These data demonstrate an unequivocal role for common genetic variants in the etiol. of typical PD and suggest population-specific genetic heterogeneity in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1PHkVNrI1D7Vg90H21EOLACvtfcHk0lidGf8h5-9QAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsbrP&md5=7dae0abacbde642a41eb9d4899b8980d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fng.487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.487%26sid%3Dliteratum%253Aachs%26aulast%3DSim%25C3%25B3n-S%25C3%25A1nchez%26aufirst%3DJ.%26aulast%3DSchulte%26aufirst%3DC.%26aulast%3DBras%26aufirst%3DJ.%2BM.%26aulast%3DSharma%26aufirst%3DM.%26aulast%3DGibbs%26aufirst%3DJ.%2BR.%26aulast%3DBerg%26aufirst%3DD.%26aulast%3DPaisan-Ruiz%26aufirst%3DC.%26aulast%3DLichtner%26aufirst%3DP.%26aulast%3DScholz%26aufirst%3DS.%2BW.%26aulast%3DHernandez%26aufirst%3DD.%2BG.%26aulast%3DKr%25C3%25BCger%26aufirst%3DR.%26aulast%3DFederoff%26aufirst%3DM.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DPerlmutter%26aufirst%3DJ.%26aulast%3DBonin%26aufirst%3DM.%26aulast%3DNalls%26aufirst%3DM.%2BA.%26aulast%3DIllig%26aufirst%3DT.%26aulast%3DGieger%26aufirst%3DC.%26aulast%3DHoulden%26aufirst%3DH.%26aulast%3DSteffens%26aufirst%3DM.%26aulast%3DOkun%26aufirst%3DM.%2BS.%26aulast%3DRacette%26aufirst%3DB.%2BA.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26aulast%3DFoote%26aufirst%3DK.%2BD.%26aulast%3DFernandez%26aufirst%3DH.%2BH.%26aulast%3DTraynor%26aufirst%3DB.%2BJ.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DArepalli%26aufirst%3DS.%26aulast%3DZonozi%26aufirst%3DR.%26aulast%3DGwinn%26aufirst%3DK.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%26aulast%3DLopez%26aufirst%3DG.%26aulast%3DChanock%26aufirst%3DS.%2BJ.%26aulast%3DSchatzkin%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DHollenbeck%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DWood%26aufirst%3DN.%2BW.%26aulast%3DLorenz%26aufirst%3DD.%26aulast%3DDeuschl%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DRiess%26aufirst%3DO.%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DSingleton%26aufirst%3DA.%2BB.%26aulast%3DGasser%26aufirst%3DT.%26atitle%3DGenome-wide%2520association%2520study%2520reveals%2520genetic%2520risk%2520underlying%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Genet.%26date%3D2009%26volume%3D41%26spage%3D1308%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Mata, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, K. A.</span><span> </span><span class="NLM_article-title">LRRK2 in Parkinson’s disease: protein domains and functional insights</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">286</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=286-293&author=I.+F.+Mataauthor=W.+J.+Wedemeyerauthor=M.+J.+Farrerauthor=J.+P.+Taylorauthor=K.+A.+Gallo&title=LRRK2+in+Parkinson%E2%80%99s+disease%3A+protein+domains+and+functional+insights"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMata%26aufirst%3DI.%2BF.%26aulast%3DWedemeyer%26aufirst%3DW.%2BJ.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26aulast%3DTaylor%26aufirst%3DJ.%2BP.%26aulast%3DGallo%26aufirst%3DK.%2BA.%26atitle%3DLRRK2%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520protein%2520domains%2520and%2520functional%2520insights%26jtitle%3DTrends%2520Neurosci.%26date%3D2006%26volume%3D29%26spage%3D286%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 mutations and Parkinson’s disease: three questions</span> <span class="citation_source-journal">ASN Neuro</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">e00002</span><span class="NLM_x">) </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1042%2FAN20090007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KmsrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=13-24&issue=e00002&author=E.+Greggioauthor=M.+R.+Cookson&title=Leucine-rich+repeat+kinase+2+mutations+and+Parkinson%E2%80%99s+disease%3A+three+questions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions</span></div><div class="casAuthors">Greggio, Elisa; Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">ASN Neuro</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-24</span>CODEN:
                <span class="NLM_cas:coden">ANSEFU</span>;
        ISSN:<span class="NLM_cas:issn">1759-0914</span>.
    
            (<span class="NLM_cas:orgname">Portland Press</span>)
        </div><div class="casAbstract">A review.  Mutations in the gene encoding LRRK2 (leucine-rich repeat kinase 2) were first identified in 2004 and have since been shown to be the single most common cause of inherited Parkinson's disease.  The protein is a large GTP-regulated serine/threonine kinase that addnl. contains several protein-protein interaction domains.  In the present review, we discuss three important, but unresolved, questions concerning LRRK2.  We first ask: what is the normal function of LRRK2.  Related to this, we discuss the evidence of LRRK2 activity as a GTPase and as a kinase and the available data on protein-protein interactions.  Next we raise the question of how mutations affect LRRK2 function, focusing on some slightly controversial results related to the kinase activity of the protein in a variety of in vitro systems.  Finally, we discuss what the possible mechanisms are for LRRK2-mediated neurotoxicity, in the context of known activities of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu41GNQD0_w7Vg90H21EOLACvtfcHk0ljbGtWw03WcPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KmsrvI&md5=6d987ceba6d48841f06baf41455a1f6b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1042%2FAN20090007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FAN20090007%26sid%3Dliteratum%253Aachs%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520mutations%2520and%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520three%2520questions%26jtitle%3DASN%2520Neuro%26date%3D2009%26volume%3D1%26issue%3De00002%26spage%3D13%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Gandhi, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson-Delfosse, A. L.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">1283</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1002%2Fjnr.21949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=19025767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1Wnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2009&pages=1283-1295&author=P.+N.+Gandhiauthor=S.+G.+Chenauthor=A.+L.+Wilson-Delfosse&title=Leucine-rich+repeat+kinase+2+%28LRRK2%29%3A+a+key+player+in+the+pathogenesis+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease</span></div><div class="casAuthors">Gandhi, Payal N.; Chen, Shu G.; Wilson-Delfosse, Amy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1283-1295</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is the most common neurodegenerative movement disorder, with a prevalence of more than 1% after the age of 65 years.  Mutations in the gene encoding leucine-rich repeat kinase-2 (LRRK2) have recently been linked to autosomal dominant, late-onset PD that is clin. indistinguishable from typical, idiopathic disease.  LRRK2 is a multidomain protein contg. several protein interaction motifs as well as dual enzymic domains of GTPase and protein kinase activities.  Disease-assocd. mutations are found throughout the multidomain structure of the protein.  LRRK2, however, is unique among the PD-causing genes, because a missense mutation, G2019S, is a frequent determinant of not only familial but also sporadic PD.  Thus, LRRK2 has emerged as a promising therapeutic target for combating PD.  In this Mini-Review, we look at the current state of knowledge regarding the domain structure, amino acid substitutions, and potential functional roles of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhitPWE7Qj1rVg90H21EOLACvtfcHk0lg5mGcggr7RGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1Wnt70%253D&md5=81fe55081f2c1e0f665c60aaf7221951</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fjnr.21949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.21949%26sid%3Dliteratum%253Aachs%26aulast%3DGandhi%26aufirst%3DP.%2BN.%26aulast%3DChen%26aufirst%3DS.%2BG.%26aulast%3DWilson-Delfosse%26aufirst%3DA.%2BL.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%253A%2520a%2520key%2520player%2520in%2520the%2520pathogenesis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2009%26volume%3D87%26spage%3D1283%26epage%3D1295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Drolet, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. T.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions</span> <span class="citation_source-journal">J. Neurogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.3109%2F01677063.2011.627072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=22077787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=140-151&author=R.+E.+Droletauthor=J.+M.+Sandersauthor=J.+T.+Kern&title=Leucine-rich+repeat+kinase+2+%28LRRK2%29+cellular+biology%3A+a+review+of+recent+advances+in+identifying+physiological+substrates+and+cellular+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-Rich Repeat Kinase 2 (LRRK2) Cellular Biology: A Review of Recent Advances in Identifying Physiological Substrates and Cellular Functions</span></div><div class="casAuthors">Drolet, Robert E.; Sanders, John M.; Kern, Jonathan T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">140-151</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common forms of inheritable Parkinson's disease and likely play a role in sporadic disease as well.  LRRK2 is a large multidomain protein contg. two key groups, a Ras-like GTP binding domain and a serine, threonine kinase domain.  Mutations in the LRRK2 gene that assoc. with Parkinson's disease reside primarily within the two functional domains of the protein, suggesting that LRRK2 function is crit. to the pathogenesis of the disease.  The most common LRRK2 mutation increases kinase activity, making LRRK2 kinase inhibition an attractive target for small mol. drug development.  However, the physiol. function of LRRK2 kinase as well as its endogenous protein substrates remains poorly understood and has hindered drug development efforts.  Recent advances in LRRK2 biol. have revealed several potential cellular roles, interacting proteins, and putative physiol. substrates.  Together, a picture emerges of a complex multifunctional protein that exists in multiple cellular compartments.  Through unclear mechanisms, LRRK2 kinase regulates cytoskeleton architecture through control of protein translation, phosphorylation of cytoskeletal proteins, and response to cellular stressors.  This article will briefly cover some interesting recent studies in LRRK2 cellular biol. and highlight emerging cellular models of LRRK2 kinase function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIaZnsxyLANrVg90H21EOLACvtfcHk0lg5mGcggr7RGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bL&md5=b4b40ac3ccfa45091410f59e1401587c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.627072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.627072%26sid%3Dliteratum%253Aachs%26aulast%3DDrolet%26aufirst%3DR.%2BE.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DKern%26aufirst%3DJ.%2BT.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520cellular%2520biology%253A%2520a%2520review%2520of%2520recent%2520advances%2520in%2520identifying%2520physiological%2520substrates%2520and%2520cellular%2520functions%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26spage%3D140%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugayenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Parkinson’s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">16842</span><span class="NLM_x">–</span> <span class="NLM_lpage">16847</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16842-16847&author=A.+B.+Westauthor=D.+J.+Mooreauthor=S.+Biskupauthor=A.+Bugayenkoauthor=W.+W.+Smithauthor=C.+A.+Rossauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Parkinson%E2%80%99s+disease-associated+mutations+in+leucine-rich+repeat+kinase+2+augment+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DBugayenko%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DParkinson%25E2%2580%2599s%2520disease-associated%2520mutations%2520in%2520leucine-rich%2520repeat%2520kinase%25202%2520augment%2520kinase%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D16842%26epage%3D16847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsbury, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandopadhyay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaganovich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beilina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackinton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesavapany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Kinase activity is required for the toxic effects of mutant LRRK2/dardarin</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1016%2Fj.nbd.2006.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=16750377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD28Xntl2ntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=329-341&author=E.+Greggioauthor=S.+Jainauthor=A.+Kingsburyauthor=R.+Bandopadhyayauthor=P.+Lewisauthor=A.+Kaganovichauthor=M.+P.+van+der+Brugauthor=A.+Beilinaauthor=J.+Blackintonauthor=K.+J.+Thomasauthor=R.+Ahmadauthor=D.+W.+Millerauthor=S.+Kesavapanyauthor=A.+Singletonauthor=A.+Leesauthor=R.+J.+Harveyauthor=K.+Harveyauthor=M.+R.+Cookson&title=Kinase+activity+is+required+for+the+toxic+effects+of+mutant+LRRK2%2Fdardarin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase activity is required for the toxic effects of mutant LRRK2/dardarin</span></div><div class="casAuthors">Greggio, Elisa; Jain, Shushant; Kingsbury, Ann; Bandopadhyay, Rina; Lewis, Patrick; Kaganovich, Alice; van der Brug, Marcel P.; Beilina, Alexandra; Blackinton, Jeff; Thomas, Kelly Jean; Ahmad, Rili; Miller, David W.; Kesavapany, Sashi; Singleton, Andrew; Lees, Andrew; Harvey, Robert J.; Harvey, Kirsten; Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">329-341</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD).  Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain.  However, it is not clear if kinase activity is important for the damaging effects of pathogenic mutations.  In this study, we noted two cellular phenotypes assocd. with mutant dardarin.  First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies.  Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.  Manipulating activity by replacing the kinase domain with a kinase-dead' version blocks inclusion body formation and strongly delays cell death.  This predicts that kinase inhibitors will be useful therapeutic agents in patients with LRRK2 mutations and, perhaps, in sporadic PD.  We also show that dardarin protein is expressed within human midbrain neurons and that C-terminal epitopes are also found in some Lewy bodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Hag6uVnmkLVg90H21EOLACvtfcHk0lg6nxOoBXSb_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xntl2ntrk%253D&md5=52b400fe2f04c2cdeae2a2aa0be67ece</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2006.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2006.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DKingsbury%26aufirst%3DA.%26aulast%3DBandopadhyay%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DP.%26aulast%3DKaganovich%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%2BP.%26aulast%3DBeilina%26aufirst%3DA.%26aulast%3DBlackinton%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DK.%2BJ.%26aulast%3DAhmad%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DD.%2BW.%26aulast%3DKesavapany%26aufirst%3DS.%26aulast%3DSingleton%26aufirst%3DA.%26aulast%3DLees%26aufirst%3DA.%26aulast%3DHarvey%26aufirst%3DR.%2BJ.%26aulast%3DHarvey%26aufirst%3DK.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DKinase%2520activity%2520is%2520required%2520for%2520the%2520toxic%2520effects%2520of%2520mutant%2520LRRK2%252Fdardarin%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2006%26volume%3D23%26spage%3D329%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1038%2Fnrn2935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=21088684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVersLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=791-797&author=M.+R.+Cookson&title=The+role+of+leucine-rich+repeat+kinase+2+%28LRRK2%29+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease</span></div><div class="casAuthors">Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">791-797</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component.  Here, I discuss how mutations in a large complex gene - leucine-rich repeat kinase 2 (LRRK2) - affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically α-synuclein and tau.  These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIZ6sTeax7vLVg90H21EOLACvtfcHk0lg6nxOoBXSb_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVersLbO&md5=1600eaee5fea809aa325e2d7a7963b35</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrn2935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2935%26sid%3Dliteratum%253Aachs%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DThe%2520role%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2010%26volume%3D11%26spage%3D791%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Rudenko, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson’s disease?</span> <span class="citation_source-journal">BMC Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1186%2F1741-7015-10-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=22361010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsVams7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=20-27&author=I.+N.+Rudenkoauthor=R.+Chiaauthor=M.+R.+Cookson&title=Is+inhibition+of+kinase+activity+the+only+therapeutic+strategy+for+LRRK2-associated+Parkinson%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?</span></div><div class="casAuthors">Rudenko, Iakov N.; Chia, Ruth; Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20</span>CODEN:
                <span class="NLM_cas:coden">BMMECZ</span>;
        ISSN:<span class="NLM_cas:issn">1741-7015</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a common cause of familial Parkinson's disease (PD).  Variation around the LRRK2 locus also contributes to the risk of sporadic PD.  The LRRK2 protein contains a central catalytic region, and pathogenic mutations cluster in the Ras of complex protein C terminus of Ras of complex protein (mutations N1437H, R1441G/C and Y1699C) and kinase (G2019S and I2020T) domains.  Much attention has been focused on the kinase domain, because kinase-dead versions of mutant LRRK2 are less toxic than kinase-active versions of the same proteins.  Furthermore, kinase inhibitors may be able to mimic this effect in mouse models, although the currently tested inhibitors are not completely specific.  In this review, we discuss the recent progress in the development of specific LRRK2 kinase inhibitors.  We also discuss non-kinase-based therapeutic strategies for LRRK2-assocd. PD as it is possible that different approaches may be needed for different mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrArNzblopm1bVg90H21EOLACvtfcHk0liD-jYK5PMEUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsVams7k%253D&md5=e1de091de6b38b8a1138327f7292ae48</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1186%2F1741-7015-10-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7015-10-20%26sid%3Dliteratum%253Aachs%26aulast%3DRudenko%26aufirst%3DI.%2BN.%26aulast%3DChia%26aufirst%3DR.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DIs%2520inhibition%2520of%2520kinase%2520activity%2520the%2520only%2520therapeutic%2520strategy%2520for%2520LRRK2-associated%2520Parkinson%25E2%2580%2599s%2520disease%253F%26jtitle%3DBMC%2520Med.%26date%3D2012%26volume%3D10%26spage%3D20%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamamichi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span> </span><span class="NLM_article-title">Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in <i>Caenorhabditis elegans</i> and <i>Drosophila</i> Parkinson’s disease models</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3933</span><span class="NLM_x">–</span> <span class="NLM_lpage">3942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1093%2Fhmg%2Fddr312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=21768216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ajtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=3933-3942&author=Z.+Liuauthor=S.+Hamamichiauthor=B.+D.+Leeauthor=D.+Yangauthor=A.+Rayauthor=G.+A.+Caldwellauthor=K.+A.+Caldwellauthor=T.+M.+Dawsonauthor=W.+W.+Smithauthor=V.+L.+Dawson&title=Inhibitors+of+LRRK2+kinase+attenuate+neurodegeneration+and+Parkinson-like+phenotypes+in+Caenorhabditis+elegans+and+Drosophila+Parkinson%E2%80%99s+disease+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models</span></div><div class="casAuthors">Liu, Zhao-Hui; Hamamichi, Shusei; Lee, Byoung-Dae; Yang, De-Jun; Ray, Arpita; Caldwell, Guy A.; Caldwell, Kim A.; Dawson, Ted M.; Smith, Wanli W.; Dawson, Valina L.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3933-3942</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) have been identified as a genetic cause of familial Parkinson's disease (PD) and have also been found in the more common sporadic form of PD, thus positioning LRRK2 as important in the pathogenesis of PD.  Biochem. studies of the disease-causing mutants of LRRK2 implicates an enhancement of kinase activity as the basis of neuronal toxicity and thus possibly the pathogenesis of PD due to LRRK2 mutations.  Previously, a chem. library screen identified inhibitors of LRRK2 kinase activity.  Here, two of these inhibitors, GW5074 and sorafenib, are shown to protect against G2019S LRRK2-induced neurodegeneration in vivo in Caenorhabditis elegans and in Drosophila.  These findings indicate that increased kinase activity of LRRK2 is neurotoxic and that inhibition of LRRK2 activity can have a disease-modifying effect.  This suggests that inhibition of LRRK2 holds promise as a treatment for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUI1BJ-I2FnrVg90H21EOLACvtfcHk0liD-jYK5PMEUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ajtbnL&md5=53f130209a8364ac8c8c1f553ab4cd63</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr312%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHamamichi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DCaldwell%26aufirst%3DG.%2BA.%26aulast%3DCaldwell%26aufirst%3DK.%2BA.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26atitle%3DInhibitors%2520of%2520LRRK2%2520kinase%2520attenuate%2520neurodegeneration%2520and%2520Parkinson-like%2520phenotypes%2520in%2520Caenorhabditis%2520elegans%2520and%2520Drosophila%2520Parkinson%25E2%2580%2599s%2520disease%2520models%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2011%26volume%3D20%26spage%3D3933%26epage%3D3942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanKampen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire-Zeiss, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federoff, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson’s disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1038%2Fnm.2199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=20729864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=998-1000&author=B.+D.+Leeauthor=J.-H.+Shinauthor=J.+VanKampenauthor=L.+Petrucelliauthor=A.+B.+Westauthor=H.+S.+Koauthor=Y.-I.+Leeauthor=K.+A.+Maguire-Zeissauthor=W.+J.+Bowersauthor=H.+J.+Federoffauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Inhibitors+of+leucine-rich+repeat+kinase-2+protect+against+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease</span></div><div class="casAuthors">Lee, Byoung Dae; Shin, Joo-Ho; Van Kampen, Jackalina; Petrucelli, Leonard; West, Andrew B.; Ko, Han Seok; Lee, Yun-Il; Maguire-Zeiss, Kathleen A.; Bowers, William J.; Federoff, Howard J.; Dawson, Valina L.; Dawson, Ted M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">998-1000</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Leucine-rich repeat kinase-2 (LRRK2) mutations are a common cause of Parkinson's disease.  Here we identify inhibitors of LRRK2 kinase that are protective in in vitro and in vivo models of LRRK2-induced neurodegeneration.  These results establish that LRRK2-induced degeneration of neurons in vivo is kinase dependent and that LRRK2 kinase inhibition provides a potential new neuroprotective paradigm for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn78Hm84uiebVg90H21EOLACvtfcHk0liD-jYK5PMEUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtLbE&md5=d6c5df67511a2f154b21a523af408f65</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnm.2199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2199%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DShin%26aufirst%3DJ.-H.%26aulast%3DVanKampen%26aufirst%3DJ.%26aulast%3DPetrucelli%26aufirst%3DL.%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DKo%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DY.-I.%26aulast%3DMaguire-Zeiss%26aufirst%3DK.%2BA.%26aulast%3DBowers%26aufirst%3DW.%2BJ.%26aulast%3DFederoff%26aufirst%3DH.%2BJ.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DInhibitors%2520of%2520leucine-rich%2520repeat%2520kinase-2%2520protect%2520against%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2010%26volume%3D16%26spage%3D998%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Garcia-Serna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestres, J.</span><span> </span><span class="NLM_article-title">Chemical Probes for biological systems</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=99-106&author=R.+Garcia-Sernaauthor=J.+Mestres&title=Chemical+Probes+for+biological+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Serna%26aufirst%3DR.%26aulast%3DMestres%26aufirst%3DJ.%26atitle%3DChemical%2520Probes%2520for%2520biological%2520systems%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D99%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of a selective inhibitor of the Parkinson’s disease kinase LRRK2</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1038%2Fnchembio.538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=21378983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=203-205&author=X.+Dengauthor=N.+Dzamkoauthor=A.+Prescottauthor=P.+Daviesauthor=Q.+Liuauthor=Q.+Yangauthor=J.-D.+Leeauthor=M.+P.+Patricelliauthor=T.+K.+Nomanbhoyauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+a+selective+inhibitor+of+the+Parkinson%E2%80%99s+disease+kinase+LRRK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2</span></div><div class="casAuthors">Deng, Xianming; Dzamko, Nicolas; Prescott, Alan; Davies, Paul; Liu, Qingsong; Yang, Qingkai; Lee, Jiing-Dwan; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly assocd. with late-onset autosomal dominant Parkinson's disease.  We employed a new, parallel, compd.-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of LRRK2 within aggregate structures.  LRRK2-IN-1 will serve as a versatile tool to pharmacol. interrogate LRRK2 biol. and study its role in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwLpGURHqDULVg90H21EOLACvtfcHk0ljh2KirpU9g2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D&md5=9f48f74cad9988e3ea8bb7af280473c1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.538%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DPrescott%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.-D.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520a%2520selective%2520inhibitor%2520of%2520the%2520Parkinson%25E2%2580%2599s%2520disease%2520kinase%2520LRRK2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D203%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ramsden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren., Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span> </span><span class="NLM_article-title">Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson’s disease-related toxicity in human neurons</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1028</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb2002413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1021-1028&author=N.+Ramsdenauthor=J.+Perrinauthor=Z.+Ren.author=B.+D.+Leeauthor=N.+Zinnauthor=V.+L.+Dawsonauthor=D.+Tamauthor=M.+Bovaauthor=M.+Langauthor=G.+Drewesauthor=M.+Bantscheffauthor=F.+Bardauthor=T.+M.+Dawsonauthor=C.+Hopf&title=Chemoproteomics-based+design+of+potent+LRRK2-selective+lead+compounds+that+attenuate+Parkinson%E2%80%99s+disease-related+toxicity+in+human+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcb2002413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb2002413%26sid%3Dliteratum%253Aachs%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DPerrin%26aufirst%3DJ.%26aulast%3DRen.%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DZinn%26aufirst%3DN.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DBova%26aufirst%3DM.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DBard%26aufirst%3DF.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DHopf%26aufirst%3DC.%26atitle%3DChemoproteomics-based%2520design%2520of%2520potent%2520LRRK2-selective%2520lead%2520compounds%2520that%2520attenuate%2520Parkinson%25E2%2580%2599s%2520disease-related%2520toxicity%2520in%2520human%2520neurons%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D1021%26epage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of TAE684 as a potent LRRK2 kinase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1869</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1864-1869&author=J.+Zhangauthor=X.+Dengauthor=H.+G.+Choiauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+TAE684+as+a+potent+LRRK2+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520TAE684%2520as%2520a%2520potent%2520LRRK2%2520kinase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1864%26epage%3D1869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Kramer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Monte, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goering, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okala Amombo, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title">Small molecule kinase inhibitors for LRRK2 and their application to parkinson’s disease models</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200117j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=151-160&author=T.+Kramerauthor=F.+Lo+Monteauthor=S.+Goeringauthor=G.+M.+Okala+Amomboauthor=B.+Schmidt&title=Small+molecule+kinase+inhibitors+for+LRRK2+and+their+application+to+parkinson%E2%80%99s+disease+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Kinase Inhibitors for LRRK2 and Their Application to Parkinson's Disease Models</span></div><div class="casAuthors">Kramer, Thomas; Lo Monte, Fabio; Goering, Stefan; Okala Amombo, Ghislaine Marlyse; Schmidt, Boris</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">151-160</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is the second most common neurodegenerative disorder.  Several single gene mutations have been linked to this disease.  Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) indicate LRRK2 as promising therapeutic target for the treatment of PD.  LRRK2 mutations were obsd. in sporadic as well as familial PD patients and have been investigated intensively.  LRRK2 is a large and complex protein, with multiple enzymic and protein-interaction domains, each of which is effected by mutations.  The most common mutation in PD patients is G2019S.  Several LRRK2 inhibitors have been reported already, although the crystal structure of LRRK2 has not yet been detd.  This review provides a summary of known LRRK2 inhibitors and will discuss recent in vitro and in vivo results of these inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqUiu7gx3NxLVg90H21EOLACvtfcHk0lgZmeQYbKmxlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFentA%253D%253D&md5=bda078bde5e0b515ca9d6f183d8b06f8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fcn200117j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200117j%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DT.%26aulast%3DLo%2BMonte%26aufirst%3DF.%26aulast%3DGoering%26aufirst%3DS.%26aulast%3DOkala%2BAmombo%26aufirst%3DG.%2BM.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DSmall%2520molecule%2520kinase%2520inhibitors%2520for%2520LRRK2%2520and%2520their%2520application%2520to%2520parkinson%25E2%2580%2599s%2520disease%2520models%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D151%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Lovitt, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderporten, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span> </span><span class="NLM_article-title">Differential effects of divalent manganese and magnesium on the kinase activity of leucine-rich repeat kinase 2 (LRRK2)</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3092</span><span class="NLM_x">–</span> <span class="NLM_lpage">3100</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi901726c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=3092-3100&author=B+Lovittauthor=E.+C.+Vanderportenauthor=Z.+Shengauthor=H.+Zhuauthor=J.+Drummondauthor=Y.+Liu&title=Differential+effects+of+divalent+manganese+and+magnesium+on+the+kinase+activity+of+leucine-rich+repeat+kinase+2+%28LRRK2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi901726c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi901726c%26sid%3Dliteratum%253Aachs%26aulast%3DLovitt%26aufirst%3DB%26aulast%3DVanderporten%26aufirst%3DE.%2BC.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DDifferential%2520effects%2520of%2520divalent%2520manganese%2520and%2520magnesium%2520on%2520the%2520kinase%2520activity%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D3092%26epage%3D3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lgZmeQYbKmxlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2ebOQuSE8JNsubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0ljs_R83kbM_tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Moore, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorarensen, A.</span><span> </span><span class="NLM_article-title">An analysis of the diaminopyrimidine patent estates describing spleen tyrosine kinase inhibitors by Rigel and Portola</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1703</span><span class="NLM_x">–</span> <span class="NLM_lpage">1722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1517%2F13543776.2010.534459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=21073366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1703-1722&author=W.+J.+Mooreauthor=D.+Richardauthor=A.+Thorarensen&title=An+analysis+of+the+diaminopyrimidine+patent+estates+describing+spleen+tyrosine+kinase+inhibitors+by+Rigel+and+Portola"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">An analysis of the diaminopyrimidine patent estates describing spleen tyrosine kinase inhibitors by Rigel and Portola</span></div><div class="casAuthors">Moore, William J.; Richard, David; Thorarensen, Atli</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1703-1722</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Discovery of small mol. inhibitors for treatment of rheumatoid arthritis is a major ongoing effort within the pharmaceutical industry.  Spleen tyrosine kinase (SYK) is one of the leading small mol. targets with regard to clin. developments due to the efforts of Rigel and Portola.Areas covered in this review: Diaminopyrimidines are one of the most prominent structural elements incorporated into the design of kinase inhibitors.  This review provides an extensive overview of the patent estates for the leading discovery programs at Portola and Rigel on diaminopyrimidines and how their patent estates are in relationship with the competition and prior art.What the reader will gain: An overview of the patent landscape for diaminopyrimidines.  In addn., the reader will be updated on what modifications in these scaffolds lead to very potent SYK inhibitors as judged by the applications.  Finally, the authors will provide their best guess on what the structure is of Portola's recently announced clin. candidate.Take home message: The Rigel and the Portola research organizations have filed a series of patent applications on diaminopyrimidines as inhibitors of SYK.  The scope of these applications is broad in a crowded chem. space.  These applications contain very broad claims and the future will tell how much of the generic space claimed will be allowed in granted patents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7wp-QGiNYmrVg90H21EOLACvtfcHk0ljs_R83kbM_tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7bJ&md5=a594fee4a53660d83042531aaf569eaf</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.534459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.534459%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DW.%2BJ.%26aulast%3DRichard%26aufirst%3DD.%26aulast%3DThorarensen%26aufirst%3DA.%26atitle%3DAn%2520analysis%2520of%2520the%2520diaminopyrimidine%2520patent%2520estates%2520describing%2520spleen%2520tyrosine%2520kinase%2520inhibitors%2520by%2520Rigel%2520and%2520Portola%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D1703%26epage%3D1722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beilina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Structure of the ROC domain from the Parkinson’s disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1499</span><span class="NLM_x">–</span> <span class="NLM_lpage">1504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=1499-1504&author=J.+Dengauthor=P.+A.+Lewisauthor=E.+Greggioauthor=E.+Sluchauthor=A.+Beilinaauthor=M.+R.+Cookson&title=Structure+of+the+ROC+domain+from+the+Parkinson%E2%80%99s+disease-associated+leucine-rich+repeat+kinase+2+reveals+a+dimeric+GTPase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DP.%2BA.%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DSluch%26aufirst%3DE.%26aulast%3DBeilina%26aufirst%3DA.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DStructure%2520of%2520the%2520ROC%2520domain%2520from%2520the%2520Parkinson%25E2%2580%2599s%2520disease-associated%2520leucine-rich%2520repeat%2520kinase%25202%2520reveals%2520a%2520dimeric%2520GTPase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D1499%26epage%3D1504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Marín, I.</span><span> </span><span class="NLM_article-title">The Parkinson disease gene LRRK2: evolutionary and structural insights</span> <span class="citation_source-journal">Mol. Biol. Evol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2423</span><span class="NLM_x">–</span> <span class="NLM_lpage">2433</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=2423-2433&author=I.+Mar%C3%ADn&title=The+Parkinson+disease+gene+LRRK2%3A+evolutionary+and+structural+insights"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMar%25C3%25ADn%26aufirst%3DI.%26atitle%3DThe%2520Parkinson%2520disease%2520gene%2520LRRK2%253A%2520evolutionary%2520and%2520structural%2520insights%26jtitle%3DMol.%2520Biol.%2520Evol.%26date%3D2006%26volume%3D23%26spage%3D2423%26epage%3D2433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Nichols, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutti, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson’s disease</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">424</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2009&pages=47-60&author=R.+J.+Nicholsauthor=N.+Dzamkoauthor=J.+E.+Huttiauthor=L.+C.+Cantleyauthor=M.+Deakauthor=J.+Moranauthor=P.+Bamboroughauthor=A.+D.+Reithauthor=D.+R.+Alessi&title=Substrate+specificity+and+inhibitors+of+LRRK2%2C+a+protein+kinase+mutated+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DHutti%26aufirst%3DJ.%2BE.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DSubstrate%2520specificity%2520and%2520inhibitors%2520of%2520LRRK2%252C%2520a%2520protein%2520kinase%2520mutated%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D424%26spage%3D47%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaitsev, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glicksman, M. A.</span><span> </span><span class="NLM_article-title">Kinetic, mechanistic, and structural modeling studies of truncated wild-type leucine-rich repeat kinase 2 and the G2019S mutant</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">9399</span><span class="NLM_x">–</span> <span class="NLM_lpage">9408</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi201173d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=9399-9408&author=M.+Liuauthor=S.+Kangauthor=S.+Rayauthor=J.+Jacksonauthor=A.+D.+Zaitsevauthor=S.+A.+Gerberauthor=G.+D.+Cunyauthor=M.+A.+Glicksman&title=Kinetic%2C+mechanistic%2C+and+structural+modeling+studies+of+truncated+wild-type+leucine-rich+repeat+kinase+2+and+the+G2019S+mutant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fbi201173d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi201173d%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DJ.%26aulast%3DZaitsev%26aufirst%3DA.%2BD.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DGlicksman%26aufirst%3DM.%2BA.%26atitle%3DKinetic%252C%2520mechanistic%252C%2520and%2520structural%2520modeling%2520studies%2520of%2520truncated%2520wild-type%2520leucine-rich%2520repeat%2520kinase%25202%2520and%2520the%2520G2019S%2520mutant%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D9399%26epage%3D9408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Cavasotto, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phatak, S. S.</span><span> </span><span class="NLM_article-title">Homology modeling in drug discovery: current trends and applications</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">676</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1016%2Fj.drudis.2009.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=19422931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFyktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=676-683&author=C.+N.+Cavasottoauthor=S.+S.+Phatak&title=Homology+modeling+in+drug+discovery%3A+current+trends+and+applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Homology modeling in drug discovery: current trends and applications</span></div><div class="casAuthors">Cavasotto, Claudio N.; Phatak, Sharangdhar S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13/14</span>),
    <span class="NLM_cas:pages">676-683</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  As structural genomics (SG) projects continue to deposit representative 3D structures of proteins, homol. modeling methods will play an increasing role in structure-based drug discovery.  Although computational structure prediction methods provide a cost-effective alternative in the absence of exptl. structures, developing accurate enough models still remains a big challenge.  In this contribution, we report the current developments in this field, discuss in silico modeling limitations, and review the successful application of this technique to different stages of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplkpoeHZH5nrVg90H21EOLACvtfcHk0lgO3SGmZDwwCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFyktLs%253D&md5=aec3151d1c1adddaedb5d552ad93071c</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DCavasotto%26aufirst%3DC.%2BN.%26aulast%3DPhatak%26aufirst%3DS.%2BS.%26atitle%3DHomology%2520modeling%2520in%2520drug%2520discovery%253A%2520current%2520trends%2520and%2520applications%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D676%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Grant, M. A.</span><span> </span><span class="NLM_article-title">Protein structure prediction in structure-based ligand design and virtual screening</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">940</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.2174%2F138620709789824718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=20025561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGqsbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=940-960&author=M.+A.+Grant&title=Protein+structure+prediction+in+structure-based+ligand+design+and+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Protein structure prediction in structure-based ligand design and virtual screening</span></div><div class="casAuthors">Grant, Marianne A.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">940-960</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Advances in protein modeling algorithms and state-of-the-art sequence similarity comparison and fold recognition methods, in combination with growing protein structure information, are facilitating "genome-to-drug lead" approaches in which chems. are virtually screened against computationally-predicted protein targets.  Although the quality of predicted protein structures by homol. modeling methods, and thus their applicability to drug discovery initiatives, predominantly depends on the sequence similarity between the protein of known structure and the protein target to be modeled, recent research underscores that this approach can be used to significant advantage in the identification and optimization of lead compds., as well as for the identification and validation of drug targets.  Rational structure-based drug design cycles begin with an iterative procedure that is dependent on the initial detn. of the structure of the target protein, followed by the prediction of ligands for the target protein from mol. modeling computation.  The structure detn. of all proteins encoded by vast genome sequencing efforts appears to be an unrealistic goal with current technologies.  Therefore, other approaches based on the development of technol. useful for accurately predicting and modeling the structures of proteins have become exceedingly important in certain structure-based drug design efforts.  Here, the author provides an overview of the recent method advancements in protein structure prediction by homol. modeling and includes an assessment of the application of homol. modeling to pharmaceutically relevant questions.  In addn., examples of successful applications of homol. modeling approaches to genome-to-drug lead investigations are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5wlvLv0iXS7Vg90H21EOLACvtfcHk0lh32J-IcRcPGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGqsbbM&md5=62d737964bc3a49205786f1c10c2c3e8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F138620709789824718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620709789824718%26sid%3Dliteratum%253Aachs%26aulast%3DGrant%26aufirst%3DM.%2BA.%26atitle%3DProtein%2520structure%2520prediction%2520in%2520structure-based%2520ligand%2520design%2520and%2520virtual%2520screening%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2009%26volume%3D12%26spage%3D940%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Cavasotto, C. N.</span><span> </span><span class="NLM_article-title">Homology models in docking and high-throughput docking</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1528</span><span class="NLM_x">–</span> <span class="NLM_lpage">1534</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.2174%2F156802611795860951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=21510834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFOrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=1528-1534&author=C.+N.+Cavasotto&title=Homology+models+in+docking+and+high-throughput+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Homology models in docking and high-throughput docking</span></div><div class="casAuthors">Cavasotto, Claudio N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1528-1534</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The use of homol. models in docking-based drug discovery is already established, and provides an effective and computationally affordable alternative whenever exptl. structures are not available.  Recent methodol. studies have confirmed and benchmarked the feasibility of using structural models in docking.  However, more accurate methods are expected to be developed in the near future, esp. for the model refinement stage.  In this review, the latest developments in homol. modeling in the context of structure-based virtual screening are presented, together with the recent success stories of homol. modeling in actual docking-based drug discovery endeavors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRlZbSdsKo-rVg90H21EOLACvtfcHk0lh32J-IcRcPGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFOrtbc%253D&md5=58c45631128d284cc8e829e3e4a50472</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F156802611795860951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611795860951%26sid%3Dliteratum%253Aachs%26aulast%3DCavasotto%26aufirst%3DC.%2BN.%26atitle%3DHomology%2520models%2520in%2520docking%2520and%2520high-throughput%2520docking%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D1528%26epage%3D1534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Bairoch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasteiger, E.</span><span> </span><span class="NLM_article-title">Swiss-Prot: juggling between evolution and stability</span> <span class="citation_source-journal">Briefings Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1093%2Fbib%2F5.1.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=15153305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ahsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=39-55&author=A.+Bairochauthor=B.+Boeckmannauthor=S.+Ferroauthor=E.+Gasteiger&title=Swiss-Prot%3A+juggling+between+evolution+and+stability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Swiss-Prot: juggling between evolution and stability</span></div><div class="casAuthors">Bairoch, Amos; Boeckmann, Brigitte; Ferro, Serenella; Gasteiger, Elisabeth</div><div class="citationInfo"><span class="NLM_cas:title">Briefings in Bioinformatics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-55</span>CODEN:
                <span class="NLM_cas:coden">BBIMFX</span>;
        ISSN:<span class="NLM_cas:issn">1467-5463</span>.
    
            (<span class="NLM_cas:orgname">Henry Stewart Publications</span>)
        </div><div class="casAbstract">Some of the aspects of Swiss-Prot that make it unique are described and the developments that are necessary for the database to continue to play its role as a focal point of protein knowledge are discussed.  Advices pertinent to the development of high-quality knowledge resources on one aspect or the other of the life sciences are provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEgdtQ3E4iD7Vg90H21EOLACvtfcHk0lh32J-IcRcPGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ahsbw%253D&md5=20bac4d8d69b26959f71a271299fd233</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1093%2Fbib%2F5.1.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbib%252F5.1.39%26sid%3Dliteratum%253Aachs%26aulast%3DBairoch%26aufirst%3DA.%26aulast%3DBoeckmann%26aufirst%3DB.%26aulast%3DFerro%26aufirst%3DS.%26aulast%3DGasteiger%26aufirst%3DE.%26atitle%3DSwiss-Prot%253A%2520juggling%2520between%2520evolution%2520and%2520stability%26jtitle%3DBriefings%2520Bioinf.%26date%3D2004%26volume%3D5%26spage%3D39%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Altschul, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madden, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäffer, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipman, D. J.</span><span> </span><span class="NLM_article-title">Gapped BLAST and PSI-BLAST: a new generation of protein database search programs</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3389</span><span class="NLM_x">–</span> <span class="NLM_lpage">3402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1093%2Fnar%2F25.17.3389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=9254694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADyaK2sXlvFyhu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1997&pages=3389-3402&author=S.+F.+Altschulauthor=T.+L.+Maddenauthor=A.+A.+Sch%C3%A4fferauthor=J.+Zhangauthor=Z.+Zhangauthor=W.+Millerauthor=D.+J.+Lipman&title=Gapped+BLAST+and+PSI-BLAST%3A+a+new+generation+of+protein+database+search+programs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Gapped BLAST and PSI-BLAST: a new generation of protein database search programs</span></div><div class="casAuthors">Altschul, Stephen F.; Madden, Thomas L.; Schaffer, Alejandro A.; Zhang, Jinghui; Zhang, Zheng; Miller, Webb; Lipman, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3389-3402</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The BLAST programs are widely used tools for searching protein and DNA databases for sequence similarities.  For protein comparisons, a variety of definitional, algorithmic and statistical refinements described here permits the execution time of the BLAST programs to be decreased substantially while enhancing their sensitivity to weak similarities.  A new criterion for triggering the extension of word hits, combined with a new heuristic for generating gapped alignments, yields a gapped BLAST program that runs at approx. three times the speed of the original.  In addn., a method is introduced for automatically combining statistically significant alignments produced by BLAST into a position-specific score matrix, and searching the database using this matrix.  The resulting Position-Specific Iterated BLAST (PSI-BLAST) program runs at approx. the same speed per iteration as gapped BLAST, but in many cases is much more sensitive to weak but biol. relevant sequence similarities.  PSI-BLAST is used to uncover several new and interesting members of the BRCT superfamily.  The source code for the new BLAST programs is available by anonymous ftp from the machine ncbi.nlm.nih.gov, within the directory 'blast', and the programs may be run from NCBIs web site at http://www.ncbi.nlm.nih.gov/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfl-GGLfjeoLVg90H21EOLACvtfcHk0lh32J-IcRcPGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvFyhu7w%253D&md5=4e44123e5984e4aca46a9899d347a176</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F25.17.3389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F25.17.3389%26sid%3Dliteratum%253Aachs%26aulast%3DAltschul%26aufirst%3DS.%2BF.%26aulast%3DMadden%26aufirst%3DT.%2BL.%26aulast%3DSch%25C3%25A4ffer%26aufirst%3DA.%2BA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DMiller%26aufirst%3DW.%26aulast%3DLipman%26aufirst%3DD.%2BJ.%26atitle%3DGapped%2520BLAST%2520and%2520PSI-BLAST%253A%2520a%2520new%2520generation%2520of%2520protein%2520database%2520search%2520programs%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1997%26volume%3D25%26spage%3D3389%26epage%3D3402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span> <span class="citation_source-book">MOE</span>, version <span class="NLM_edition">2009.10</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">Montreal, Canada</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE%2C+version+2009.10%3B+Chemical+Computing+Group+Inc.%3A+Montreal%2C+Canada."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMOE%26pub%3DChemical%2520Computing%2520Group%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuccola, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogan, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jepson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shlyakter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furey, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frantz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauffenbach, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germann, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namchuk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledeboer, M. W.</span><span> </span><span class="NLM_article-title">Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindole</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7938</span><span class="NLM_x">–</span> <span class="NLM_lpage">7941</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901383u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7938-7941&author=T.+Wangauthor=J.+P.+Duffyauthor=J.+Wangauthor=S.+Halasauthor=F.+G.+Salituroauthor=A.+C.+Pierceauthor=H.+J.+Zuccolaauthor=J.+R.+Blackauthor=J.+K.+Hoganauthor=S.+Jepsonauthor=D.+Shlyakterauthor=S.+Mahajanauthor=Y.+Guauthor=T.+Hoockauthor=M.+Woodauthor=B.+F.+Fureyauthor=J.+D.+Frantzauthor=L.+M.+Dauffenbachauthor=U.+A.+Germannauthor=B.+Fanauthor=M.+Namchukauthor=Y.+L.+Bennaniauthor=M.+W.+Ledeboer&title=Janus+kinase+2+inhibitors.+Synthesis+and+characterization+of+a+novel+polycyclic+azaindole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm901383u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901383u%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DDuffy%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHalas%26aufirst%3DS.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3DZuccola%26aufirst%3DH.%2BJ.%26aulast%3DBlack%26aufirst%3DJ.%2BR.%26aulast%3DHogan%26aufirst%3DJ.%2BK.%26aulast%3DJepson%26aufirst%3DS.%26aulast%3DShlyakter%26aufirst%3DD.%26aulast%3DMahajan%26aufirst%3DS.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHoock%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DFurey%26aufirst%3DB.%2BF.%26aulast%3DFrantz%26aufirst%3DJ.%2BD.%26aulast%3DDauffenbach%26aufirst%3DL.%2BM.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DFan%26aufirst%3DB.%26aulast%3DNamchuk%26aufirst%3DM.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26aulast%3DLedeboer%26aufirst%3DM.%2BW.%26atitle%3DJanus%2520kinase%25202%2520inhibitors.%2520Synthesis%2520and%2520characterization%2520of%2520a%2520novel%2520polycyclic%2520azaindole%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7938%26epage%3D7941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Covy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giasson, B. I.</span><span> </span><span class="NLM_article-title">Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">378</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2009&pages=473-477&author=J.+P.+Covyauthor=B.+I.+Giasson&title=Identification+of+compounds+that+inhibit+the+kinase+activity+of+leucine-rich+repeat+kinase+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCovy%26aufirst%3DJ.%2BP.%26aulast%3DGiasson%26aufirst%3DB.%2BI.%26atitle%3DIdentification%2520of%2520compounds%2520that%2520inhibit%2520the%2520kinase%2520activity%2520of%2520leucine-rich%2520repeat%2520kinase%25202%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D378%26spage%3D473%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span> <span class="citation_source-book">Maestro</span>; <span class="NLM_publisher-name">Schrödinger, Inc.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%3B+Schr%C3%B6dinger%2C+Inc.%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Gould, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C. F.</span><span> </span><span class="NLM_article-title">Designing specific protein kinase inhibitors: insights from computer simulations and comparative sequence/structure analysis</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1016%2FS0163-7258%2802%2900186-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=12191609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD38XksVShtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2002&pages=169-178&author=C.+Gouldauthor=C.+F.+Wong&title=Designing+specific+protein+kinase+inhibitors%3A+insights+from+computer+simulations+and+comparative+sequence%2Fstructure+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Designing specific protein kinase inhibitors: insights from computer simulations and comparative sequence/structure analysis</span></div><div class="casAuthors">Gould, Christine; Wong, Chung F.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">169-178</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Protein kinases are important targets for designing therapeutic drugs.  We describe here a computational approach to extend the usefulness of a single protein-inhibitor structure in aiding the design of protein kinase inhibitors.  This approach is based on using sensitivity anal. to identify the most significant functional groups of a lead compd. in accounting for binding affinity and on using comparative sequence/structure anal. to examine whether these functional groups would present specificity.  A sensitivity anal. study is similar to genetic or chem. modification expts. in which specific features of a lead compd. are modified to examine whether they affect properties such as binding affinity.  In this study, the binding affinity was estd. by using an implicit-solvent model in which the electrostatic contributions were obtained by solving the Poisson equation, and the hydrophobic effects were accounted for by using surface-area-dependent terms.  The comparative sequence/structure anal. involves the study of the amino acid distributions of a large no. of protein kinases (384 in this study) near the ligand-binding sites.  This anal. provides useful guiding principles for designing specific inhibitors targeted towards a particular kinase.  Here, we illustrate the utility of these computational approaches by applying them to identify the determinants of the recognition between the protein kinase A and two of its inhibitors.  One inhibitor, balanol, binds to the ATP-binding pocket.  The other, protein kinase inhibitor, binds to the substrate-binding site.  These analyses have helped to construct pharmacophore models for mining new drug leads from small-mol. libraries and for suggesting how a lead compd. or a peptide inhibitor may be modified to generate selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD4cNyidIWgLVg90H21EOLACvtfcHk0ljPAZc_NStu7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksVShtbc%253D&md5=81c5c5809f3bedad54f9bc0559aca972</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2802%2900186-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252802%252900186-9%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DC.%2BF.%26atitle%3DDesigning%2520specific%2520protein%2520kinase%2520inhibitors%253A%2520insights%2520from%2520computer%2520simulations%2520and%2520comparative%2520sequence%252Fstructure%2520analysis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2002%26volume%3D93%26spage%3D169%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Caffrey, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moshinsky, D. J.</span><span> </span><span class="NLM_article-title">Prediction of specificity-determining residues for small-molecule kinase inhibitors</span> <span class="citation_source-journal">BMC Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1186%2F1471-2105-9-491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=19032760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A280%3ADC%252BD1cjovF2itA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=491-505&author=D.+R.+Caffreyauthor=E.+A.+Lunneyauthor=D.+J.+Moshinsky&title=Prediction+of+specificity-determining+residues+for+small-molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of specificity-determining residues for small-molecule kinase inhibitors</span></div><div class="casAuthors">Caffrey Daniel R; Lunney Elizabeth A; Moshinsky Deborah J</div><div class="citationInfo"><span class="NLM_cas:title">BMC bioinformatics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">491</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Designing small-molecule kinase inhibitors with desirable selectivity profiles is a major challenge in drug discovery.  A high-throughput screen for inhibitors of a given kinase will typically yield many compounds that inhibit more than one kinase.  A series of chemical modifications are usually required before a compound exhibits an acceptable selectivity profile.  Rationalizing the selectivity profile for a small-molecule inhibitor in terms of the specificity-determining kinase residues for that molecule can be an important step toward the goal of developing selective kinase inhibitors.  RESULTS:  Here we describe S-Filter, a method that combines sequence and structural information to predict specificity-determining residues for a small molecule and its kinase selectivity profile.  Analysis was performed on seven selective kinase inhibitors where a structural basis for selectivity is known.  S-Filter correctly predicts specificity determinants that were described by independent groups.  S-Filter also predicts a number of novel specificity determinants that can often be justified by further structural comparison.  CONCLUSION:  S-Filter is a valuable tool for analyzing kinase selectivity profiles.  The method identifies potential specificity determinants that are not readily apparent, and provokes further investigation at the structural level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyqCeJ7_kELOkdrW1FkXG-fW6udTcc2ebjgtRswZMB9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjovF2itA%253D%253D&md5=46acacc7b2711b7236436b3eac33b443</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1186%2F1471-2105-9-491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2105-9-491%26sid%3Dliteratum%253Aachs%26aulast%3DCaffrey%26aufirst%3DD.%2BR.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26aulast%3DMoshinsky%26aufirst%3DD.%2BJ.%26atitle%3DPrediction%2520of%2520specificity-determining%2520residues%2520for%2520small-molecule%2520kinase%2520inhibitors%26jtitle%3DBMC%2520Bioinf.%26date%3D2008%26volume%3D9%26spage%3D491%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafleur, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevado, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span> </span><span class="NLM_article-title">Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1093%2Fbioinformatics%2Fbtp650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=19942586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=198-204&author=D.+Huangauthor=T.+Zhouauthor=K.+Lafleurauthor=C.+Nevadoauthor=A.+Caflisch&title=Kinase+selectivity+potential+for+inhibitors+targeting+the+ATP+binding+site%3A+a+network+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis</span></div><div class="casAuthors">Huang, Danzhi; Zhou, Ting; Lafleur, Karine; Nevado, Cristina; Caflisch, Amedeo</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">198-204</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Small-mol. inhibitors targeting the ATP binding pocket of the catalytic domain of protein kinases have potential to become drugs devoid of (major) side effects, particularly if they bind selectively.  Here, the sequences of the 518 human kinases are first mapped onto the structural alignment of 116 kinases of known three-dimensional structure.  The multiple structure alignment is then used to encode the known strategies for developing selective inhibitors into a fingerprint.  Finally, a network anal. is used to partition the kinases into clusters according to similarity of their fingerprints, i.e., physico-chem. characteristics of the residues responsible for selective binding.  For each kinase the network anal. reveals the likelihood to find selective inhibitors targeting the ATP binding site.  Systematic guidelines are proposed to develop selective inhibitors.  Importantly, the network anal. suggests that the tyrosine kinase EphB4 has high selectivity potential, which is consistent with the selectivity profile of two novel EphB4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQVQsrpqB_ILVg90H21EOLACvtfcHk0lg3bWVbWaVILw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlGkug%253D%253D&md5=b6c63ccd4654219a56752f9cfc1356a3</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtp650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtp650%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DLafleur%26aufirst%3DK.%26aulast%3DNevado%26aufirst%3DC.%26aulast%3DCaflisch%26aufirst%3DA.%26atitle%3DKinase%2520selectivity%2520potential%2520for%2520inhibitors%2520targeting%2520the%2520ATP%2520binding%2520site%253A%2520a%2520network%2520analysis%26jtitle%3DBioinformatics%26date%3D2010%26volume%3D26%26spage%3D198%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Posy, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermsmeier, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todderud, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippy, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughney, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span> </span><span class="NLM_article-title">Trends in kinase selectivity: insights for target class-focused library screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101195a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFSms7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=54-66&author=S.+L.+Posyauthor=M.+A.+Hermsmeierauthor=W.+Vaccaroauthor=K.+H.+Ottauthor=G.+Todderudauthor=J.+S.+Lippyauthor=G.+L.+Trainorauthor=D.+A.+Loughneyauthor=S.+R.+Johnson&title=Trends+in+kinase+selectivity%3A+insights+for+target+class-focused+library+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Trends in Kinase Selectivity: Insights for Target Class-Focused Library Screening</span></div><div class="casAuthors">Posy, Shana L.; Hermsmeier, Mark A.; Vaccaro, Wayne; Ott, Karl-Heinz; Todderud, Gordon; Lippy, Jonathan S.; Trainor, George L.; Loughney, Deborah A.; Johnson, Stephen R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-66</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A kinome-wide selectivity screen of >20000 compds. with a rich representation of many structural classes has been completed.  Anal. of the selectivity patterns for each class shows that a broad spectrum of structural scaffolds can achieve specificity for many kinase families.  Kinase selectivity and potency are inversely correlated, a trend that is also found in a large set of kinase functional data.  Although selective and nonselective compds. are mostly similar in their physicochem. characteristics, we identify specific features that are present more frequently in compds. that bind to many kinases.  Our results support a scaffold-oriented approach for building compd. collections to screen kinase targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJlqg1ZszRmLVg90H21EOLACvtfcHk0lg3bWVbWaVILw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFSms7jJ&md5=f824b454904fb99d1ddd1ac6396cb784</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm101195a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101195a%26sid%3Dliteratum%253Aachs%26aulast%3DPosy%26aufirst%3DS.%2BL.%26aulast%3DHermsmeier%26aufirst%3DM.%2BA.%26aulast%3DVaccaro%26aufirst%3DW.%26aulast%3DOtt%26aufirst%3DK.%2BH.%26aulast%3DTodderud%26aufirst%3DG.%26aulast%3DLippy%26aufirst%3DJ.%2BS.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DLoughney%26aufirst%3DD.%2BA.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26atitle%3DTrends%2520in%2520kinase%2520selectivity%253A%2520insights%2520for%2520target%2520class-focused%2520library%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D54%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, J.</span><span> </span><span class="NLM_article-title">Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1942</span><span class="NLM_x">–</span> <span class="NLM_lpage">1956</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci1005004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVSrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=1942-1956&author=E.+Martinauthor=P.+Mukherjeeauthor=D.+Sullivanauthor=J.+Jansen&title=Profile-QSAR%3A+a+novel+meta-QSAR+method+that+combines+activities+across+the+kinase+family+to+accurately+predict+affinity%2C+selectivity%2C+and+cellular+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Profile-QSAR: A Novel meta-QSAR Method that Combines Activities across the Kinase Family To Accurately Predict Affinity, Selectivity, and Cellular Activity</span></div><div class="casAuthors">Martin, Eric; Mukherjee, Prasenjit; Sullivan, David; Jansen, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1942-1956</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Profile-QSAR is a novel 2D predictive model building method for kinases.  This "meta-QSAR" method models the activity of each compd. against a new kinase target as a linear combination of its predicted activities against a large panel of 92 previously studied kinases comprised from 115 assays.  Profile-QSAR starts with a sparse incomplete kinase by compd. (KxC) activity matrix, used to generate Bayesian QSAR models for the 92 "basis-set" kinases.  These Bayesian QSARs generate a complete "synthetic" KxC activity matrix of predictions.  These synthetic activities are used as "chem. descriptors" to train partial-least squares (PLS) models, from modest amts. of medium-throughput screening data, for predicting activity against new kinases.  The Profile-QSAR predictions for the 92 kinases (115 assays) gave a median external R2ext = 0.59 on 25% held-out test sets.  The method has proven accurate enough to predict pairwise kinase selectivities with a median correlation of R2ext = 0.61 for 958 kinase pairs with at least 600 common compds.  It has been further expanded by adding a "CkXC" cellular activity matrix to the KxC matrix to predict cellular activity for 42 kinase driven cellular assays with median R2ext = 0.58 for 24 target modulation assays and R2ext = 0.41 for 18 cell proliferation assays.  The 2D Profile-QSAR, along with the 3D Surrogate AutoShim, are the foundations of an internally developed iterative medium-throughput screening (IMTS) methodol. for virtual screening (VS) of compd. archives as an alternative to exptl. high-throughput screening (HTS).  The method has been applied to 20 actual prospective kinase projects.  Biol. results have so far been obtained in eight of them.  Q2 values ranged from 0.3 to 0.7.  Hit-rates at 10 uM for exptl. tested compds. varied from 25% to 80%, except in K5, which was a special case aimed specifically at finding "type II" binders, where none of the compds. were predicted to be active at 10 μM.  These overall results are particularly striking as chem. novelty was an important criterion in selecting compds. for testing.  The method is completely automated.  Predicted activities for nearly 4 million internal and com. compds. across 115 kinase assays and 42 cellular assays are stored in the corporate database.  Like computed phys. properties, this predicted kinase activity profile can be computed and stored as each compd. is registered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjTg6KqlgEyLVg90H21EOLACvtfcHk0ligcClm2g6DwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVSrsrw%253D&md5=49422d01fd686a4befc9db7c123cfcce</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fci1005004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci1005004%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DMukherjee%26aufirst%3DP.%26aulast%3DSullivan%26aufirst%3DD.%26aulast%3DJansen%26aufirst%3DJ.%26atitle%3DProfile-QSAR%253A%2520a%2520novel%2520meta-QSAR%2520method%2520that%2520combines%2520activities%2520across%2520the%2520kinase%2520family%2520to%2520accurately%2520predict%2520affinity%252C%2520selectivity%252C%2520and%2520cellular%2520activity%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D1942%26epage%3D1956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Anderson, P. C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Sapio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmer, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoeniger, J. S.</span><span> </span><span class="NLM_article-title">Identification of binding specificity-determining features in protein families</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1926</span><span class="NLM_x">–</span> <span class="NLM_lpage">1939</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200979x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1926-1939&author=P.+C+Andersonauthor=V.+De+Sapioauthor=K.+B.+Turnerauthor=S.+P.+Elmerauthor=D.+C.+Roeauthor=J.+S.+Schoeniger&title=Identification+of+binding+specificity-determining+features+in+protein+families"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm200979x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200979x%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DP.%2BC%26aulast%3DDe%2BSapio%26aufirst%3DV.%26aulast%3DTurner%26aufirst%3DK.%2BB.%26aulast%3DElmer%26aufirst%3DS.%2BP.%26aulast%3DRoe%26aufirst%3DD.%2BC.%26aulast%3DSchoeniger%26aufirst%3DJ.%2BS.%26atitle%3DIdentification%2520of%2520binding%2520specificity-determining%2520features%2520in%2520protein%2520families%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1926%26epage%3D1939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0ligcClm2g6DwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Korr, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toschi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohlenz, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreft, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, B.</span><span> </span><span class="NLM_article-title">LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">910</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1016%2Fj.cellsig.2005.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=16243488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=910-920&author=D.+Korrauthor=L.+Toschiauthor=P.+Donnerauthor=H.+D.+Pohlenzauthor=B.+Kreftauthor=B.+Weiss&title=LRRK1+protein+kinase+activity+is+stimulated+upon+binding+of+GTP+to+its+Roc+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain</span></div><div class="casAuthors">Korr, Daniel; Toschi, Luisella; Donner, Peter; Pohlenz, Hans-Dieter; Kreft, Bertolt; Weiss, Bertram</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">910-920</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human leucine-rich repeat kinase 1 (LRRK1) is a multi-domain protein of unknown function belonging to the ROCO family of complex proteins.  Here, we report the mol. characterization of human LRRK1 and show, for the first time, that LRRK1 is both a functional protein kinase and a GDP/GTP-binding protein.  Binding of GTP to LRRK1 is specific, requires the GTPase-like Roc domain, and leads to a stimulation of LRRK1 kinase activity.  LRRK1 is the first example of a GTP-regulated protein kinase harboring both the kinase effector domain and the GTP-binding regulatory domain.  Hence, we propose a model in which LRRK1 cycles between a GTP-bound active and a GDP-bound inactive state.  Moreover, we mutated LRRK1 to mimic mutations previously identified in LRRK2/dardarin, the only human paralogue of LRRK1, that have been linked to autosomal-dominant parkinsonism.  We demonstrate that three of four mutations analyzed significantly downregulate LRRK1 kinase activity.  Ultimately, the results presented for LRRK1 may contribute to the elucidation of LRRK2's role in the pathogenesis of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy_2JwaZskS7Vg90H21EOLACvtfcHk0ligcClm2g6DwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlakurc%253D&md5=52b70550b230dc8be509aa3767a1f2f5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2005.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2005.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DKorr%26aufirst%3DD.%26aulast%3DToschi%26aufirst%3DL.%26aulast%3DDonner%26aufirst%3DP.%26aulast%3DPohlenz%26aufirst%3DH.%2BD.%26aulast%3DKreft%26aufirst%3DB.%26aulast%3DWeiss%26aufirst%3DB.%26atitle%3DLRRK1%2520protein%2520kinase%2520activity%2520is%2520stimulated%2520upon%2520binding%2520of%2520GTP%2520to%2520its%2520Roc%2520domain%26jtitle%3DCell.%2520Signalling%26date%3D2006%26volume%3D18%26spage%3D910%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48a"><span><span class="NLM_contrib-group">Galkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span> </span><span class="NLM_article-title">Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=270-275&author=A.+V.+Galkinauthor=J.+S.+Melnickauthor=S.+Kimauthor=T.+L.+Hoodauthor=N.+Liauthor=L.+Liauthor=G.+Xiaauthor=R.+Steensmaauthor=G.+Chopiukauthor=J.+Jiangauthor=Y.+Wanauthor=P.+Dingauthor=Y.+Liuauthor=F.+Sunauthor=P.+G.+Schultzauthor=N.+S.+Grayauthor=M.+Warmuth&title=Identification+of+NVP-TAE684%2C+a+potent%2C+selective%2C+and+efficacious+inhibitor+of+NPM-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalkin%26aufirst%3DA.%2BV.%26aulast%3DMelnick%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHood%26aufirst%3DT.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWarmuth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520NVP-TAE684%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitor%2520of%2520NPM-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D270%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit48b"><span>Erratum in  <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">2025</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Erratum+in+Proc.+Natl.+Acad.+Sci.+U.S.A.+2007%2C+104%2C+2025."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D2025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Pyrrolopyridine inhibitors of mitogen-activated protein kinase activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0611004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2647-2654&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=W.+F.+Vernierauthor=M.+W.+Mahoneyauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=J.+F.+Schindlerauthor=D.+B.+Reitzauthor=R.+J.+Mourey&title=Pyrrolopyridine+inhibitors+of+mitogen-activated+protein+kinase+activated+protein+kinase+2+%28MK-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm0611004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611004%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DPyrrolopyridine%2520inhibitors%2520of%2520mitogen-activated%2520protein%2520kinase%2520activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2647%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Huggins, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span> </span><span class="NLM_article-title">Rational approaches to improving selectivity in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1424</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2010332" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1424-1444&author=D.+J.+Hugginsauthor=W.+Shermanauthor=B.+Tidor&title=Rational+approaches+to+improving+selectivity+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Approaches to Improving Selectivity in Drug Design</span></div><div class="casAuthors">Huggins, David J.; Sherman, Woody; Tidor, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1424-1444</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Rational Approaches to improving selectivity in Drug Design are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJv9AbW-c3TbVg90H21EOLACvtfcHk0ljrtaJyYLoxgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D&md5=5b7bf49f9f96a05adad4d42f63739252</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm2010332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010332%26sid%3Dliteratum%253Aachs%26aulast%3DHuggins%26aufirst%3DD.%2BJ.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DTidor%26aufirst%3DB.%26atitle%3DRational%2520approaches%2520to%2520improving%2520selectivity%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1424%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosgrove, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruston, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFaul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colclough, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, B.</span><span> </span><span class="NLM_article-title">Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6672</span><span class="NLM_x">–</span> <span class="NLM_lpage">6682</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0605233" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6672-6682&author=A.+G.+Leachauthor=H.+D.+Jonesauthor=D.+A.+Cosgroveauthor=P.+W.+Kennyauthor=L.+Rustonauthor=P.+MacFaulauthor=J.+M.+Woodauthor=N.+Colcloughauthor=B.+Law&title=Matched+molecular+pairs+as+a+guide+in+the+optimization+of+pharmaceutical+properties%3B+a+study+of+aqueous+solubility%2C+plasma+protein+binding+and+oral+exposure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Guide in the Optimization of Pharmaceutical Properties; a Study of Aqueous Solubility, Plasma Protein Binding and Oral Exposure</span></div><div class="casAuthors">Leach, Andrew G.; Jones, Huw D.; Cosgrove, David A.; Kenny, Peter W.; Ruston, Linette; MacFaul, Philip; Wood, J. Matthew; Colclough, Nicola; Law, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6672-6682</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By identifying every pair of mols. that differ only by a particular, well-defined, structural transformation in a database of measured properties and computing the corresponding change in property, we obtain an overview of the effect that structural change has upon the property and set an expectation for what will happen when that transformation is applied elsewhere.  The mean change indicates the expected magnitude of the change in the property and the no. of cases in which the property increases give the probability that the structural transformation will cause the property to increase.  Outliers indicate potential ways of avoiding the general trend.  Comparing to changes in lipophilicity highlights structural transformations that have unusual effects, some of which can be explained by conformational changes.  In this paper, we focus upon the effects on aq. soly., plasma protein binding and oral exposure of adding substituents to arom. rings and methylating heteroatoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcyrloR79Oq7Vg90H21EOLACvtfcHk0ljrtaJyYLoxgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO&md5=2c143b424aee3ddb6c34616aff699ee0</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm0605233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605233%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DJones%26aufirst%3DH.%2BD.%26aulast%3DCosgrove%26aufirst%3DD.%2BA.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DRuston%26aufirst%3DL.%26aulast%3DMacFaul%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DLaw%26aufirst%3DB.%26atitle%3DMatched%2520molecular%2520pairs%2520as%2520a%2520guide%2520in%2520the%2520optimization%2520of%2520pharmaceutical%2520properties%253B%2520a%2520study%2520of%2520aqueous%2520solubility%252C%2520plasma%2520protein%2520binding%2520and%2520oral%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6672%26epage%3D6682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Peltason, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">SAR index: quantifying the nature of structure–activity relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5571</span><span class="NLM_x">–</span> <span class="NLM_lpage">5578</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0705713" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5571-5578&author=L.+Peltasonauthor=J.+Bajorath&title=SAR+index%3A+quantifying+the+nature+of+structure%E2%80%93activity+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm0705713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0705713%26sid%3Dliteratum%253Aachs%26aulast%3DPeltason%26aufirst%3DL.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DSAR%2520index%253A%2520quantifying%2520the%2520nature%2520of%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5571%26epage%3D5578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Wassermann, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Chemical substitutions that introduce activity cliffs across different compound classes and biological targets</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1248</span><span class="NLM_x">–</span> <span class="NLM_lpage">1256</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci1001845" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVGhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=1248-1256&author=A.+M.+Wassermannauthor=J.+Bajorath&title=Chemical+substitutions+that+introduce+activity+cliffs+across+different+compound+classes+and+biological+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Substitutions That Introduce Activity Cliffs Across Different Compound Classes and Biological Targets</span></div><div class="casAuthors">Wassermann, Anne Mai; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1248-1256</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Applying the concept of matched mol. pairs, the authors have systematically analyzed the ability of defined chem. changes to introduce activity cliffs.  Public domain compd. data were systematically screened for matched mol. pairs that were then organized according to chem. transformations they represent and assocd. potency changes.  From vast available chem. transformation space, including both R-group and core substructure changes, ∼250 nonredundant substitutions were identified that displayed a general tendency to form activity cliffs.  These substitutions introduced activity cliffs in the structural context of diverse scaffolds and in compds. active against many different targets.  Activity cliff-forming transformations were often rather simple, including replacements of small functional groups.  Moreover, in many instances, chem. very similar transformations were identified that had a much lower propensity to form activity cliffs or no detectable cliff potential.  Thus, clear preferences emerged for specific transformations.  A compendium of substitutions with general activity cliff-forming potential is provided to aid in compd. optimization efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUSS8Tj-rk8bVg90H21EOLACvtfcHk0lhm-UxE3x47RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVGhtrY%253D&md5=381262f83abb19d326dbf95ddc367565</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fci1001845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci1001845%26sid%3Dliteratum%253Aachs%26aulast%3DWassermann%26aufirst%3DA.%2BM.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DChemical%2520substitutions%2520that%2520introduce%2520activity%2520cliffs%2520across%2520different%2520compound%2520classes%2520and%2520biological%2520targets%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D1248%26epage%3D1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Peltason, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Computational analysis of activity and selectivity cliffs</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">672</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1007%2F978-1-60761-839-3_4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=20838966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlaqu7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=672&publication_year=2011&pages=119-132&author=L.+Peltasonauthor=J.+Bajorath&title=Computational+analysis+of+activity+and+selectivity+cliffs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Computational analysis of activity and selectivity cliffs</span></div><div class="casAuthors">Peltason, Lisa; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">672</span>
        (<span class="NLM_cas:issue">Chemoinformatics and Computational Chemical Biology</span>),
    <span class="NLM_cas:pages">119-132</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The exploration of structure-activity relationships (SARs) is a major challenge in medicinal chem. and usually focuses on compd. potency for individual targets.  However, selectivity of small mols. that are active against related targets is another crit. parameter in chem. lead optimization.  Here, an integrative approach for the systematic anal. of SARs and structure-selectivity relationships (SSRs) of small mols. is presented.  The computational methodol. is described and a cathepsin inhibitor set is used to discuss key aspects of the anal.  Combining a numerical scoring scheme and graphical visualization of mol. networks, the approach enables the identification of different local SAR and SSR environments.  Comparative anal. of these environments reveals variable relationships between mol. structure, potency, and selectivity.  Furthermore, key compds. are identified that are involved in the formation of activity and/or selectivity cliffs and often display structural features that det. compd. selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1gw1jY9CO97Vg90H21EOLACvtfcHk0lhm-UxE3x47RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlaqu7fF&md5=76cdbdc87385c145a0b4cd08a22039cc</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2F978-1-60761-839-3_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-60761-839-3_4%26sid%3Dliteratum%253Aachs%26aulast%3DPeltason%26aufirst%3DL.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DComputational%2520analysis%2520of%2520activity%2520and%2520selectivity%2520cliffs%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2011%26volume%3D672%26spage%3D119%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Griffen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. J.</span><span> </span><span class="NLM_article-title">Matched molecular pairs as a medicinal chemistry tool</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7739</span><span class="NLM_x">–</span> <span class="NLM_lpage">7750</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200452d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7739-7750&author=E.+Griffenauthor=A.+G.+Leachauthor=G.+R.+Robbauthor=D.+J.+Warner&title=Matched+molecular+pairs+as+a+medicinal+chemistry+tool"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Medicinal Chemistry Tool</span></div><div class="casAuthors">Griffen, Ed; Leach, Andrew G.; Robb, Graeme R.; Warner, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7739-7750</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">At the very heart of the role of a medicinal chemist or drug designer is the ability to link chem. structure to mol. properties.  This is the structure-activity relationship(SAR) or structure-property relationship(SPR).  Drug discovery projects often discover that a particular structural change causes a change to a property of interest.  The authors of this paper have been involved in developing and implementing some variations on the original theme of MMPA (matched mol. pairs anal.) and felt this to be the time to highlight some of these and to point toward future developments.  All of them are involved in the process of drug design, and it is within this context that they will set their comments.  In outline, they introduce matched mol. pair anal. and highlight why it fits so well with the kind of problem solving that is required in the process of drug design.  This will be followed by some comments concerning when the application of the methodol. is appropriate.  Then in a section intended for those with more computational interests, the authors describe the various ways that have been devised for identifying such matched pairs.  Throughout the paper, the authors have elected to use a publicly available data set to illustrate some of the comments: the ChEMBL database of inhibitors of the epidermal growth factor receptor tyrosine kinase (EGFR).  This consists of 2899 measurements of an IC50 annotated as a binding measurement on 2348 unique compds.  These measurements are drawn from a no. of sources, having been abstracted from the scientific literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMGFfO8Flm5bVg90H21EOLACvtfcHk0lhm-UxE3x47RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK&md5=fab3344d790d1c0ae688ec65830d9143</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm200452d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200452d%26sid%3Dliteratum%253Aachs%26aulast%3DGriffen%26aufirst%3DE.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DWarner%26aufirst%3DD.%2BJ.%26atitle%3DMatched%2520molecular%2520pairs%2520as%2520a%2520medicinal%2520chemistry%2520tool%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7739%26epage%3D7750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Seebeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagener, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">From activity cliffs to target-specific scoring models and pharmacophore hypotheses</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1639</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1630-1639&author=B.+Seebeckauthor=M.+Wagenerauthor=M.+Rarey&title=From+activity+cliffs+to+target-specific+scoring+models+and+pharmacophore+hypotheses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeebeck%26aufirst%3DB.%26aulast%3DWagener%26aufirst%3DM.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DFrom%2520activity%2520cliffs%2520to%2520target-specific%2520scoring%2520models%2520and%2520pharmacophore%2520hypotheses%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1630%26epage%3D1639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Scherrmann, J. M.</span><span> </span><span class="NLM_article-title">Expression and function of multidrug resistance transporters at the blood–brain barriers</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1517%2F17425255.1.2.233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=16922639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKltLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=233-246&author=J.+M.+Scherrmann&title=Expression+and+function+of+multidrug+resistance+transporters+at+the+blood%E2%80%93brain+barriers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and function of multidrug resistance transporters at the blood-brain barriers</span></div><div class="casAuthors">Scherrmann, Jean-Michel</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-246</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  The presence of active carrier-mediated transport of substrates from the brain to the blood is a major feature of the barrier properties of the blood-brain barrier (BBB).  These proteins lie in the luminal or abluminal membranes of the endothelial cells that form the BBB.  Some are ATP-binding cassette proteins (ABC) and many amphipathic cationic drugs are carried by P-glyco-protein (ABCB1) or ABCG2, which lie at the luminal pole of the BBB.  Several multidrug resistance-assocd. proteins (MRPs, ABCCs) are also present on the membranes of brain microvessels; these are mainly involved in the efflux of anionic compds.  All these ABC proteins help to protect the brain and form a crit. target for CNS Pharmaceuticals, influencing the clin. variability of responses to, and the design of, these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCALgzku018LVg90H21EOLACvtfcHk0lix12Qn0lLgQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKltLfM&md5=90d19490f886b3dcf00c9b71246409f9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1517%2F17425255.1.2.233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.1.2.233%26sid%3Dliteratum%253Aachs%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26atitle%3DExpression%2520and%2520function%2520of%2520multidrug%2520resistance%2520transporters%2520at%2520the%2520blood%25E2%2580%2593brain%2520barriers%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2005%26volume%3D1%26spage%3D233%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Schinkel, A. H.</span><span> </span><span class="NLM_article-title">P-Glycoprotein, a gatekeeper in the blood–brain barrier</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1999&pages=179-194&author=A.+H.+Schinkel&title=P-Glycoprotein%2C+a+gatekeeper+in+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DP-Glycoprotein%252C%2520a%2520gatekeeper%2520in%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1999%26volume%3D36%26spage%3D179%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieplak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1074</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=1049-1074&author=J.+Wangauthor=P.+Cieplakauthor=P.+A.+Kollman&title=How+well+does+a+restrained+electrostatic+potential+%28RESP%29+model+perform+in+calculating+conformational+energies+of+organic+and+biological+molecules%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span></div><div class="casAuthors">Wang, Junmei; Cieplak, Piotr; Kollman, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1049-1074</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The authors present conformational energies for a mol. mech. model (Parm99) developed for org. and biol. mols. using the restrained electrostatic potential (RESP) approach to derive the partial charges.  This approach uses the simple generic force field model (Parm94), and attempts to add a minimal no. of extra Fourier components to the torsional energies, but doing so only when there is a phys. justification.  The results are quite encouraging, not only for the 34-mol. set that was studied by both the highest level ab initio model (GVB/LMP2) and expt., but also for the 55-mol. set for which high-quality exptl. data are available.  Considering the 55 mols. studied by all the force field models for which there are exptl. data, the av. abs. errors (AAEs) are 0.28 (this model), 0.52 (MM3), 0.57 (CHARMm [MSI]), and 0.43 kcal/mol (MMFF).  For the 34-mol. set, the AAEs of this model vs. expt. and ab initio are 0.28 and 0.27 kcal/mol, resp.  This is a lower error than found with MM3 and CHARMm, and is comparable to that found with MMFF (0.31 and 0.22 kcal/mol).  The authors also present 2 examples of how well the torsional parameters are transferred from the training set to the test set.  The abs. errors of mols. in the test set are only slightly larger than in the training set (differences of <0.1 kcal/mol).  Therefore, a simple generic force field with a limited no. of specific torsional parameters can describe intra- and intermol. interactions, although all comparison mols. were selected from 82-compd. training set.  Also this effective 2-body model can be extended for use with a nonadditive force field (NAFF), both with and without lone pairs.  Without changing the torsional parameters, the use of more accurate charges and polarization increases av. abs. error compared with expt., but adjustment of the parameters restores the level of agreement found with the additive model.  After reoptimizing the Ψ, Φ torsional parameters in peptides using alanine dipeptide (6 conformational pairs) and alanine tetrapeptide (11 conformational pairs), the new model gives better energies than the Cornell et al. force field.  The av. abs. error of this model for high-level ab initio calcn. is 0.82 kcal/mol for alanine dipeptide and tetrapeptide as compared with 1.80 kcal/mol for the Cornell et al. model.  For nucleosides, the new model also gives improved energies compared with the Cornell et al. model.  To optimize force field parameters, the authors developed a program called parmscan, which can iteratively scan the torsional parameters in a systematic manner and finally obtain the vest torsional potentials.  Besides the org. mols. in test set, parmscan was also successful in optimizing the Ψ, Φ torsional parameters in peptides to significantly improve agreement between mol. mech. and high-level ab initio energies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0dHME9_PfT7Vg90H21EOLACvtfcHk0lix12Qn0lLgQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D&md5=c81631289cf58f63917e2a9fa9547ab6</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-987X%2528200009%252921%253A12%253C1049%253A%253AAID-JCC3%253E3.0.CO%253B2-F%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DHow%2520well%2520does%2520a%2520restrained%2520electrostatic%2520potential%2520%2528RESP%2529%2520model%2520perform%2520in%2520calculating%2520conformational%2520energies%2520of%2520organic%2520and%2520biological%2520molecules%253F%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2000%26volume%3D21%26spage%3D1049%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Thompson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. J.</span><span> </span><span class="NLM_article-title">CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4673</span><span class="NLM_x">–</span> <span class="NLM_lpage">4680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1994&pages=4673-4680&author=J.+D.+Thompsonauthor=D.+G.+Higginsauthor=T.+J.+Gibson&title=CLUSTAL+W%3A+improving+the+sensitivity+of+progressive+multiple+sequence+alignment+through+sequence+weighting%2C+position+specific+gap+penalties+and+weight+matrix+choice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DJ.%2BD.%26aulast%3DHiggins%26aufirst%3DD.%2BG.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26atitle%3DCLUSTAL%2520W%253A%2520improving%2520the%2520sensitivity%2520of%2520progressive%2520multiple%2520sequence%2520alignment%2520through%2520sequence%2520weighting%252C%2520position%2520specific%2520gap%2520penalties%2520and%2520weight%2520matrix%2520choice%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1994%26volume%3D22%26spage%3D4673%26epage%3D4680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span> <span class="citation_source-book">Pipeline Pilot</span>, version <span class="NLM_edition">7.5</span>; <span class="NLM_publisher-name">Accelrys Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pipeline+Pilot%2C+version+7.5%3B+Accelrys+Inc.%3A+San+Diego%2C+CA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DPipeline%2520Pilot%26pub%3DAccelrys%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Rogers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, M.</span><span> </span><span class="NLM_article-title">Extended-connectivity fingerprints</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci100050t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=742-754&author=D.+Rogersauthor=M.+Hahn&title=Extended-connectivity+fingerprints"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-Connectivity Fingerprints</span></div><div class="casAuthors">Rogers, David; Hahn, Mathew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">742-754</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Extended-connectivity fingerprints (ECFPs) are a novel class of topol. fingerprints for mol. characterization.  Historically, topol. fingerprints were developed for substructure and similarity searching.  ECFPs were developed specifically for structure-activity modeling.  ECFPs are circular fingerprints with a no. of useful qualities: they can be very rapidly calcd.; they are not predefined and can represent an essentially infinite no. of different mol. features (including stereochem. information); their features represent the presence of particular substructures, allowing easier interpretation of anal. results; and the ECFP algorithm can be tailored to generate different types of circular fingerprints, optimized for different uses.  While the use of ECFPs has been widely adopted and validated, a description of their implementation has not previously been presented in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra43orI-Y7lbVg90H21EOLACvtfcHk0lix12Qn0lLgQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D&md5=cd6c736cd7a3d280b67f5316acce8006</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fci100050t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100050t%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DD.%26aulast%3DHahn%26aufirst%3DM.%26atitle%3DExtended-connectivity%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D742%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48a','cit48b'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 57 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Douglas S. Williamson, Garrick P. Smith, Gitte K. Mikkelsen, Thomas Jensen, Pamela Acheson-Dossang, Lassina Badolo, Simon T. Bedford, Victoria Chell, I-Jen Chen, Pawel Dokurno, Morten Hentzer, Samantha Newland, Stuart C. Ray, Terry Shaw, Allan E. Surgenor, Lindsey Terry, Yikang Wang, <span class="NLM_string-name hlFld-ContribAuthor">Kenneth V. Christensen</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Pyrrolo[2,3-d]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 10312-10332. <a href="https://doi.org/10.1021/acs.jmedchem.1c00720" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00720%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BPyrrolo%25255B2%25252C3-d%25255Dpyrimidine-Derived%252BLeucine-Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%252BInhibitors%252BUsing%252Ba%252BCheckpoint%252BKinase%252B1%252B%252528CHK1%252529-Derived%252BCrystallographic%252BSurrogate%26aulast%3DWilliamson%26aufirst%3DDouglas%2BS.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D20042021%26date%3D29062021%26volume%3D64%26issue%3D14%26spage%3D10312%26epage%3D10332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Josefa Zaldivar-Diez, Lingling Li, Ana M. Garcia, Wen-Ning Zhao, Cristina Medina-Menendez, Stephen. J. Haggarty, Carmen Gil, Aixa V. Morales, <span class="NLM_string-name hlFld-ContribAuthor">Ana Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">Benzothiazole-Based LRRK2 Inhibitors as Wnt Enhancers and Promoters of Oligodendrocytic Fate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2638-2655. <a href="https://doi.org/10.1021/acs.jmedchem.9b01752" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01752</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01752%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzothiazole-Based%252BLRRK2%252BInhibitors%252Bas%252BWnt%252BEnhancers%252Band%252BPromoters%252Bof%252BOligodendrocytic%252BFate%26aulast%3DZaldivar-Diez%26aufirst%3DJosefa%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D22102019%26date%3D26122019%26date%3D11122019%26volume%3D63%26issue%3D5%26spage%3D2638%26epage%3D2655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas S.  Williamson</span>, <span class="hlFld-ContribAuthor ">Garrick P.  Smith</span>, <span class="hlFld-ContribAuthor ">Pamela  Acheson-Dossang</span>, <span class="hlFld-ContribAuthor ">Simon T.  Bedford</span>, <span class="hlFld-ContribAuthor ">Victoria  Chell</span>, <span class="hlFld-ContribAuthor ">I-Jen  Chen</span>, <span class="hlFld-ContribAuthor ">Justus C. A.  Daechsel</span>, <span class="hlFld-ContribAuthor ">Zoe  Daniels</span>, <span class="hlFld-ContribAuthor ">Laurent  David</span>, <span class="hlFld-ContribAuthor ">Pawel  Dokurno</span>, <span class="hlFld-ContribAuthor ">Morten  Hentzer</span>, <span class="hlFld-ContribAuthor ">Martin C.  Herzig</span>, <span class="hlFld-ContribAuthor ">Roderick E.  Hubbard</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Moore</span>, <span class="hlFld-ContribAuthor ">James B.  Murray</span>, <span class="hlFld-ContribAuthor ">Samantha  Newland</span>, <span class="hlFld-ContribAuthor ">Stuart C.  Ray</span>, <span class="hlFld-ContribAuthor ">Terry  Shaw</span>, <span class="hlFld-ContribAuthor ">Allan E.  Surgenor</span>, <span class="hlFld-ContribAuthor ">Lindsey  Terry</span>, <span class="hlFld-ContribAuthor ">Kenneth  Thirstrup</span>, <span class="hlFld-ContribAuthor ">Yikang  Wang</span>, and <span class="hlFld-ContribAuthor ">Kenneth V.  Christensen</span>  . </span><span class="cited-content_cbyCitation_article-title">Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (21)
                                     , 8945-8962. <a href="https://doi.org/10.1021/acs.jmedchem.7b01186" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01186%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BLeucine-Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%252BInhibitors%252BUsing%252Ba%252BCrystallographic%252BSurrogate%252BDerived%252Bfrom%252BCheckpoint%252BKinase%252B1%252B%252528CHK1%252529%26aulast%3DWilliamson%26aufirst%3DDouglas%2BS.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15082017%26date%3D27102017%26date%3D09112017%26date%3D12102017%26volume%3D60%26issue%3D21%26spage%3D8945%26epage%3D8962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serge  Christmann-Franck</span>, <span class="hlFld-ContribAuthor ">Gerard J. P.  van Westen</span>, <span class="hlFld-ContribAuthor ">George  Papadatos</span>, <span class="hlFld-ContribAuthor ">Fanny  Beltran Escudie</span>, <span class="hlFld-ContribAuthor ">Alexander  Roberts</span>, <span class="hlFld-ContribAuthor ">John P.  Overington</span>, and <span class="hlFld-ContribAuthor ">Daniel  Domine</span>  . </span><span class="cited-content_cbyCitation_article-title">Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound–Kinase Activities: A Way toward Selective Promiscuity by Design?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (9)
                                     , 1654-1675. <a href="https://doi.org/10.1021/acs.jcim.6b00122" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00122%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DUnprecedently%252BLarge-Scale%252BKinase%252BInhibitor%252BSet%252BEnabling%252Bthe%252BAccurate%252BPrediction%252Bof%252BCompound%2525E2%252580%252593Kinase%252BActivities%25253A%252BA%252BWay%252Btoward%252BSelective%252BPromiscuity%252Bby%252BDesign%25253F%26aulast%3DChristmann-Franck%26aufirst%3DSerge%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03032016%26date%3D11082016%26date%3D26092016%26date%3D02082016%26volume%3D56%26issue%3D9%26spage%3D1654%26epage%3D1675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2016,</strong> <em>29 </em>
                                    (4)
                                     , 564-616. <a href="https://doi.org/10.1021/acs.chemrestox.6b00043" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.6b00043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.6b00043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.6b00043%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DImproving%252BDrug%252BDesign%25253A%252BAn%252BUpdate%252Bon%252BRecent%252BApplications%252Bof%252BEfficiency%252BMetrics%25252C%252BStrategies%252Bfor%252BReplacing%252BProblematic%252BElements%25252C%252Band%252BCompounds%252Bin%252BNontraditional%252BDrug%252BSpace%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03022016%26date%3D14032016%26date%3D18042016%26volume%3D29%26issue%3D4%26spage%3D564%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marian C.  Bryan</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Burdick</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">Yuan  Chen</span>, <span class="hlFld-ContribAuthor ">Saundra  Clausen</span>, <span class="hlFld-ContribAuthor ">Jennafer  Dotson</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Richard  Elliott</span>, <span class="hlFld-ContribAuthor ">Emily J.  Hanan</span>, <span class="hlFld-ContribAuthor ">Robert  Heald</span>, <span class="hlFld-ContribAuthor ">Philip  Jackson</span>, <span class="hlFld-ContribAuthor ">Hank  La</span>, <span class="hlFld-ContribAuthor ">Michael  Lainchbury</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Sam E.  Mann</span>, <span class="hlFld-ContribAuthor ">Hans E.  Purkey</span>, <span class="hlFld-ContribAuthor ">Gabriele  Schaefer</span>, <span class="hlFld-ContribAuthor ">Stephen  Schmidt</span>, <span class="hlFld-ContribAuthor ">Eileen  Seward</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Shumei  Wang</span>, <span class="hlFld-ContribAuthor ">Ivana  Yen</span>, <span class="hlFld-ContribAuthor ">Christine  Yu</span>, and <span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>  . </span><span class="cited-content_cbyCitation_article-title">Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFR. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     , 100-104. <a href="https://doi.org/10.1021/acsmedchemlett.5b00428" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00428</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00428%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPyridones%252Bas%252BHighly%252BSelective%25252C%252BNoncovalent%252BInhibitors%252Bof%252BT790M%252BDouble%252BMutants%252Bof%252BEGFR%26aulast%3DBryan%26aufirst%3DMarian%2BC.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D06112015%26date%3D17122015%26date%3D21122015%26date%3D14012016%26date%3D17122015%26volume%3D7%26issue%3D1%26spage%3D100%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span> and <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (17)
                                     , 6733-6746. <a href="https://doi.org/10.1021/acs.jmedchem.5b00261" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00261%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemical%252BBiology%252Bof%252BLeucine-Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%252BInhibitors%26aulast%3DEstrada%26aufirst%3DAnthony%2BA.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13022015%26date%3D14052015%26date%3D10092015%26date%3D27042015%26volume%3D58%26issue%3D17%26spage%3D6733%26epage%3D6746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernd K.  Gilsbach</span>, <span class="hlFld-ContribAuthor ">Ana C.  Messias</span>, <span class="hlFld-ContribAuthor ">Genta  Ito</span>, <span class="hlFld-ContribAuthor ">Michael  Sattler</span>, <span class="hlFld-ContribAuthor ">Dario R.  Alessi</span>, <span class="hlFld-ContribAuthor ">Alfred  Wittinghofer</span>, and <span class="hlFld-ContribAuthor ">Arjan  Kortholt</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Characterization of LRRK2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (9)
                                     , 3751-3756. <a href="https://doi.org/10.1021/jm5018779" title="DOI URL">https://doi.org/10.1021/jm5018779</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5018779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5018779%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BCharacterization%252Bof%252BLRRK2%252BInhibitors%26aulast%3DGilsbach%26aufirst%3DBernd%2BK.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D04122014%26date%3D01052015%26date%3D14052015%26date%3D21042015%26volume%3D58%26issue%3D9%26spage%3D3751%26epage%3D3756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaclyn L.  Henderson</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Hayward</span>, <span class="hlFld-ContribAuthor ">Karen J.  Coffman</span>, <span class="hlFld-ContribAuthor ">Jayasankar  Jasti</span>, <span class="hlFld-ContribAuthor ">Ravi G.  Kurumbail</span>, <span class="hlFld-ContribAuthor ">Travis T.  Wager</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>, <span class="hlFld-ContribAuthor ">G. Stephen  Noell</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Elie  Needle</span>, <span class="hlFld-ContribAuthor ">Zdenek  Berger</span>, <span class="hlFld-ContribAuthor ">Stefanus J.  Steyn</span>, <span class="hlFld-ContribAuthor ">Christopher  Houle</span>, <span class="hlFld-ContribAuthor ">Warren D.  Hirst</span>, and <span class="hlFld-ContribAuthor ">Paul  Galatsis</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Preclinical Profiling of 3-[4-(Morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a Highly Potent, Selective, Brain Penetrant, and in Vivo Active LRRK2 Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 419-432. <a href="https://doi.org/10.1021/jm5014055" title="DOI URL">https://doi.org/10.1021/jm5014055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5014055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5014055%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BPreclinical%252BProfiling%252Bof%252B3-%25255B4-%252528Morpholin-4-yl%252529-7H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidin-5-yl%25255Dbenzonitrile%252B%252528PF-06447475%252529%25252C%252Ba%252BHighly%252BPotent%25252C%252BSelective%25252C%252BBrain%252BPenetrant%25252C%252Band%252Bin%252BVivo%252BActive%252BLRRK2%252BKinase%252BInhibitor%26aulast%3DHenderson%26aufirst%3DJaclyn%2BL.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D12092014%26date%3D17112014%26date%3D08012015%26date%3D29102014%26volume%3D58%26issue%3D1%26spage%3D419%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">Charles  Baker-Glenn</span>, <span class="hlFld-ContribAuthor ">Alan  Beresford</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Burdick</span>, <span class="hlFld-ContribAuthor ">Mark  Chambers</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>, <span class="hlFld-ContribAuthor ">Sara L.  Dominguez</span>, <span class="hlFld-ContribAuthor ">Jennafer  Dotson</span>, <span class="hlFld-ContribAuthor ">Jason  Drummond</span>, <span class="hlFld-ContribAuthor ">Michael  Flagella</span>, <span class="hlFld-ContribAuthor ">Reina  Fuji</span>, <span class="hlFld-ContribAuthor ">Andrew  Gill</span>, <span class="hlFld-ContribAuthor ">Jason  Halladay</span>, <span class="hlFld-ContribAuthor ">Seth F.  Harris</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>, <span class="hlFld-ContribAuthor ">Tracy  Kleinheinz</span>, <span class="hlFld-ContribAuthor ">Donna W.  Lee</span>, <span class="hlFld-ContribAuthor ">Claire E. Le  Pichon</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Medhurst</span>, <span class="hlFld-ContribAuthor ">John G.  Moffat</span>, <span class="hlFld-ContribAuthor ">Kevin  Nash</span>, <span class="hlFld-ContribAuthor ">Kimberly  Scearce-Levie</span>, <span class="hlFld-ContribAuthor ">Zejuan  Sheng</span>, <span class="hlFld-ContribAuthor ">Daniel G.  Shore</span>, <span class="hlFld-ContribAuthor ">Susan  Wong</span>, <span class="hlFld-ContribAuthor ">Shuo  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Zhang</span>, <span class="hlFld-ContribAuthor ">Haitao  Zhu</span>, and <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (3)
                                     , 921-936. <a href="https://doi.org/10.1021/jm401654j" title="DOI URL">https://doi.org/10.1021/jm401654j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401654j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401654j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BHighly%252BPotent%25252C%252BSelective%25252C%252Band%252BBrain-Penetrant%252BAminopyrazole%252BLeucine-Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%252BSmall%252BMolecule%252BInhibitors%26aulast%3DEstrada%26aufirst%3DAnthony%2BA.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D25102013%26date%3D15012014%26date%3D13022014%26date%3D19122013%26volume%3D57%26issue%3D3%26spage%3D921%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yangbo  Feng</span>, <span class="hlFld-ContribAuthor ">Jeremy W.  Chambers</span>, <span class="hlFld-ContribAuthor ">Sarah  Iqbal</span>, <span class="hlFld-ContribAuthor ">Marcel  Koenig</span>, <span class="hlFld-ContribAuthor ">HaJeung  Park</span>, <span class="hlFld-ContribAuthor ">Lisa  Cherry</span>, <span class="hlFld-ContribAuthor ">Pamela  Hernandez</span>, <span class="hlFld-ContribAuthor ">Mariana  Figuera-Losada</span>, and <span class="hlFld-ContribAuthor ">Philip V.  LoGrasso</span>  . </span><span class="cited-content_cbyCitation_article-title">A Small Molecule Bidentate-Binding Dual Inhibitor Probe of the LRRK2 and JNK Kinases. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2013,</strong> <em>8 </em>
                                    (8)
                                     , 1747-1754. <a href="https://doi.org/10.1021/cb3006165" title="DOI URL">https://doi.org/10.1021/cb3006165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb3006165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb3006165%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DA%252BSmall%252BMolecule%252BBidentate-Binding%252BDual%252BInhibitor%252BProbe%252Bof%252Bthe%252BLRRK2%252Band%252BJNK%252BKinases%26aulast%3DFeng%26aufirst%3DYangbo%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D14112012%26date%3D28052013%26date%3D10062013%26date%3D16082013%26volume%3D8%26issue%3D8%26spage%3D1747%26epage%3D1754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Liu</span>, <span class="hlFld-ContribAuthor ">Samantha A.  Bender</span>, <span class="hlFld-ContribAuthor ">Gregory D.  Cuny</span>, <span class="hlFld-ContribAuthor ">Woody  Sherman</span>, <span class="hlFld-ContribAuthor ">Marcie  Glicksman</span>, and <span class="hlFld-ContribAuthor ">Soumya S.  Ray</span>  . </span><span class="cited-content_cbyCitation_article-title">Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson’s Disease-Linked LRRK2 Mutant G2019S. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2013,</strong> <em>52 </em>
                                    (10)
                                     , 1725-1736. <a href="https://doi.org/10.1021/bi3012077" title="DOI URL">https://doi.org/10.1021/bi3012077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi3012077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi3012077%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DType%252BII%252BKinase%252BInhibitors%252BShow%252Ban%252BUnexpected%252BInhibition%252BMode%252Bagainst%252BParkinson%2525E2%252580%252599s%252BDisease-Linked%252BLRRK2%252BMutant%252BG2019S%26aulast%3DLiu%26aufirst%3DMin%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D2013%26date%3D05092012%26date%3D04022013%26date%3D01032013%26date%3D12032013%26date%3D05022013%26volume%3D52%26issue%3D10%26spage%3D1725%26epage%3D1736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>, <span class="hlFld-ContribAuthor ">John  Atherall</span>, <span class="hlFld-ContribAuthor ">Charles  Baker-Glenn</span>, <span class="hlFld-ContribAuthor ">Alan  Beresford</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Burdick</span>, <span class="hlFld-ContribAuthor ">Mark  Chambers</span>, <span class="hlFld-ContribAuthor ">Sara L.  Dominguez</span>, <span class="hlFld-ContribAuthor ">Jason  Drummond</span>, <span class="hlFld-ContribAuthor ">Andrew  Gill</span>, <span class="hlFld-ContribAuthor ">Tracy  Kleinheinz</span>, <span class="hlFld-ContribAuthor ">Claire E.  Le Pichon</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Medhurst</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">John G.  Moffat</span>, <span class="hlFld-ContribAuthor ">Kevin  Nash</span>, <span class="hlFld-ContribAuthor ">Kimberly  Scearce-Levie</span>, <span class="hlFld-ContribAuthor ">Zejuan  Sheng</span>, <span class="hlFld-ContribAuthor ">Daniel G.  Shore</span>, <span class="hlFld-ContribAuthor ">Hervé  Van de Poël</span>, <span class="hlFld-ContribAuthor ">Shuo  Zhang</span>, <span class="hlFld-ContribAuthor ">Haitao  Zhu</span>, and <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (1)
                                     , 85-90. <a href="https://doi.org/10.1021/ml3003007" title="DOI URL">https://doi.org/10.1021/ml3003007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml3003007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml3003007%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BHighly%252BSelective%25252C%252BBrain-Penetrant%252BAminopyrazole%252BLRRK2%252BInhibitor%26aulast%3DChan%26aufirst%3DBryan%2BK.%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D24092012%26date%3D23112012%26date%3D29112012%26date%3D10012013%26date%3D23112012%26volume%3D4%26issue%3D1%26spage%3D85%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Charles  Baker-Glenn</span>, <span class="hlFld-ContribAuthor ">Alan  Beresford</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Burdick</span>, <span class="hlFld-ContribAuthor ">Mark  Chambers</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Antonio G.  DiPasquale</span>, <span class="hlFld-ContribAuthor ">Sara L.  Dominguez</span>, <span class="hlFld-ContribAuthor ">Jennafer  Dotson</span>, <span class="hlFld-ContribAuthor ">Jason  Drummond</span>, <span class="hlFld-ContribAuthor ">Michael  Flagella</span>, <span class="hlFld-ContribAuthor ">Sean  Flynn</span>, <span class="hlFld-ContribAuthor ">Reina  Fuji</span>, <span class="hlFld-ContribAuthor ">Andrew  Gill</span>, <span class="hlFld-ContribAuthor ">Janet  Gunzner-Toste</span>, <span class="hlFld-ContribAuthor ">Seth F.  Harris</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>, <span class="hlFld-ContribAuthor ">Tracy  Kleinheinz</span>, <span class="hlFld-ContribAuthor ">Donna W.  Lee</span>, <span class="hlFld-ContribAuthor ">Claire E.  Le Pichon</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Medhurst</span>, <span class="hlFld-ContribAuthor ">John G.  Moffat</span>, <span class="hlFld-ContribAuthor ">Susmith  Mukund</span>, <span class="hlFld-ContribAuthor ">Kevin  Nash</span>, <span class="hlFld-ContribAuthor ">Kimberly  Scearce-Levie</span>, <span class="hlFld-ContribAuthor ">Zejuan  Sheng</span>, <span class="hlFld-ContribAuthor ">Daniel G.  Shore</span>, <span class="hlFld-ContribAuthor ">Thuy  Tran</span>, <span class="hlFld-ContribAuthor ">Naimisha  Trivedi</span>, <span class="hlFld-ContribAuthor ">Shumei  Wang</span>, <span class="hlFld-ContribAuthor ">Shuo  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Zhang</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Haitao  Zhu</span>, and <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 9416-9433. <a href="https://doi.org/10.1021/jm301020q" title="DOI URL">https://doi.org/10.1021/jm301020q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301020q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301020q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BHighly%252BPotent%25252C%252BSelective%25252C%252Band%252BBrain-Penetrable%252BLeucine-Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%252BSmall%252BMolecule%252BInhibitors%26aulast%3DEstrada%26aufirst%3DAnthony%2BA.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D12072012%26date%3D15102012%26date%3D26112012%26date%3D17092012%26volume%3D55%26issue%3D22%26spage%3D9416%26epage%3D9433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hwan Geun  Choi</span>, <span class="hlFld-ContribAuthor ">Jinwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Xianming  Deng</span>, <span class="hlFld-ContribAuthor ">John M.  Hatcher</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Patricelli</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Dario R.  Alessi</span>, and <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>  . </span><span class="cited-content_cbyCitation_article-title">Brain Penetrant LRRK2 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (8)
                                     , 658-662. <a href="https://doi.org/10.1021/ml300123a" title="DOI URL">https://doi.org/10.1021/ml300123a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml300123a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml300123a%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBrain%252BPenetrant%252BLRRK2%252BInhibitor%26aulast%3DChoi%26aufirst%3DHwan%2BGeun%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D22052012%26date%3D18062012%26date%3D22062012%26date%3D09082012%26date%3D18062012%26volume%3D3%26issue%3D8%26spage%3D658%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dominika Natalia  Wojewska</span>, <span class="hlFld-ContribAuthor ">Arjan  Kortholt</span>. </span><span class="cited-content_cbyCitation_article-title">LRRK2 Targeting Strategies as Potential Treatment of Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (8)
                                     , 1101. <a href="https://doi.org/10.3390/biom11081101" title="DOI URL">https://doi.org/10.3390/biom11081101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11081101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11081101%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DLRRK2%252BTargeting%252BStrategies%252Bas%252BPotential%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DWojewska%26aufirst%3DDominika%2BNatalia%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D8%26spage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anmol  Gulati</span>, <span class="hlFld-ContribAuthor ">Charles S.  Yeung</span>, <span class="hlFld-ContribAuthor ">Blair  Lapointe</span>, <span class="hlFld-ContribAuthor ">Solomon D.  Kattar</span>, <span class="hlFld-ContribAuthor ">Hakan  Gunaydin</span>, <span class="hlFld-ContribAuthor ">Jack D.  Scott</span>, <span class="hlFld-ContribAuthor ">Kaleen K.  Childers</span>, <span class="hlFld-ContribAuthor ">Joey L.  Methot</span>, <span class="hlFld-ContribAuthor ">Vladimir  Simov</span>, <span class="hlFld-ContribAuthor ">Ravi  Kurukulasuriya</span>, <span class="hlFld-ContribAuthor ">Barbara  Pio</span>, <span class="hlFld-ContribAuthor ">Greg J.  Morriello</span>, <span class="hlFld-ContribAuthor ">Ping  Liu</span>, <span class="hlFld-ContribAuthor ">Haiqun  Tang</span>, <span class="hlFld-ContribAuthor ">Santhosh  Neelamkavil</span>, <span class="hlFld-ContribAuthor ">Harold B.  Wood</span>, <span class="hlFld-ContribAuthor ">Vanessa L.  Rada</span>, <span class="hlFld-ContribAuthor ">Michael J.  Ardolino</span>, <span class="hlFld-ContribAuthor ">Xin Cindy  Yan</span>, <span class="hlFld-ContribAuthor ">Rachel  Palte</span>, <span class="hlFld-ContribAuthor ">Karin  Otte</span>, <span class="hlFld-ContribAuthor ">Robert  Faltus</span>, <span class="hlFld-ContribAuthor ">Janice  Woodhouse</span>, <span class="hlFld-ContribAuthor ">Laxminarayan G.  Hegde</span>, <span class="hlFld-ContribAuthor ">Paul  Ciaccio</span>, <span class="hlFld-ContribAuthor ">Ellen C.  Minnihan</span>, <span class="hlFld-ContribAuthor ">Erin F.  DiMauro</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Fell</span>, <span class="hlFld-ContribAuthor ">Peter H.  Fuller</span>, <span class="hlFld-ContribAuthor ">J. Michael  Ellis</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (7)
                                     , 1164-1173. <a href="https://doi.org/10.1039/D1MD00097G" title="DOI URL">https://doi.org/10.1039/D1MD00097G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00097G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00097G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252Bbrain-penetrant%252Bpicolinamide%252Bderived%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Binhibitors%26aulast%3DGulati%26aufirst%3DAnmol%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D7%26spage%3D1164%26epage%3D1173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonia  Azeggagh</span>, <span class="hlFld-ContribAuthor ">Daniel C.  Berwick</span>. </span><span class="cited-content_cbyCitation_article-title">The development of inhibitors of leucine‐rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of play. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2021,</strong> <em>10 </em><a href="https://doi.org/10.1111/bph.15575" title="DOI URL">https://doi.org/10.1111/bph.15575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.15575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.15575%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DThe%252Bdevelopment%252Bof%252Binhibitors%252Bof%252Bleucine%2525E2%252580%252590rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Bas%252Ba%252Btherapeutic%252Bstrategy%252Bfor%252BParkinson%252527s%252Bdisease%25253A%252Bthe%252Bcurrent%252Bstate%252Bof%252Bplay%26aulast%3DAzeggagh%26aufirst%3DSonia%26date%3D2021%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liqian  Gao</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Xuan  Wang</span>, <span class="hlFld-ContribAuthor ">Fen  Yang</span>, <span class="hlFld-ContribAuthor ">Liuxing  Xie</span>, <span class="hlFld-ContribAuthor ">Jun  Shen</span>, <span class="hlFld-ContribAuthor ">Margaret A.  Brimble</span>, <span class="hlFld-ContribAuthor ">Qicai  Xiao</span>, <span class="hlFld-ContribAuthor ">Shao Q.  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescent probes for bioimaging of potential biomarkers in Parkinson's disease. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>50 </em>
                                    (2)
                                     , 1219-1250. <a href="https://doi.org/10.1039/D0CS00115E" title="DOI URL">https://doi.org/10.1039/D0CS00115E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CS00115E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CS00115E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DFluorescent%252Bprobes%252Bfor%252Bbioimaging%252Bof%252Bpotential%252Bbiomarkers%252Bin%252BParkinson%252527s%252Bdisease%26aulast%3DGao%26aufirst%3DLiqian%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D2%26spage%3D1219%26epage%3D1250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Zhang</span>, <span class="hlFld-ContribAuthor ">Shiou  Zhu</span>, <span class="hlFld-ContribAuthor ">Jiamei  Li</span>, <span class="hlFld-ContribAuthor ">Tingting  Jiang</span>, <span class="hlFld-ContribAuthor ">Lu  Feng</span>, <span class="hlFld-ContribAuthor ">Junping  Pei</span>, <span class="hlFld-ContribAuthor ">Guan  Wang</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>386 </em><a href="https://doi.org/10.1016/j.apsb.2021.02.016" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.02.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.02.016%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DTargeting%252Bautophagy%252Busing%252Bsmall-molecule%252Bcompounds%252Bto%252Bimprove%252Bpotential%252Btherapy%252Bof%252BParkinson%252527s%252Bdisease%26aulast%3DZhang%26aufirst%3DKai%26date%3D2021%26volume%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sofia  Domingos</span>, <span class="hlFld-ContribAuthor ">Teresa  Duarte</span>, <span class="hlFld-ContribAuthor ">Lucília  Saraiva</span>, <span class="hlFld-ContribAuthor ">Rita C  Guedes</span>, <span class="hlFld-ContribAuthor ">Rui  Moreira</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of Parkinson's disease. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (15)
                                     , 1953-1977. <a href="https://doi.org/10.4155/fmc-2018-0484" title="DOI URL">https://doi.org/10.4155/fmc-2018-0484</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0484%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Bfor%252Bthe%252Btreatment%252Bof%252BParkinson%252527s%252Bdisease%26aulast%3DDomingos%26aufirst%3DSofia%26date%3D2019%26volume%3D11%26issue%3D15%26spage%3D1953%26epage%3D1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">B.  Srinu</span>, <span class="hlFld-ContribAuthor ">R.  Parameshwar</span>, <span class="hlFld-ContribAuthor ">G.  Kali Charan</span>, <span class="hlFld-ContribAuthor ">E.  Srinivas</span>, <span class="hlFld-ContribAuthor ">Ch. P.  Koteswara Rao</span>, <span class="hlFld-ContribAuthor ">J. N.  Narendra Sharath Chandra</span>, <span class="hlFld-ContribAuthor ">S.  Naresh Varma</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Antitubercular Activity, and Molecular Docking Studies of Novel 2-(4-Chlorobenzylamino)-4-(cyclohexylmethylamino)-pyrimidine-5-carboxamides. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2019,</strong> <em>89 </em>
                                    (4)
                                     , 836-843. <a href="https://doi.org/10.1134/S1070363219040327" title="DOI URL">https://doi.org/10.1134/S1070363219040327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363219040327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363219040327%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DSynthesis%25252C%252BAntitubercular%252BActivity%25252C%252Band%252BMolecular%252BDocking%252BStudies%252Bof%252BNovel%252B2-%2525284-Chlorobenzylamino%252529-4-%252528cyclohexylmethylamino%252529-pyrimidine-5-carboxamides%26aulast%3DSrinu%26aufirst%3DB.%26date%3D2019%26date%3D2019%26volume%3D89%26issue%3D4%26spage%3D836%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel G.M.  Shore</span>, <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>, <span class="hlFld-ContribAuthor ">Alan  Beresford</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>, <span class="hlFld-ContribAuthor ">Jason  Drummond</span>, <span class="hlFld-ContribAuthor ">Andrew  Gill</span>, <span class="hlFld-ContribAuthor ">Tracy  Kleinheinz</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Medhurst</span>, <span class="hlFld-ContribAuthor ">Edward G.  McIver</span>, <span class="hlFld-ContribAuthor ">John G.  Moffat</span>, <span class="hlFld-ContribAuthor ">Haitao  Zhu</span>, <span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent azaindazole leucine-rich repeat kinase 2 (LRRK2) inhibitors possessing a key intramolecular hydrogen bond – Part 2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (4)
                                     , 674-680. <a href="https://doi.org/10.1016/j.bmcl.2018.10.017" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.10.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.10.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpotent%252Bazaindazole%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Binhibitors%252Bpossessing%252Ba%252Bkey%252Bintramolecular%252Bhydrogen%252Bbond%252B%2525E2%252580%252593%252BPart%252B2%26aulast%3DShore%26aufirst%3DDaniel%2BG.M.%26date%3D2019%26volume%3D29%26issue%3D4%26spage%3D674%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanne  Osborne</span>, <span class="hlFld-ContribAuthor ">Kristian  Birchall</span>, <span class="hlFld-ContribAuthor ">Denise J.  Tsagris</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Lewis</span>, <span class="hlFld-ContribAuthor ">Ela  Smiljanic-Hurley</span>, <span class="hlFld-ContribAuthor ">Debra L.  Taylor</span>, <span class="hlFld-ContribAuthor ">Alison  Levy</span>, <span class="hlFld-ContribAuthor ">Dario R.  Alessi</span>, <span class="hlFld-ContribAuthor ">Edward G.  McIver</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent and selective 5-azaindazole inhibitors of leucine-rich repeat kinase 2 (LRRK2) – Part 1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (4)
                                     , 668-673. <a href="https://doi.org/10.1016/j.bmcl.2018.11.058" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.11.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.11.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.11.058%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpotent%252Band%252Bselective%252B5-azaindazole%252Binhibitors%252Bof%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252B%2525E2%252580%252593%252BPart%252B1%26aulast%3DOsborne%26aufirst%3DJoanne%26date%3D2019%26volume%3D29%26issue%3D4%26spage%3D668%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Luigi Piero  Stasi</span>, <span class="hlFld-ContribAuthor ">Ming-Hsun  Ho</span>, <span class="hlFld-ContribAuthor ">Baowei  Zhao</span>, <span class="hlFld-ContribAuthor ">Hailong  Wang</span>, <span class="hlFld-ContribAuthor ">Kai  Long</span>, <span class="hlFld-ContribAuthor ">Qiongfeng  Xu</span>, <span class="hlFld-ContribAuthor ">Yingxia  Sang</span>, <span class="hlFld-ContribAuthor ">Changhui  Sun</span>, <span class="hlFld-ContribAuthor ">Huan  Hu</span>, <span class="hlFld-ContribAuthor ">Haihua  Yu</span>, <span class="hlFld-ContribAuthor ">Zehong  Wan</span>, <span class="hlFld-ContribAuthor ">Lizhen  Wang</span>, <span class="hlFld-ContribAuthor ">Colin  Edge</span>, <span class="hlFld-ContribAuthor ">Qian  Liu</span>, <span class="hlFld-ContribAuthor ">Yi  Li</span>, <span class="hlFld-ContribAuthor ">Kelly  Dong</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Guan</span>, <span class="hlFld-ContribAuthor ">F. David  Tattersall</span>, <span class="hlFld-ContribAuthor ">Alastair D.  Reith</span>, <span class="hlFld-ContribAuthor ">Feng  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-ethoxy-7H-pyrrolo[2,3-d]pyrimidin-2-amines as potent, selective and orally bioavailable LRRK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (9)
                                     , 1615-1620. <a href="https://doi.org/10.1016/j.bmcl.2018.03.045" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.03.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.03.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.03.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B4-ethoxy-7H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidin-2-amines%252Bas%252Bpotent%25252C%252Bselective%252Band%252Borally%252Bbioavailable%252BLRRK2%252Binhibitors%26aulast%3DDing%26aufirst%3DXiao%26date%3D2018%26volume%3D28%26issue%3D9%26spage%3D1615%26epage%3D1620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohit  Tripathi</span>, <span class="hlFld-ContribAuthor ">Shabana I.  Khan</span>, <span class="hlFld-ContribAuthor ">Prija  Ponnan</span>, <span class="hlFld-ContribAuthor ">Rohit  Kholiya</span>, <span class="hlFld-ContribAuthor ">Diwan S.  Rawat</span>. </span><span class="cited-content_cbyCitation_article-title">Aminoquinoline-Pyrimidine-Modified Anilines: Synthesis, In Vitro Antiplasmodial Activity, Cytotoxicity, Mechanistic Studies and ADME Predictions. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2017,</strong> <em>2 </em>
                                    (28)
                                     , 9074-9083. <a href="https://doi.org/10.1002/slct.201701558" title="DOI URL">https://doi.org/10.1002/slct.201701558</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201701558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201701558%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DAminoquinoline-Pyrimidine-Modified%252BAnilines%25253A%252BSynthesis%25252C%252BIn%252BVitro%252BAntiplasmodial%252BActivity%25252C%252BCytotoxicity%25252C%252BMechanistic%252BStudies%252Band%252BADME%252BPredictions%26aulast%3DTripathi%26aufirst%3DMohit%26date%3D2017%26date%3D2017%26volume%3D2%26issue%3D28%26spage%3D9074%26epage%3D9083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene G.  Salado</span>, <span class="hlFld-ContribAuthor ">Josefa  Zaldivar-Diez</span>, <span class="hlFld-ContribAuthor ">Víctor  Sebastián-Pérez</span>, <span class="hlFld-ContribAuthor ">Lingling  Li</span>, <span class="hlFld-ContribAuthor ">Larissa  Geiger</span>, <span class="hlFld-ContribAuthor ">Silvia  González</span>, <span class="hlFld-ContribAuthor ">Nuria E.  Campillo</span>, <span class="hlFld-ContribAuthor ">Carmen  Gil</span>, <span class="hlFld-ContribAuthor ">Aixa V.  Morales</span>, <span class="hlFld-ContribAuthor ">Daniel I.  Perez</span>, <span class="hlFld-ContribAuthor ">Ana  Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>138 </em>, 328-342. <a href="https://doi.org/10.1016/j.ejmech.2017.06.060" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.06.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.06.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.06.060%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLeucine%252Brich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Binhibitors%252Bbased%252Bon%252Bindolinone%252Bscaffold%25253A%252BPotential%252Bpro-neurogenic%252Bagents%26aulast%3DSalado%26aufirst%3DIrene%2BG.%26date%3D2017%26volume%3D138%26spage%3D328%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuela  Gancia</span>, <span class="hlFld-ContribAuthor ">Marcel  De Groot</span>, <span class="hlFld-ContribAuthor ">Brenda  Burton</span>, <span class="hlFld-ContribAuthor ">David E.  Clark</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of LRRK2 inhibitors by using an ensemble of virtual screening methods. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 2520-2527. <a href="https://doi.org/10.1016/j.bmcl.2017.03.098" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.098%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BLRRK2%252Binhibitors%252Bby%252Busing%252Ban%252Bensemble%252Bof%252Bvirtual%252Bscreening%252Bmethods%26aulast%3DGancia%26aufirst%3DEmanuela%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D2520%26epage%3D2527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Mingzhang  Gao</span>, <span class="hlFld-ContribAuthor ">Zhidong  Xu</span>, <span class="hlFld-ContribAuthor ">Qi-Huang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of [11C]HG-10-102-01 as a new potential PET agent for imaging of LRRK2 enzyme in Parkinson’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (6)
                                     , 1351-1355. <a href="https://doi.org/10.1016/j.bmcl.2017.02.019" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.02.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.02.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252B%25255B11C%25255DHG-10-102-01%252Bas%252Ba%252Bnew%252Bpotential%252BPET%252Bagent%252Bfor%252Bimaging%252Bof%252BLRRK2%252Benzyme%252Bin%252BParkinson%2525E2%252580%252599s%252Bdisease%26aulast%3DWang%26aufirst%3DMin%26date%3D2017%26volume%3D27%26issue%3D6%26spage%3D1351%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John M.  Hatcher</span>, <span class="hlFld-ContribAuthor ">Hwan Geun  Choi</span>, <span class="hlFld-ContribAuthor ">Dario R.  Alessi</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors of LRRK2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 241-264. <a href="https://doi.org/10.1007/978-3-319-49969-7_13" title="DOI URL">https://doi.org/10.1007/978-3-319-49969-7_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-49969-7_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-49969-7_13%26sid%3Dliteratum%253Aachs%26atitle%3DSmall-Molecule%252BInhibitors%252Bof%252BLRRK2%26aulast%3DHatcher%26aufirst%3DJohn%2BM.%26date%3D2017%26date%3D2017%26spage%3D241%26epage%3D264%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DLeucine-Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%26aulast%3DRideout%26aufirst%3DHardy%2BJ.%26date%3D2017%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.G.  Leach</span>, <span class="hlFld-ContribAuthor ">I.  Lukac</span>, <span class="hlFld-ContribAuthor ">J.M.  Zarnecka</span>, <span class="hlFld-ContribAuthor ">A.G.  Dossetter</span>, <span class="hlFld-ContribAuthor ">E.J.  Griffen</span>. </span><span class="cited-content_cbyCitation_article-title">Matched Molecular Pair Analysis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 221-252. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12347-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12347-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12347-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12347-9%26sid%3Dliteratum%253Aachs%26atitle%3DMatched%252BMolecular%252BPair%252BAnalysis%26aulast%3DLeach%26aufirst%3DA.G.%26date%3D2017%26spage%3D221%26epage%3D252%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.V.  Christensen</span>, <span class="hlFld-ContribAuthor ">G.P.  Smith</span>, <span class="hlFld-ContribAuthor ">D.S.  Williamson</span>. </span><span class="cited-content_cbyCitation_article-title">Development of LRRK2 Inhibitors for the Treatment of Parkinson's Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 37-80. <a href="https://doi.org/10.1016/bs.pmch.2016.11.002" title="DOI URL">https://doi.org/10.1016/bs.pmch.2016.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2016.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2016.11.002%26sid%3Dliteratum%253Aachs%26atitle%3DDevelopment%252Bof%252BLRRK2%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BParkinson%252527s%252BDisease%26aulast%3DChristensen%26aufirst%3DK.V.%26date%3D2017%26spage%3D37%26epage%3D80%26pub%3DElsevier%26date%3D2017%26volume%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heather  Mortiboys</span>. </span><span class="cited-content_cbyCitation_article-title">Screening for chemical modulators for LRRK2. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Society Transactions</span><span> <strong>2016,</strong> <em>44 </em>
                                    (6)
                                     , 1617-1623. <a href="https://doi.org/10.1042/BST20160242" title="DOI URL">https://doi.org/10.1042/BST20160242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BST20160242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBST20160242%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Society%2520Transactions%26atitle%3DScreening%252Bfor%252Bchemical%252Bmodulators%252Bfor%252BLRRK2%26aulast%3DMortiboys%26aufirst%3DHeather%26date%3D2016%26date%3D2016%26volume%3D44%26issue%3D6%26spage%3D1617%26epage%3D1623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas J.  Greshock</span>, <span class="hlFld-ContribAuthor ">John M.  Sanders</span>, <span class="hlFld-ContribAuthor ">Robert E.  Drolet</span>, <span class="hlFld-ContribAuthor ">Hemaka A.  Rajapakse</span>, <span class="hlFld-ContribAuthor ">Ronald K.  Chang</span>, <span class="hlFld-ContribAuthor ">Boyoung  Kim</span>, <span class="hlFld-ContribAuthor ">Vanessa L.  Rada</span>, <span class="hlFld-ContribAuthor ">Heather E.  Tiscia</span>, <span class="hlFld-ContribAuthor ">Hua  Su</span>, <span class="hlFld-ContribAuthor ">Ming-Tain  Lai</span>, <span class="hlFld-ContribAuthor ">Sylvie M.  Sur</span>, <span class="hlFld-ContribAuthor ">Rosa I.  Sanchez</span>, <span class="hlFld-ContribAuthor ">Mark T.  Bilodeau</span>, <span class="hlFld-ContribAuthor ">John J.  Renger</span>, <span class="hlFld-ContribAuthor ">Jonathan T.  Kern</span>, <span class="hlFld-ContribAuthor ">John A.  McCauley</span>. </span><span class="cited-content_cbyCitation_article-title">Potent, selective and orally bioavailable leucine-rich repeat kinase 2 (LRRK2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (11)
                                     , 2631-2635. <a href="https://doi.org/10.1016/j.bmcl.2016.04.021" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.04.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.04.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%25252C%252Bselective%252Band%252Borally%252Bbioavailable%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Binhibitors%26aulast%3DGreshock%26aufirst%3DThomas%2BJ.%26date%3D2016%26volume%3D26%26issue%3D11%26spage%3D2631%26epage%3D2635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E.  Pourbasheer</span>, <span class="hlFld-ContribAuthor ">R.  Aalizadeh</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and molecular docking study of LRRK2 kinase inhibitors by CoMFA and CoMSIA methods. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2016,</strong> <em>27 </em>
                                    (5)
                                     , 385-407. <a href="https://doi.org/10.1080/1062936X.2016.1184713" title="DOI URL">https://doi.org/10.1080/1062936X.2016.1184713</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2016.1184713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2016.1184713%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3D3D-QSAR%252Band%252Bmolecular%252Bdocking%252Bstudy%252Bof%252BLRRK2%252Bkinase%252Binhibitors%252Bby%252BCoMFA%252Band%252BCoMSIA%252Bmethods%26aulast%3DPourbasheer%26aufirst%3DE.%26date%3D2016%26date%3D2016%26volume%3D27%26issue%3D5%26spage%3D385%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takumi  Kagawa</span>, <span class="hlFld-ContribAuthor ">Daiki  Shigehiro</span>, <span class="hlFld-ContribAuthor ">Kosuke  Kawada</span>. </span><span class="cited-content_cbyCitation_article-title">Trifluoroethoxy group as a leaving group for regioselective sequential substitution reactions of 5-trifluoromethylpyrimidine derivative with heteroatom nucleophiles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2015,</strong> <em>179 </em>, 150-158. <a href="https://doi.org/10.1016/j.jfluchem.2015.07.016" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2015.07.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2015.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2015.07.016%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DTrifluoroethoxy%252Bgroup%252Bas%252Ba%252Bleaving%252Bgroup%252Bfor%252Bregioselective%252Bsequential%252Bsubstitution%252Breactions%252Bof%252B5-trifluoromethylpyrimidine%252Bderivative%252Bwith%252Bheteroatom%252Bnucleophiles%26aulast%3DKagawa%26aufirst%3DTakumi%26date%3D2015%26volume%3D179%26spage%3D150%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petranka  Krumova</span>, <span class="hlFld-ContribAuthor ">Lauran  Reyniers</span>, <span class="hlFld-ContribAuthor ">Marc  Meyer</span>, <span class="hlFld-ContribAuthor ">Evy  Lobbestael</span>, <span class="hlFld-ContribAuthor ">Daniela  Stauffer</span>, <span class="hlFld-ContribAuthor ">Bertran  Gerrits</span>, <span class="hlFld-ContribAuthor ">Lionel  Muller</span>, <span class="hlFld-ContribAuthor ">Sjouke  Hoving</span>, <span class="hlFld-ContribAuthor ">Klemens  Kaupmann</span>, <span class="hlFld-ContribAuthor ">Johannes  Voshol</span>, <span class="hlFld-ContribAuthor ">Doriano  Fabbro</span>, <span class="hlFld-ContribAuthor ">Andreas  Bauer</span>, <span class="hlFld-ContribAuthor ">Giorgio  Rovelli</span>, <span class="hlFld-ContribAuthor ">Jean‐Marc  Taymans</span>, <span class="hlFld-ContribAuthor ">Tewis  Bouwmeester</span>, <span class="hlFld-ContribAuthor ">Veerle  Baekelandt</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical genetic approach identifies microtubule affinity‐regulating kinase 1 as a leucine‐rich repeat kinase 2 substrate. </span><span class="cited-content_cbyCitation_journal-name">The FASEB Journal</span><span> <strong>2015,</strong> <em>29 </em>
                                    (7)
                                     , 2980-2992. <a href="https://doi.org/10.1096/fj.14-262329" title="DOI URL">https://doi.org/10.1096/fj.14-262329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1096/fj.14-262329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1096%2Ffj.14-262329%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FASEB%2520Journal%26atitle%3DChemical%252Bgenetic%252Bapproach%252Bidentifies%252Bmicrotubule%252Baffinity%2525E2%252580%252590regulating%252Bkinase%252B1%252Bas%252Ba%252Bleucine%2525E2%252580%252590rich%252Brepeat%252Bkinase%252B2%252Bsubstrate%26aulast%3DKrumova%26aufirst%3DPetranka%26date%3D2015%26date%3D2015%26volume%3D29%26issue%3D7%26spage%3D2980%26epage%3D2992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar  Delgado</span>, <span class="hlFld-ContribAuthor ">Francisca  Delgado</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Vega</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>. </span><span class="cited-content_cbyCitation_article-title">N-bridged 5,6-bicyclic pyridines: Recent applications in central nervous system disorders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>97 </em>, 719-731. <a href="https://doi.org/10.1016/j.ejmech.2014.12.034" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.12.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.12.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.12.034%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-bridged%252B5%25252C6-bicyclic%252Bpyridines%25253A%252BRecent%252Bapplications%252Bin%252Bcentral%252Bnervous%252Bsystem%252Bdisorders%26aulast%3DDelgado%26aufirst%3DOscar%26date%3D2015%26volume%3D97%26spage%3D719%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Göring</span>, <span class="hlFld-ContribAuthor ">Jean-Marc  Taymans</span>, <span class="hlFld-ContribAuthor ">Veerle  Baekelandt</span>, <span class="hlFld-ContribAuthor ">Boris  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Indolinone based LRRK2 kinase inhibitors with a key hydrogen bond. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (19)
                                     , 4630-4637. <a href="https://doi.org/10.1016/j.bmcl.2014.08.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.08.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.08.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.08.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIndolinone%252Bbased%252BLRRK2%252Bkinase%252Binhibitors%252Bwith%252Ba%252Bkey%252Bhydrogen%252Bbond%26aulast%3DG%25C3%25B6ring%26aufirst%3DStefan%26date%3D2014%26volume%3D24%26issue%3D19%26spage%3D4630%26epage%3D4637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Galatsis</span>, <span class="hlFld-ContribAuthor ">Jaclyn L.  Henderson</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Seungil  Han</span>, <span class="hlFld-ContribAuthor ">Ravi G.  Kurumbail</span>, <span class="hlFld-ContribAuthor ">Travis T.  Wager</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>, <span class="hlFld-ContribAuthor ">G. Stephen  Noell</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Elie  Needle</span>, <span class="hlFld-ContribAuthor ">Zdenek  Berger</span>, <span class="hlFld-ContribAuthor ">Stefanus J.  Steyn</span>, <span class="hlFld-ContribAuthor ">Christopher  Houle</span>, <span class="hlFld-ContribAuthor ">Warren D.  Hirst</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-b]pyridazine scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (17)
                                     , 4132-4140. <a href="https://doi.org/10.1016/j.bmcl.2014.07.052" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.07.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.07.052%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DKinase%252Bdomain%252Binhibition%252Bof%252Bleucine%252Brich%252Brepeat%252Bkinase%252B2%252B%252528LRRK2%252529%252Busing%252Ba%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B4%25252C3-b%25255Dpyridazine%252Bscaffold%26aulast%3DGalatsis%26aufirst%3DPaul%26date%3D2014%26volume%3D24%26issue%3D17%26spage%3D4132%26epage%3D4140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sagar S.  Bhayye</span>, <span class="hlFld-ContribAuthor ">Kunal  Roy</span>, <span class="hlFld-ContribAuthor ">Achintya  Saha</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring structural requirement, pharmacophore modeling, and de novo design of LRRK2 inhibitors using homology modeling approach. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2014,</strong> <em>23 </em>
                                    (8)
                                     , 3705-3713. <a href="https://doi.org/10.1007/s00044-014-0955-7" title="DOI URL">https://doi.org/10.1007/s00044-014-0955-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-014-0955-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-014-0955-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DExploring%252Bstructural%252Brequirement%25252C%252Bpharmacophore%252Bmodeling%25252C%252Band%252Bde%252Bnovo%252Bdesign%252Bof%252BLRRK2%252Binhibitors%252Busing%252Bhomology%252Bmodeling%252Bapproach%26aulast%3DBhayye%26aufirst%3DSagar%2BS.%26date%3D2014%26date%3D2014%26volume%3D23%26issue%3D8%26spage%3D3705%26epage%3D3713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raghava R  Kethiri</span>, <span class="hlFld-ContribAuthor ">Rajagopal  Bakthavatchalam</span>. </span><span class="cited-content_cbyCitation_article-title">Leucine-rich repeat kinase 2 inhibitors: a review of recent patents (2011 – 2013). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (7)
                                     , 745-757. <a href="https://doi.org/10.1517/13543776.2014.907275" title="DOI URL">https://doi.org/10.1517/13543776.2014.907275</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.907275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.907275%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DLeucine-rich%252Brepeat%252Bkinase%252B2%252Binhibitors%25253A%252Ba%252Breview%252Bof%252Brecent%252Bpatents%252B%2525282011%252B%2525E2%252580%252593%252B2013%252529%26aulast%3DKethiri%26aufirst%3DRaghava%2BR%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D7%26spage%3D745%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iiris  Kahn</span>, <span class="hlFld-ContribAuthor ">Andre  Lomaka</span>, <span class="hlFld-ContribAuthor ">Mati  Karelson</span>. </span><span class="cited-content_cbyCitation_article-title">Topological Fingerprints as an Aid in Finding Structural Patterns for LRRK2 Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2014,</strong> <em>33 </em>
                                    (4)
                                     , 269-275. <a href="https://doi.org/10.1002/minf.201300057" title="DOI URL">https://doi.org/10.1002/minf.201300057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.201300057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.201300057%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DTopological%252BFingerprints%252Bas%252Ban%252BAid%252Bin%252BFinding%252BStructural%252BPatterns%252Bfor%252BLRRK2%252BInhibition%26aulast%3DKahn%26aufirst%3DIiris%26date%3D2014%26date%3D2014%26volume%3D33%26issue%3D4%26spage%3D269%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Tianlin  Guo</span>, <span class="hlFld-ContribAuthor ">Xitao  Li</span>, <span class="hlFld-ContribAuthor ">Yi  Dong</span>, <span class="hlFld-ContribAuthor ">Paul  Galatsis</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Zhengying  Pan</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of selective 2,4-diaminopyrimidine-based photoaffinity probes for glyoxalase I. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2014,</strong> <em>5 </em>
                                    (3)
                                     , 352-357. <a href="https://doi.org/10.1039/C3MD00286A" title="DOI URL">https://doi.org/10.1039/C3MD00286A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C3MD00286A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC3MD00286A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252Bselective%252B2%25252C4-diaminopyrimidine-based%252Bphotoaffinity%252Bprobes%252Bfor%252Bglyoxalase%252BI%26aulast%3DZhou%26aufirst%3DYiqing%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D3%26spage%3D352%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Galatsis</span>, <span class="hlFld-ContribAuthor ">Jaclyn L.  Henderson</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Warren D.  Hirst</span>. </span><span class="cited-content_cbyCitation_article-title">Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 111-148. <a href="https://doi.org/10.1007/7355_2014_69" title="DOI URL">https://doi.org/10.1007/7355_2014_69</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_69%26sid%3Dliteratum%253Aachs%26atitle%3DLeucine-Rich%252BRepeat%252BKinase%252B2%252B%252528LRRK2%252529%252BInhibitors%26aulast%3DGalatsis%26aufirst%3DPaul%26date%3D2014%26date%3D2014%26spage%3D111%26epage%3D148%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DNovel%252BTherapeutic%252BApproaches%252Bto%252Bthe%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DHopkins%26aufirst%3DCorey%2BR.%26date%3D2016%26volume%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Galatsis</span>, <span class="hlFld-ContribAuthor ">Jaclyn  Henderson</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Warren D.  Hirst</span>. </span><span class="cited-content_cbyCitation_article-title">Development of LRRK2 Kinase Inhibitors for Parkinson's Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 43-58. <a href="https://doi.org/10.1016/B978-0-12-800167-7.00004-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-800167-7.00004-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-800167-7.00004-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-800167-7.00004-3%26sid%3Dliteratum%253Aachs%26atitle%3DDevelopment%252Bof%252BLRRK2%252BKinase%252BInhibitors%252Bfor%252BParkinson%252527s%252BDisease%26aulast%3DGalatsis%26aufirst%3DPaul%26date%3D2014%26spage%3D43%26epage%3D58%26pub%3DElsevier%26date%3D2014%26volume%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Omar  Aziz</span>, <span class="hlFld-ContribAuthor ">Roland W.  Bürli</span>, <span class="hlFld-ContribAuthor ">David F.  Fischer</span>, <span class="hlFld-ContribAuthor ">Julie  Frearson</span>, <span class="hlFld-ContribAuthor ">Michael D.  Wall</span>. </span><span class="cited-content_cbyCitation_article-title">Towards Small Molecules as Therapies for Alzheimer’s Disease and Other Neurodegenerative Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 199-290. <a href="https://doi.org/10.1016/B978-0-12-803959-5.50004-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-803959-5.50004-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803959-5.50004-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803959-5.50004-0%26sid%3Dliteratum%253Aachs%26atitle%3DTowards%252BSmall%252BMolecules%252Bas%252BTherapies%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Band%252BOther%252BNeurodegenerative%252BDisorders%26aulast%3DAziz%26aufirst%3DOmar%26date%3D2014%26spage%3D199%26epage%3D290%26pub%3DElsevier%26atitle%3DDrug%252BDesign%252Band%252BDiscovery%252Bin%252BAlzheimer%252527s%252BDisease%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haitao  Zhu</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>, <span class="hlFld-ContribAuthor ">William  Cho</span>, <span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>, <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>. </span><span class="cited-content_cbyCitation_article-title">From Human Genetics to Drug Candidates: An Industrial Perspective on LRRK2 Inhibition as a Treatment for Parkinson's Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 227-254. <a href="https://doi.org/10.1002/9783527677252.ch10" title="DOI URL">https://doi.org/10.1002/9783527677252.ch10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527677252.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527677252.ch10%26sid%3Dliteratum%253Aachs%26atitle%3DFrom%252BHuman%252BGenetics%252Bto%252BDrug%252BCandidates%25253A%252BAn%252BIndustrial%252BPerspective%252Bon%252BLRRK2%252BInhibition%252Bas%252Ba%252BTreatment%252Bfor%252BParkinson%252527s%252BDisease%26aulast%3DZhu%26aufirst%3DHaitao%26date%3D2013%26date%3D2013%26spage%3D227%26epage%3D254%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DMedicinal%252BChemistry%252BApproaches%252Bto%252BPersonalized%252BMedicine%26aulast%3DLackey%26aufirst%3DKaren%26date%3D2013%26volume%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharon L  Chan</span>, <span class="hlFld-ContribAuthor ">Dario C  Angeles</span>, <span class="hlFld-ContribAuthor ">Eng-King  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting leucine-rich repeat kinase 2 in Parkinson's disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2013,</strong> <em>17 </em>
                                    (12)
                                     , 1471-1482. <a href="https://doi.org/10.1517/14728222.2013.842978" title="DOI URL">https://doi.org/10.1517/14728222.2013.842978</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728222.2013.842978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728222.2013.842978%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DTargeting%252Bleucine-rich%252Brepeat%252Bkinase%252B2%252Bin%252BParkinson%252527s%252Bdisease%26aulast%3DChan%26aufirst%3DSharon%2BL%26date%3D2013%26date%3D2013%26volume%3D17%26issue%3D12%26spage%3D1471%26epage%3D1482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel T.  Richter</span>, <span class="hlFld-ContribAuthor ">John C.  Kath</span>, <span class="hlFld-ContribAuthor ">Michael J.  Luzzio</span>, <span class="hlFld-ContribAuthor ">Nandell  Keene</span>, <span class="hlFld-ContribAuthor ">Martin A.  Berliner</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Wessel</span>. </span><span class="cited-content_cbyCitation_article-title">Selective addition of amines to 5-trifluoromethyl-2,4-dichloropyrimidine induced by Lewis acids. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2013,</strong> <em>54 </em>
                                    (35)
                                     , 4610-4612. <a href="https://doi.org/10.1016/j.tetlet.2013.06.025" title="DOI URL">https://doi.org/10.1016/j.tetlet.2013.06.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2013.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2013.06.025%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSelective%252Baddition%252Bof%252Bamines%252Bto%252B5-trifluoromethyl-2%25252C4-dichloropyrimidine%252Binduced%252Bby%252BLewis%252Bacids%26aulast%3DRichter%26aufirst%3DDaniel%2BT.%26date%3D2013%26volume%3D54%26issue%3D35%26spage%3D4610%26epage%3D4612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Madeline E.  Kavanagh</span>, <span class="hlFld-ContribAuthor ">Munikumar Reddy  Doddareddy</span>, <span class="hlFld-ContribAuthor ">Michael  Kassiou</span>. </span><span class="cited-content_cbyCitation_article-title">The development of CNS-active LRRK2 inhibitors using property-directed optimisation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (13)
                                     , 3690-3696. <a href="https://doi.org/10.1016/j.bmcl.2013.04.086" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.04.086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.04.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.04.086%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdevelopment%252Bof%252BCNS-active%252BLRRK2%252Binhibitors%252Busing%252Bproperty-directed%252Boptimisation%26aulast%3DKavanagh%26aufirst%3DMadeline%2BE.%26date%3D2013%26volume%3D23%26issue%3D13%26spage%3D3690%26epage%3D3696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Troxler</span>, <span class="hlFld-ContribAuthor ">Paulette  Greenidge</span>, <span class="hlFld-ContribAuthor ">Kaspar  Zimmermann</span>, <span class="hlFld-ContribAuthor ">Sandrine  Desrayaud</span>, <span class="hlFld-ContribAuthor ">Peter  Drückes</span>, <span class="hlFld-ContribAuthor ">Tatjana  Schweizer</span>, <span class="hlFld-ContribAuthor ">Daniela  Stauffer</span>, <span class="hlFld-ContribAuthor ">Giorgio  Rovelli</span>, <span class="hlFld-ContribAuthor ">Derya R.  Shimshek</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel indolinone-based, potent, selective and brain penetrant inhibitors of LRRK2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (14)
                                     , 4085-4090. <a href="https://doi.org/10.1016/j.bmcl.2013.05.054" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.05.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.05.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.05.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bindolinone-based%25252C%252Bpotent%25252C%252Bselective%252Band%252Bbrain%252Bpenetrant%252Binhibitors%252Bof%252BLRRK2%26aulast%3DTroxler%26aufirst%3DThomas%26date%3D2013%26volume%3D23%26issue%3D14%26spage%3D4085%26epage%3D4090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Dzamko</span>, <span class="hlFld-ContribAuthor ">Glenda M  Halliday</span>. </span><span class="cited-content_cbyCitation_article-title">Unlocking the secrets of LRRK2 function with selective kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Neurology</span><span> <strong>2013,</strong> <em>8 </em>
                                    (3)
                                     , 347-357. <a href="https://doi.org/10.2217/fnl.13.9" title="DOI URL">https://doi.org/10.2217/fnl.13.9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fnl.13.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffnl.13.9%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Neurology%26atitle%3DUnlocking%252Bthe%252Bsecrets%252Bof%252BLRRK2%252Bfunction%252Bwith%252Bselective%252Bkinase%252Binhibitors%26aulast%3DDzamko%26aufirst%3DNicolas%26date%3D2013%26volume%3D8%26issue%3D3%26spage%3D347%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maurizio  Franzini</span>, <span class="hlFld-ContribAuthor ">Xiaocong M.  Ye</span>, <span class="hlFld-ContribAuthor ">Marc  Adler</span>, <span class="hlFld-ContribAuthor ">Danielle L.  Aubele</span>, <span class="hlFld-ContribAuthor ">Albert W.  Garofalo</span>, <span class="hlFld-ContribAuthor ">Shawn  Gauby</span>, <span class="hlFld-ContribAuthor ">Erich  Goldbach</span>, <span class="hlFld-ContribAuthor ">Gary D.  Probst</span>, <span class="hlFld-ContribAuthor ">Kevin P.  Quinn</span>, <span class="hlFld-ContribAuthor ">Pam  Santiago</span>, <span class="hlFld-ContribAuthor ">Hing L.  Sham</span>, <span class="hlFld-ContribAuthor ">Danny  Tam</span>, <span class="hlFld-ContribAuthor ">Anh  Truong</span>, <span class="hlFld-ContribAuthor ">Zhao  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Triazolopyridazine LRRK2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (7)
                                     , 1967-1973. <a href="https://doi.org/10.1016/j.bmcl.2013.02.043" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.02.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.02.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.02.043%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTriazolopyridazine%252BLRRK2%252Bkinase%252Binhibitors%26aulast%3DFranzini%26aufirst%3DMaurizio%26date%3D2013%26volume%3D23%26issue%3D7%26spage%3D1967%26epage%3D1973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel Jon  Burdick</span>. </span><span class="cited-content_cbyCitation_article-title">Response to Deng
              et al.
              's LRRK2 patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (2)
                                     , 279-279. <a href="https://doi.org/10.1517/13543776.2013.757594" title="DOI URL">https://doi.org/10.1517/13543776.2013.757594</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.757594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.757594%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DResponse%252Bto%252BDeng%252Bet%252Bal.%252B%252527s%252BLRRK2%252Bpatent%252Breview%26aulast%3DBurdick%26aufirst%3DDaniel%2BJon%26date%3D2013%26date%3D2012%26volume%3D23%26issue%3D2%26spage%3D279%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Z.  Sheng</span>, <span class="hlFld-ContribAuthor ">S.  Zhang</span>, <span class="hlFld-ContribAuthor ">D.  Bustos</span>, <span class="hlFld-ContribAuthor ">T.  Kleinheinz</span>, <span class="hlFld-ContribAuthor ">C. E.  Le Pichon</span>, <span class="hlFld-ContribAuthor ">S. L.  Dominguez</span>, <span class="hlFld-ContribAuthor ">H. O.  Solanoy</span>, <span class="hlFld-ContribAuthor ">J.  Drummond</span>, <span class="hlFld-ContribAuthor ">X.  Zhang</span>, <span class="hlFld-ContribAuthor ">X.  Ding</span>, <span class="hlFld-ContribAuthor ">F.  Cai</span>, <span class="hlFld-ContribAuthor ">Q.  Song</span>, <span class="hlFld-ContribAuthor ">X.  Li</span>, <span class="hlFld-ContribAuthor ">Z.  Yue</span>, <span class="hlFld-ContribAuthor ">M. P.  van der Brug</span>, <span class="hlFld-ContribAuthor ">D. J.  Burdick</span>, <span class="hlFld-ContribAuthor ">J.  Gunzner-Toste</span>, <span class="hlFld-ContribAuthor ">H.  Chen</span>, <span class="hlFld-ContribAuthor ">X.  Liu</span>, <span class="hlFld-ContribAuthor ">A. A.  Estrada</span>, <span class="hlFld-ContribAuthor ">Z. K.  Sweeney</span>, <span class="hlFld-ContribAuthor ">K.  Scearce-Levie</span>, <span class="hlFld-ContribAuthor ">J. G.  Moffat</span>, <span class="hlFld-ContribAuthor ">D. S.  Kirkpatrick</span>, <span class="hlFld-ContribAuthor ">H.  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations. </span><span class="cited-content_cbyCitation_journal-name">Science Translational Medicine</span><span> <strong>2012,</strong> <em>4 </em>
                                    (164)
                                     , 164ra161-164ra161. <a href="https://doi.org/10.1126/scitranslmed.3004485" title="DOI URL">https://doi.org/10.1126/scitranslmed.3004485</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scitranslmed.3004485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscitranslmed.3004485%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Translational%2520Medicine%26atitle%3DSer1292%252BAutophosphorylation%252BIs%252Ban%252BIndicator%252Bof%252BLRRK2%252BKinase%252BActivity%252Band%252BContributes%252Bto%252Bthe%252BCellular%252BEffects%252Bof%252BPD%252BMutations%26aulast%3DSheng%26aufirst%3DZ.%26date%3D2012%26date%3D2012%26volume%3D4%26issue%3D164%26spage%3D164ra161%26epage%3D164ra161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xianming  Deng</span>, <span class="hlFld-ContribAuthor ">Hwan Geun  Choi</span>, <span class="hlFld-ContribAuthor ">Sara J.  Buhrlage</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 – 2011). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2012,</strong> <em>22 </em>
                                    (12)
                                     , 1415-1426. <a href="https://doi.org/10.1517/13543776.2012.729041" title="DOI URL">https://doi.org/10.1517/13543776.2012.729041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2012.729041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2012.729041%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DLeucine-rich%252Brepeat%252Bkinase%252B2%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282006%252B%2525E2%252580%252593%252B2011%252529%26aulast%3DDeng%26aufirst%3DXianming%26date%3D2012%26date%3D2012%26volume%3D22%26issue%3D12%26spage%3D1415%26epage%3D1426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300452p&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of high-throughput screening hits <b>1</b> and <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300452p&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) LRRK2 kinase domain homology model with the N-terminal domain on top and C-terminal domain at bottom. The solvent accessible surface of the ATP-binding site is colored in pink, while the cartoon defining the protein backbone is colored in green. (B) LRRK2 ATP-binding site in complex with ATP (colored in yellow) looking down through the N-terminal domain. Side chains of binding site residues are shown as sticks and colored in green. Side chains of the four key selectivity residues (Phe1883, Leu1949, Ser1954, and Arg1957) are colored in magenta. The alternative conformations of Arg1957 and Gln1961 are shown in cyan. Hydrogen bond interactions between ATP and LRRK2 are shown as yellow dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300452p&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Docking model of compound <b>1</b> (green) in LRRK2 binding site. Key hydrogen bonds are shown in yellow dashed lines. Solvent accessible surface is shown in pink. (B) Docking model of compound <b>1</b> in JAK2. (C) Overlay of compound <b>1</b> (green) and <b>8</b> (magenta) docking models in LRRK2 (colored in white with L1949 in green). The side chain of Y931 of JAK2 is also shown and colored in cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300452p&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Docking model of compound <b>2</b> (green) in LRRK2 binding site. (B) Overlay of docking models of compound <b>11</b> (magenta) and <b>15</b> (green) in LRRK2 binding site. Intermolecular hydrogen bonds are shown as dashed yellow lines, while the solvent accessible surface is shown in pink. Leu1949 is shown in light green sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300452p&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/medium/jm-2012-00452p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-11/jm300452p/production/images/large/jm-2012-00452p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm300452p&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 8 M methylamine in ethanol, methanol; (b) Ar-NH<sub>2</sub>, <i>n</i>-butanol; (c) TFA, 2-methoxyethanol.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66764" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66764" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 62 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_contrib-group">Lees, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revesz, T.</span><span> </span><span class="NLM_article-title">Parkinson’s disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">2055</span><span class="NLM_x">–</span> <span class="NLM_lpage">2066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2009&pages=2055-2066&author=A.+J.+Leesauthor=J.+Hardyauthor=T.+Revesz&title=Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DA.%2BJ.%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DRevesz%26aufirst%3DT.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%26jtitle%3DLancet%26date%3D2009%26volume%3D373%26spage%3D2055%26epage%3D2066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span>Erratum in  <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">684</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Erratum+in+Lancet+2009%2C+374%2C+684."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DLancet%26date%3D2009%26volume%3D374%26spage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Zimprich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lincoln, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachergus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulihan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uitti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoessl, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeiffer, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patenge, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbajal, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieregge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asmus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Myhsok, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meitinger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wszolek, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span> </span><span class="NLM_article-title">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1016%2Fj.neuron.2004.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=15541309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=601-607&author=A.+Zimprichauthor=S.+Biskupauthor=P.+Leitnerauthor=P.+Lichtnerauthor=M.+Farrerauthor=S.+Lincolnauthor=J.+Kachergusauthor=M.+Hulihanauthor=R.+J.+Uittiauthor=D.+B.+Calneauthor=A.+J.+Stoesslauthor=R.+F.+Pfeifferauthor=N.+Patengeauthor=I.+C.+Carbajalauthor=P.+Viereggeauthor=F.+Asmusauthor=B.+Muller-Myhsokauthor=D.+W.+Dicksonauthor=T.+Meitingerauthor=T.+M.+Stromauthor=Z.+K.+Wszolekauthor=T.+Gasser&title=Mutations+in+LRRK2+cause+autosomal-dominant+parkinsonism+with+pleomorphic+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology</span></div><div class="casAuthors">Zimprich, Alexander; Biskup, Saskia; Leitner, Petra; Lichtner, Peter; Farrer, Matthew; Lincoln, Sarah; Kachergus, Jennifer; Hulihan, Mary; Uitti, Ryan J.; Calne, Donald B.; Stoessl, A. Jon; Pfeiffer, Ronald F.; Patenge, Nadja; Carbajal, Iria Carballo; Vieregge, Peter; Asmus, Friedrich; Mueller-Myhsok, Bertram; Dickson, Dennis W.; Meitinger, Thomas; Strom, Tim M.; Wszolek, Zbigniew K.; Gasser, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">601-607</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We have previously linked families with autosomaldominant, late-onset parkinsonism to chromosome 12p11.2-q13.1 (PARK8).  By high-resoln. recombination mapping and candidate gene sequencing in 46 families, we have found six disease-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large, multifunctional protein, LRRK2 (leucine-rich repeat kinase 2).  It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains.  Within affected carriers of families A and D, six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies.  These include abnormalities consistent with Lewy body Parkinson's disease, diffuse Lewy body disease, nigral degeneration without distinctive histopathol., and progressive supranuclear palsy-like pathol.  Clin. diagnoses of Parkinsonism with dementia or amyotrophy or both, with their assocd. pathologies, are also noted.  Hence, LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders assocd. with parkinsonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9aK6wacZJhbVg90H21EOLACvtfcHk0lg8WxDjpH4dEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhurjL&md5=9ae4c87ce3172e29829e317d94b5cdaa</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2004.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2004.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DZimprich%26aufirst%3DA.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DLeitner%26aufirst%3DP.%26aulast%3DLichtner%26aufirst%3DP.%26aulast%3DFarrer%26aufirst%3DM.%26aulast%3DLincoln%26aufirst%3DS.%26aulast%3DKachergus%26aufirst%3DJ.%26aulast%3DHulihan%26aufirst%3DM.%26aulast%3DUitti%26aufirst%3DR.%2BJ.%26aulast%3DCalne%26aufirst%3DD.%2BB.%26aulast%3DStoessl%26aufirst%3DA.%2BJ.%26aulast%3DPfeiffer%26aufirst%3DR.%2BF.%26aulast%3DPatenge%26aufirst%3DN.%26aulast%3DCarbajal%26aufirst%3DI.%2BC.%26aulast%3DVieregge%26aufirst%3DP.%26aulast%3DAsmus%26aufirst%3DF.%26aulast%3DMuller-Myhsok%26aufirst%3DB.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DMeitinger%26aufirst%3DT.%26aulast%3DStrom%26aufirst%3DT.%2BM.%26aulast%3DWszolek%26aufirst%3DZ.%2BK.%26aulast%3DGasser%26aufirst%3DT.%26atitle%3DMutations%2520in%2520LRRK2%2520cause%2520autosomal-dominant%2520parkinsonism%2520with%2520pleomorphic%2520pathology%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D601%26epage%3D607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Paisan-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilks, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez de Munain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparicio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrera, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Silva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marti-Masso, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Tur, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A. B.</span><span> </span><span class="NLM_article-title">Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2004&pages=595-600&author=C.+Paisan-Ruizauthor=S.+Jainauthor=E.+W.+Evansauthor=W.+P.+Gilksauthor=J.+Simonauthor=M.+van+der+Brugauthor=A.+Lopez+de+Munainauthor=S.+Aparicioauthor=A.+M.+Gilauthor=N.+Khanauthor=J.+Johnsonauthor=J.+R.+Martinezauthor=D.+Nichollauthor=I.+M.+Carreraauthor=A.+S.+Penaauthor=R.+de+Silvaauthor=A.+Leesauthor=J.+F.+Marti-Massoauthor=J.+Perez-Turauthor=N.+W.+Woodauthor=A.+B.+Singleton&title=Cloning+of+the+gene+containing+mutations+that+cause+PARK8-linked+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaisan-Ruiz%26aufirst%3DC.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DEvans%26aufirst%3DE.%2BW.%26aulast%3DGilks%26aufirst%3DW.%2BP.%26aulast%3DSimon%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%26aulast%3DLopez%2Bde%2BMunain%26aufirst%3DA.%26aulast%3DAparicio%26aufirst%3DS.%26aulast%3DGil%26aufirst%3DA.%2BM.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DMartinez%26aufirst%3DJ.%2BR.%26aulast%3DNicholl%26aufirst%3DD.%26aulast%3DCarrera%26aufirst%3DI.%2BM.%26aulast%3DPena%26aufirst%3DA.%2BS.%26aulast%3Dde%2BSilva%26aufirst%3DR.%26aulast%3DLees%26aufirst%3DA.%26aulast%3DMarti-Masso%26aufirst%3DJ.%2BF.%26aulast%3DPerez-Tur%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DN.%2BW.%26aulast%3DSingleton%26aufirst%3DA.%2BB.%26atitle%3DCloning%2520of%2520the%2520gene%2520containing%2520mutations%2520that%2520cause%2520PARK8-linked%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2004%26volume%3D44%26spage%3D595%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Dachsel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span> </span><span class="NLM_article-title">LRRK2 and Parkinson disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1001%2Farchneurol.2010.79" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=20457952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A280%3ADC%252BC3czisFOrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=542-547&author=J.+C.+Dachselauthor=M.+J.+Farrer&title=LRRK2+and+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK2 and Parkinson disease</span></div><div class="casAuthors">Dachsel Justus C; Farrer Matthew J</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">542-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  To review the molecular genetics and functional biology of leucine-rich repeat kinase 2 (LRRK2) in parkinsonism and to summarize the opportunities and challenges to develop interventions for Parkinson disease (PD) based on this genetic insight.  DATA SOURCES:  Publications cited are focused on LRRK2 biology between 2004 and March 2009.  STUDY SELECTION:  Literature selected was based on original contributions, seminal observations, and thoughtful reviews.  DATA EXTRACTION:  Unless stated otherwise, data was primarily abstracted from peer-reviewed literature appearing on PubMed.  DATA SYNTHESIS:  Genetic mutations that predispose PD are diagnostically useful in early or atypical presentations.  The molecular pathways identified suggest therapeutic interventions for Lrrk2 and idiopathic PD and the rationale and opportunity to develop physiologically relevant biomarkers and experimental models with which to test them.  CONCLUSIONS:  Both affected and asymptomatic LRRK2 carriers now provide the opportunity to define the natural history of PD.  This includes the frequency, penetrance, and rate of motor symptoms, nonmotor comorbidities, and their associated biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3dH7Qk4jbtZPlX7E30qdzfW6udTcc2eYusYOz7osJfrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czisFOrsQ%253D%253D&md5=7f08a3bbe3fc77c7d9bac287a1ff5316</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2010.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2010.79%26sid%3Dliteratum%253Aachs%26aulast%3DDachsel%26aufirst%3DJ.%2BC.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26atitle%3DLRRK2%2520and%2520Parkinson%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2010%26volume%3D67%26spage%3D542%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Satake, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakabayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuta, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsunoda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obata, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakoda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, T.</span><span> </span><span class="NLM_article-title">Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1307</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1038%2Fng.485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=19915576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1303-1307&author=W.+Satakeauthor=Y.+Nakabayashiauthor=I.+Mizutaauthor=Y.+Hirotaauthor=C.+Itoauthor=M.+Kuboauthor=T.+Kawaguchiauthor=T.+Tsunodaauthor=M.+Watanabeauthor=A.+Takedaauthor=H.+Tomiyamaauthor=K.+Nakashimaauthor=K.+Hasegawaauthor=F.+Obataauthor=T.+Yoshikawaauthor=H.+Kawakamiauthor=S.+Sakodaauthor=M.+Yamamotoauthor=N.+Hattoriauthor=M.+Murataauthor=Y.+Nakamuraauthor=T.+Toda&title=Genome-wide+association+study+identifies+common+variants+at+four+loci+as+genetic+risk+factors+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease</span></div><div class="casAuthors">Satake, Wataru; Nakabayashi, Yuko; Mizuta, Ikuko; Hirota, Yushi; Ito, Chiyomi; Kubo, Michiaki; Kawaguchi, Takahisa; Tsunoda, Tatsuhiko; Watanabe, Masahiko; Takeda, Atsushi; Tomiyama, Hiroyuki; Nakashima, Kenji; Hasegawa, Kazuko; Obata, Fumiya; Yoshikawa, Takeo; Kawakami, Hideshi; Sakoda, Saburo; Yamamoto, Mitsutoshi; Hattori, Nobutaka; Murata, Miho; Nakamura, Yusuke; Toda, Tatsushi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1303-1307</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To identify susceptibility variants for Parkinson's disease (PD), we performed a genome-wide assocn. study (GWAS) and two replication studies in a total of 2,011 cases and 18,381 controls from Japan.  We identified a new susceptibility locus on 1q32 (P = 1.52 × 10-12) and designated this as PARK16, and we also identified BST1 on 4p15 as a second new risk locus (P = 3.94 × 10-9).  We also detected strong assocns. at SNCA on 4q22 (P = 7.35 × 10-17) and LRRK2 on 12q12 (P = 2.72 × 10-8), both of which are implicated in autosomal dominant forms of parkinsonism.  By comparing results of a GWAS performed on individuals of European ancestry, we identified PARK16, SNCA and LRRK2 as shared risk loci for PD and BST1 and MAPT as loci showing population differences.  Our results identify two new PD susceptibility loci, show involvement of autosomal dominant parkinsonism loci in typical PD and suggest that population differences contribute to genetic heterogeneity in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiCdi72L_e27Vg90H21EOLACvtfcHk0lhLLb5-V0kC2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsb7O&md5=46e665390ca8166d83a4688d4f581cf5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fng.485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.485%26sid%3Dliteratum%253Aachs%26aulast%3DSatake%26aufirst%3DW.%26aulast%3DNakabayashi%26aufirst%3DY.%26aulast%3DMizuta%26aufirst%3DI.%26aulast%3DHirota%26aufirst%3DY.%26aulast%3DIto%26aufirst%3DC.%26aulast%3DKubo%26aufirst%3DM.%26aulast%3DKawaguchi%26aufirst%3DT.%26aulast%3DTsunoda%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DTomiyama%26aufirst%3DH.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DObata%26aufirst%3DF.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DKawakami%26aufirst%3DH.%26aulast%3DSakoda%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHattori%26aufirst%3DN.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DToda%26aufirst%3DT.%26atitle%3DGenome-wide%2520association%2520study%2520identifies%2520common%2520variants%2520at%2520four%2520loci%2520as%2520genetic%2520risk%2520factors%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Genet.%26date%3D2009%26volume%3D41%26spage%3D1303%26epage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Simón-Sánchez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bras, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paisan-Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholz, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krüger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federoff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nalls, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Illig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gieger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houlden, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okun, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Racette, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foote, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traynor, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arepalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonozi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwinn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanock, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schatzkin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenbeck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuschl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riess, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasser, T.</span><span> </span><span class="NLM_article-title">Genome-wide association study reveals genetic risk underlying Parkinson’s disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1308</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1038%2Fng.487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=19915575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2009&pages=1308-1312&author=J.+Sim%C3%B3n-S%C3%A1nchezauthor=C.+Schulteauthor=J.+M.+Brasauthor=M.+Sharmaauthor=J.+R.+Gibbsauthor=D.+Bergauthor=C.+Paisan-Ruizauthor=P.+Lichtnerauthor=S.+W.+Scholzauthor=D.+G.+Hernandezauthor=R.+Kr%C3%BCgerauthor=M.+Federoffauthor=C.+Kleinauthor=A.+Goateauthor=J.+Perlmutterauthor=M.+Boninauthor=M.+A.+Nallsauthor=T.+Illigauthor=C.+Giegerauthor=H.+Houldenauthor=M.+Steffensauthor=M.+S.+Okunauthor=B.+A.+Racetteauthor=M.+R.+Cooksonauthor=K.+D.+Footeauthor=H.+H.+Fernandezauthor=B.+J.+Traynorauthor=S.+Schreiberauthor=S.+Arepalliauthor=R.+Zonoziauthor=K.+Gwinnauthor=M.+van+der+Brugauthor=G.+Lopezauthor=S.+J.+Chanockauthor=A.+Schatzkinauthor=Y.+Parkauthor=A.+Hollenbeckauthor=J.+Gaoauthor=X.+Huangauthor=N.+W.+Woodauthor=D.+Lorenzauthor=G.+Deuschlauthor=H.+Chenauthor=O.+Riessauthor=J.+A.+Hardyauthor=A.+B.+Singletonauthor=T.+Gasser&title=Genome-wide+association+study+reveals+genetic+risk+underlying+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide association study reveals genetic risk underlying Parkinson's disease</span></div><div class="casAuthors">Simon-Sanchez, Javier; Schulte, Claudia; Bras, Jose M.; Sharma, Manu; Gibbs, J. Raphael; Berg, Daniela; Paisan-Ruiz, Coro; Lichtner, Peter; Scholz, Sonja W.; Hernandez, Dena G.; Krueger, Rejko; Federoff, Monica; Klein, Christine; Goate, Alison; Perlmutter, Joel; Bonin, Michael; Nalls, Michael A.; Illig, Thomas; Gieger, Christian; Houlden, Henry; Steffens, Michael; Okun, Michael S.; Racette, Brad A.; Cookson, Mark R.; Foote, Kelly D.; Fernandez, Hubert H.; Traynor, Bryan J.; Schreiber, Stefan; Arepalli, Sampath; Zonozi, Ryan; Gwinn, Katrina; van der Brug, Marcel; Lopez, Grisel; Chanock, Stephen J.; Schatzkin, Arthur; Park, Yikyung; Hollenbeck, Albert; Gao, Jianjun; Huang, Xuemei; Wood, Nick W.; Lorenz, Delia; Deuschl, Guenther; Chen, Honglei; Riess, Olaf; Hardy, John A.; Singleton, Andrew B.; Gasser, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1308-1312</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We performed a genome-wide assocn. study (GWAS) in 1713 individuals of European ancestry with Parkinson's disease (PD) and 3978 controls.  After replication in 3361 cases and 4573 controls, we obsd. two strong assocn. signals, one in the gene encoding α-synuclein (SNCA; rs2736990, OR = 1.23, P = 2.24 × 10-16) and another at the MAPT locus (rs393152, OR = 0.77, P = 1.95 × 10-16).  We exchanged data with colleagues performing a GWAS in Japanese PD cases.  Assocn. to PD at SNCA was replicated in the Japanese GWAS, confirming this as a major risk locus across populations.  We replicated the effect of a new locus detected in the Japanese cohort (PARK16, rs823128, OR = 0.66, P = 7.29 × 10-8) and provide supporting evidence that common variation around LRRK2 modulates risk for PD (rs1491923, OR = 1.14, P = 1.55 × 10-5).  These data demonstrate an unequivocal role for common genetic variants in the etiol. of typical PD and suggest population-specific genetic heterogeneity in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1PHkVNrI1D7Vg90H21EOLACvtfcHk0lge522CPhluag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWlsbrP&md5=7dae0abacbde642a41eb9d4899b8980d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fng.487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.487%26sid%3Dliteratum%253Aachs%26aulast%3DSim%25C3%25B3n-S%25C3%25A1nchez%26aufirst%3DJ.%26aulast%3DSchulte%26aufirst%3DC.%26aulast%3DBras%26aufirst%3DJ.%2BM.%26aulast%3DSharma%26aufirst%3DM.%26aulast%3DGibbs%26aufirst%3DJ.%2BR.%26aulast%3DBerg%26aufirst%3DD.%26aulast%3DPaisan-Ruiz%26aufirst%3DC.%26aulast%3DLichtner%26aufirst%3DP.%26aulast%3DScholz%26aufirst%3DS.%2BW.%26aulast%3DHernandez%26aufirst%3DD.%2BG.%26aulast%3DKr%25C3%25BCger%26aufirst%3DR.%26aulast%3DFederoff%26aufirst%3DM.%26aulast%3DKlein%26aufirst%3DC.%26aulast%3DGoate%26aufirst%3DA.%26aulast%3DPerlmutter%26aufirst%3DJ.%26aulast%3DBonin%26aufirst%3DM.%26aulast%3DNalls%26aufirst%3DM.%2BA.%26aulast%3DIllig%26aufirst%3DT.%26aulast%3DGieger%26aufirst%3DC.%26aulast%3DHoulden%26aufirst%3DH.%26aulast%3DSteffens%26aufirst%3DM.%26aulast%3DOkun%26aufirst%3DM.%2BS.%26aulast%3DRacette%26aufirst%3DB.%2BA.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26aulast%3DFoote%26aufirst%3DK.%2BD.%26aulast%3DFernandez%26aufirst%3DH.%2BH.%26aulast%3DTraynor%26aufirst%3DB.%2BJ.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DArepalli%26aufirst%3DS.%26aulast%3DZonozi%26aufirst%3DR.%26aulast%3DGwinn%26aufirst%3DK.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%26aulast%3DLopez%26aufirst%3DG.%26aulast%3DChanock%26aufirst%3DS.%2BJ.%26aulast%3DSchatzkin%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DY.%26aulast%3DHollenbeck%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DWood%26aufirst%3DN.%2BW.%26aulast%3DLorenz%26aufirst%3DD.%26aulast%3DDeuschl%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DRiess%26aufirst%3DO.%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DSingleton%26aufirst%3DA.%2BB.%26aulast%3DGasser%26aufirst%3DT.%26atitle%3DGenome-wide%2520association%2520study%2520reveals%2520genetic%2520risk%2520underlying%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Genet.%26date%3D2009%26volume%3D41%26spage%3D1308%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Mata, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, K. A.</span><span> </span><span class="NLM_article-title">LRRK2 in Parkinson’s disease: protein domains and functional insights</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">286</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=286-293&author=I.+F.+Mataauthor=W.+J.+Wedemeyerauthor=M.+J.+Farrerauthor=J.+P.+Taylorauthor=K.+A.+Gallo&title=LRRK2+in+Parkinson%E2%80%99s+disease%3A+protein+domains+and+functional+insights"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMata%26aufirst%3DI.%2BF.%26aulast%3DWedemeyer%26aufirst%3DW.%2BJ.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26aulast%3DTaylor%26aufirst%3DJ.%2BP.%26aulast%3DGallo%26aufirst%3DK.%2BA.%26atitle%3DLRRK2%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520protein%2520domains%2520and%2520functional%2520insights%26jtitle%3DTrends%2520Neurosci.%26date%3D2006%26volume%3D29%26spage%3D286%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 mutations and Parkinson’s disease: three questions</span> <span class="citation_source-journal">ASN Neuro</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">e00002</span><span class="NLM_x">) </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1042%2FAN20090007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KmsrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=13-24&issue=e00002&author=E.+Greggioauthor=M.+R.+Cookson&title=Leucine-rich+repeat+kinase+2+mutations+and+Parkinson%E2%80%99s+disease%3A+three+questions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions</span></div><div class="casAuthors">Greggio, Elisa; Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">ASN Neuro</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-24</span>CODEN:
                <span class="NLM_cas:coden">ANSEFU</span>;
        ISSN:<span class="NLM_cas:issn">1759-0914</span>.
    
            (<span class="NLM_cas:orgname">Portland Press</span>)
        </div><div class="casAbstract">A review.  Mutations in the gene encoding LRRK2 (leucine-rich repeat kinase 2) were first identified in 2004 and have since been shown to be the single most common cause of inherited Parkinson's disease.  The protein is a large GTP-regulated serine/threonine kinase that addnl. contains several protein-protein interaction domains.  In the present review, we discuss three important, but unresolved, questions concerning LRRK2.  We first ask: what is the normal function of LRRK2.  Related to this, we discuss the evidence of LRRK2 activity as a GTPase and as a kinase and the available data on protein-protein interactions.  Next we raise the question of how mutations affect LRRK2 function, focusing on some slightly controversial results related to the kinase activity of the protein in a variety of in vitro systems.  Finally, we discuss what the possible mechanisms are for LRRK2-mediated neurotoxicity, in the context of known activities of the protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu41GNQD0_w7Vg90H21EOLACvtfcHk0lge522CPhluag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KmsrvI&md5=6d987ceba6d48841f06baf41455a1f6b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1042%2FAN20090007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FAN20090007%26sid%3Dliteratum%253Aachs%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520mutations%2520and%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520three%2520questions%26jtitle%3DASN%2520Neuro%26date%3D2009%26volume%3D1%26issue%3De00002%26spage%3D13%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Gandhi, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson-Delfosse, A. L.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson’s disease</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">1283</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1002%2Fjnr.21949" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=19025767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1Wnt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2009&pages=1283-1295&author=P.+N.+Gandhiauthor=S.+G.+Chenauthor=A.+L.+Wilson-Delfosse&title=Leucine-rich+repeat+kinase+2+%28LRRK2%29%3A+a+key+player+in+the+pathogenesis+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease</span></div><div class="casAuthors">Gandhi, Payal N.; Chen, Shu G.; Wilson-Delfosse, Amy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1283-1295</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is the most common neurodegenerative movement disorder, with a prevalence of more than 1% after the age of 65 years.  Mutations in the gene encoding leucine-rich repeat kinase-2 (LRRK2) have recently been linked to autosomal dominant, late-onset PD that is clin. indistinguishable from typical, idiopathic disease.  LRRK2 is a multidomain protein contg. several protein interaction motifs as well as dual enzymic domains of GTPase and protein kinase activities.  Disease-assocd. mutations are found throughout the multidomain structure of the protein.  LRRK2, however, is unique among the PD-causing genes, because a missense mutation, G2019S, is a frequent determinant of not only familial but also sporadic PD.  Thus, LRRK2 has emerged as a promising therapeutic target for combating PD.  In this Mini-Review, we look at the current state of knowledge regarding the domain structure, amino acid substitutions, and potential functional roles of LRRK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhitPWE7Qj1rVg90H21EOLACvtfcHk0lhU7kMjvuOnbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1Wnt70%253D&md5=81fe55081f2c1e0f665c60aaf7221951</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fjnr.21949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.21949%26sid%3Dliteratum%253Aachs%26aulast%3DGandhi%26aufirst%3DP.%2BN.%26aulast%3DChen%26aufirst%3DS.%2BG.%26aulast%3DWilson-Delfosse%26aufirst%3DA.%2BL.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%253A%2520a%2520key%2520player%2520in%2520the%2520pathogenesis%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2009%26volume%3D87%26spage%3D1283%26epage%3D1295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Drolet, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. T.</span><span> </span><span class="NLM_article-title">Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions</span> <span class="citation_source-journal">J. Neurogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.3109%2F01677063.2011.627072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=22077787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=140-151&author=R.+E.+Droletauthor=J.+M.+Sandersauthor=J.+T.+Kern&title=Leucine-rich+repeat+kinase+2+%28LRRK2%29+cellular+biology%3A+a+review+of+recent+advances+in+identifying+physiological+substrates+and+cellular+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Leucine-Rich Repeat Kinase 2 (LRRK2) Cellular Biology: A Review of Recent Advances in Identifying Physiological Substrates and Cellular Functions</span></div><div class="casAuthors">Drolet, Robert E.; Sanders, John M.; Kern, Jonathan T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">140-151</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common forms of inheritable Parkinson's disease and likely play a role in sporadic disease as well.  LRRK2 is a large multidomain protein contg. two key groups, a Ras-like GTP binding domain and a serine, threonine kinase domain.  Mutations in the LRRK2 gene that assoc. with Parkinson's disease reside primarily within the two functional domains of the protein, suggesting that LRRK2 function is crit. to the pathogenesis of the disease.  The most common LRRK2 mutation increases kinase activity, making LRRK2 kinase inhibition an attractive target for small mol. drug development.  However, the physiol. function of LRRK2 kinase as well as its endogenous protein substrates remains poorly understood and has hindered drug development efforts.  Recent advances in LRRK2 biol. have revealed several potential cellular roles, interacting proteins, and putative physiol. substrates.  Together, a picture emerges of a complex multifunctional protein that exists in multiple cellular compartments.  Through unclear mechanisms, LRRK2 kinase regulates cytoskeleton architecture through control of protein translation, phosphorylation of cytoskeletal proteins, and response to cellular stressors.  This article will briefly cover some interesting recent studies in LRRK2 cellular biol. and highlight emerging cellular models of LRRK2 kinase function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIaZnsxyLANrVg90H21EOLACvtfcHk0lhU7kMjvuOnbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bL&md5=b4b40ac3ccfa45091410f59e1401587c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.627072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.627072%26sid%3Dliteratum%253Aachs%26aulast%3DDrolet%26aufirst%3DR.%2BE.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DKern%26aufirst%3DJ.%2BT.%26atitle%3DLeucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520cellular%2520biology%253A%2520a%2520review%2520of%2520recent%2520advances%2520in%2520identifying%2520physiological%2520substrates%2520and%2520cellular%2520functions%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26spage%3D140%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biskup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bugayenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Parkinson’s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">16842</span><span class="NLM_x">–</span> <span class="NLM_lpage">16847</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16842-16847&author=A.+B.+Westauthor=D.+J.+Mooreauthor=S.+Biskupauthor=A.+Bugayenkoauthor=W.+W.+Smithauthor=C.+A.+Rossauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Parkinson%E2%80%99s+disease-associated+mutations+in+leucine-rich+repeat+kinase+2+augment+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DMoore%26aufirst%3DD.%2BJ.%26aulast%3DBiskup%26aufirst%3DS.%26aulast%3DBugayenko%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DParkinson%25E2%2580%2599s%2520disease-associated%2520mutations%2520in%2520leucine-rich%2520repeat%2520kinase%25202%2520augment%2520kinase%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D16842%26epage%3D16847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsbury, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandopadhyay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaganovich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Brug, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beilina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackinton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesavapany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Kinase activity is required for the toxic effects of mutant LRRK2/dardarin</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1016%2Fj.nbd.2006.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=16750377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD28Xntl2ntrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=329-341&author=E.+Greggioauthor=S.+Jainauthor=A.+Kingsburyauthor=R.+Bandopadhyayauthor=P.+Lewisauthor=A.+Kaganovichauthor=M.+P.+van+der+Brugauthor=A.+Beilinaauthor=J.+Blackintonauthor=K.+J.+Thomasauthor=R.+Ahmadauthor=D.+W.+Millerauthor=S.+Kesavapanyauthor=A.+Singletonauthor=A.+Leesauthor=R.+J.+Harveyauthor=K.+Harveyauthor=M.+R.+Cookson&title=Kinase+activity+is+required+for+the+toxic+effects+of+mutant+LRRK2%2Fdardarin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase activity is required for the toxic effects of mutant LRRK2/dardarin</span></div><div class="casAuthors">Greggio, Elisa; Jain, Shushant; Kingsbury, Ann; Bandopadhyay, Rina; Lewis, Patrick; Kaganovich, Alice; van der Brug, Marcel P.; Beilina, Alexandra; Blackinton, Jeff; Thomas, Kelly Jean; Ahmad, Rili; Miller, David W.; Kesavapany, Sashi; Singleton, Andrew; Lees, Andrew; Harvey, Robert J.; Harvey, Kirsten; Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">329-341</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD).  Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain.  However, it is not clear if kinase activity is important for the damaging effects of pathogenic mutations.  In this study, we noted two cellular phenotypes assocd. with mutant dardarin.  First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies.  Secondly, neurons and neuronal cell lines undergo cell death after expression of mutant protein.  Manipulating activity by replacing the kinase domain with a kinase-dead' version blocks inclusion body formation and strongly delays cell death.  This predicts that kinase inhibitors will be useful therapeutic agents in patients with LRRK2 mutations and, perhaps, in sporadic PD.  We also show that dardarin protein is expressed within human midbrain neurons and that C-terminal epitopes are also found in some Lewy bodies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Hag6uVnmkLVg90H21EOLACvtfcHk0ljMqQPC-fJO8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xntl2ntrk%253D&md5=52b400fe2f04c2cdeae2a2aa0be67ece</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2006.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2006.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DJain%26aufirst%3DS.%26aulast%3DKingsbury%26aufirst%3DA.%26aulast%3DBandopadhyay%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DP.%26aulast%3DKaganovich%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BBrug%26aufirst%3DM.%2BP.%26aulast%3DBeilina%26aufirst%3DA.%26aulast%3DBlackinton%26aufirst%3DJ.%26aulast%3DThomas%26aufirst%3DK.%2BJ.%26aulast%3DAhmad%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DD.%2BW.%26aulast%3DKesavapany%26aufirst%3DS.%26aulast%3DSingleton%26aufirst%3DA.%26aulast%3DLees%26aufirst%3DA.%26aulast%3DHarvey%26aufirst%3DR.%2BJ.%26aulast%3DHarvey%26aufirst%3DK.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DKinase%2520activity%2520is%2520required%2520for%2520the%2520toxic%2520effects%2520of%2520mutant%2520LRRK2%252Fdardarin%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2006%26volume%3D23%26spage%3D329%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson’s disease</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1038%2Fnrn2935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=21088684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVersLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=791-797&author=M.+R.+Cookson&title=The+role+of+leucine-rich+repeat+kinase+2+%28LRRK2%29+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease</span></div><div class="casAuthors">Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">791-797</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component.  Here, I discuss how mutations in a large complex gene - leucine-rich repeat kinase 2 (LRRK2) - affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically α-synuclein and tau.  These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIZ6sTeax7vLVg90H21EOLACvtfcHk0ljMqQPC-fJO8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVersLbO&md5=1600eaee5fea809aa325e2d7a7963b35</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrn2935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn2935%26sid%3Dliteratum%253Aachs%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DThe%2520role%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2010%26volume%3D11%26spage%3D791%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Rudenko, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson’s disease?</span> <span class="citation_source-journal">BMC Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1186%2F1741-7015-10-20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=22361010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsVams7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=20-27&author=I.+N.+Rudenkoauthor=R.+Chiaauthor=M.+R.+Cookson&title=Is+inhibition+of+kinase+activity+the+only+therapeutic+strategy+for+LRRK2-associated+Parkinson%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?</span></div><div class="casAuthors">Rudenko, Iakov N.; Chia, Ruth; Cookson, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20</span>CODEN:
                <span class="NLM_cas:coden">BMMECZ</span>;
        ISSN:<span class="NLM_cas:issn">1741-7015</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a common cause of familial Parkinson's disease (PD).  Variation around the LRRK2 locus also contributes to the risk of sporadic PD.  The LRRK2 protein contains a central catalytic region, and pathogenic mutations cluster in the Ras of complex protein C terminus of Ras of complex protein (mutations N1437H, R1441G/C and Y1699C) and kinase (G2019S and I2020T) domains.  Much attention has been focused on the kinase domain, because kinase-dead versions of mutant LRRK2 are less toxic than kinase-active versions of the same proteins.  Furthermore, kinase inhibitors may be able to mimic this effect in mouse models, although the currently tested inhibitors are not completely specific.  In this review, we discuss the recent progress in the development of specific LRRK2 kinase inhibitors.  We also discuss non-kinase-based therapeutic strategies for LRRK2-assocd. PD as it is possible that different approaches may be needed for different mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrArNzblopm1bVg90H21EOLACvtfcHk0ljMqQPC-fJO8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsVams7k%253D&md5=e1de091de6b38b8a1138327f7292ae48</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1186%2F1741-7015-10-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1741-7015-10-20%26sid%3Dliteratum%253Aachs%26aulast%3DRudenko%26aufirst%3DI.%2BN.%26aulast%3DChia%26aufirst%3DR.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DIs%2520inhibition%2520of%2520kinase%2520activity%2520the%2520only%2520therapeutic%2520strategy%2520for%2520LRRK2-associated%2520Parkinson%25E2%2580%2599s%2520disease%253F%26jtitle%3DBMC%2520Med.%26date%3D2012%26volume%3D10%26spage%3D20%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamamichi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span> </span><span class="NLM_article-title">Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in <i>Caenorhabditis elegans</i> and <i>Drosophila</i> Parkinson’s disease models</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3933</span><span class="NLM_x">–</span> <span class="NLM_lpage">3942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1093%2Fhmg%2Fddr312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=21768216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1ajtbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=3933-3942&author=Z.+Liuauthor=S.+Hamamichiauthor=B.+D.+Leeauthor=D.+Yangauthor=A.+Rayauthor=G.+A.+Caldwellauthor=K.+A.+Caldwellauthor=T.+M.+Dawsonauthor=W.+W.+Smithauthor=V.+L.+Dawson&title=Inhibitors+of+LRRK2+kinase+attenuate+neurodegeneration+and+Parkinson-like+phenotypes+in+Caenorhabditis+elegans+and+Drosophila+Parkinson%E2%80%99s+disease+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models</span></div><div class="casAuthors">Liu, Zhao-Hui; Hamamichi, Shusei; Lee, Byoung-Dae; Yang, De-Jun; Ray, Arpita; Caldwell, Guy A.; Caldwell, Kim A.; Dawson, Ted M.; Smith, Wanli W.; Dawson, Valina L.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3933-3942</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) have been identified as a genetic cause of familial Parkinson's disease (PD) and have also been found in the more common sporadic form of PD, thus positioning LRRK2 as important in the pathogenesis of PD.  Biochem. studies of the disease-causing mutants of LRRK2 implicates an enhancement of kinase activity as the basis of neuronal toxicity and thus possibly the pathogenesis of PD due to LRRK2 mutations.  Previously, a chem. library screen identified inhibitors of LRRK2 kinase activity.  Here, two of these inhibitors, GW5074 and sorafenib, are shown to protect against G2019S LRRK2-induced neurodegeneration in vivo in Caenorhabditis elegans and in Drosophila.  These findings indicate that increased kinase activity of LRRK2 is neurotoxic and that inhibition of LRRK2 activity can have a disease-modifying effect.  This suggests that inhibition of LRRK2 holds promise as a treatment for PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUI1BJ-I2FnrVg90H21EOLACvtfcHk0ljJCCWtRgEvxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1ajtbnL&md5=53f130209a8364ac8c8c1f553ab4cd63</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr312%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHamamichi%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DRay%26aufirst%3DA.%26aulast%3DCaldwell%26aufirst%3DG.%2BA.%26aulast%3DCaldwell%26aufirst%3DK.%2BA.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26atitle%3DInhibitors%2520of%2520LRRK2%2520kinase%2520attenuate%2520neurodegeneration%2520and%2520Parkinson-like%2520phenotypes%2520in%2520Caenorhabditis%2520elegans%2520and%2520Drosophila%2520Parkinson%25E2%2580%2599s%2520disease%2520models%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2011%26volume%3D20%26spage%3D3933%26epage%3D3942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanKampen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire-Zeiss, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federoff, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson’s disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1038%2Fnm.2199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=20729864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=998-1000&author=B.+D.+Leeauthor=J.-H.+Shinauthor=J.+VanKampenauthor=L.+Petrucelliauthor=A.+B.+Westauthor=H.+S.+Koauthor=Y.-I.+Leeauthor=K.+A.+Maguire-Zeissauthor=W.+J.+Bowersauthor=H.+J.+Federoffauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Inhibitors+of+leucine-rich+repeat+kinase-2+protect+against+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease</span></div><div class="casAuthors">Lee, Byoung Dae; Shin, Joo-Ho; Van Kampen, Jackalina; Petrucelli, Leonard; West, Andrew B.; Ko, Han Seok; Lee, Yun-Il; Maguire-Zeiss, Kathleen A.; Bowers, William J.; Federoff, Howard J.; Dawson, Valina L.; Dawson, Ted M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">998-1000</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Leucine-rich repeat kinase-2 (LRRK2) mutations are a common cause of Parkinson's disease.  Here we identify inhibitors of LRRK2 kinase that are protective in in vitro and in vivo models of LRRK2-induced neurodegeneration.  These results establish that LRRK2-induced degeneration of neurons in vivo is kinase dependent and that LRRK2 kinase inhibition provides a potential new neuroprotective paradigm for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn78Hm84uiebVg90H21EOLACvtfcHk0ljJCCWtRgEvxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGgtLbE&md5=d6c5df67511a2f154b21a523af408f65</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnm.2199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2199%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DShin%26aufirst%3DJ.-H.%26aulast%3DVanKampen%26aufirst%3DJ.%26aulast%3DPetrucelli%26aufirst%3DL.%26aulast%3DWest%26aufirst%3DA.%2BB.%26aulast%3DKo%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DY.-I.%26aulast%3DMaguire-Zeiss%26aufirst%3DK.%2BA.%26aulast%3DBowers%26aufirst%3DW.%2BJ.%26aulast%3DFederoff%26aufirst%3DH.%2BJ.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DInhibitors%2520of%2520leucine-rich%2520repeat%2520kinase-2%2520protect%2520against%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2010%26volume%3D16%26spage%3D998%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Garcia-Serna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestres, J.</span><span> </span><span class="NLM_article-title">Chemical Probes for biological systems</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=99-106&author=R.+Garcia-Sernaauthor=J.+Mestres&title=Chemical+Probes+for+biological+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Serna%26aufirst%3DR.%26aulast%3DMestres%26aufirst%3DJ.%26atitle%3DChemical%2520Probes%2520for%2520biological%2520systems%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D99%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prescott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of a selective inhibitor of the Parkinson’s disease kinase LRRK2</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1038%2Fnchembio.538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=21378983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=203-205&author=X.+Dengauthor=N.+Dzamkoauthor=A.+Prescottauthor=P.+Daviesauthor=Q.+Liuauthor=Q.+Yangauthor=J.-D.+Leeauthor=M.+P.+Patricelliauthor=T.+K.+Nomanbhoyauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+a+selective+inhibitor+of+the+Parkinson%E2%80%99s+disease+kinase+LRRK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2</span></div><div class="casAuthors">Deng, Xianming; Dzamko, Nicolas; Prescott, Alan; Davies, Paul; Liu, Qingsong; Yang, Qingkai; Lee, Jiing-Dwan; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">203-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly assocd. with late-onset autosomal dominant Parkinson's disease.  We employed a new, parallel, compd.-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of LRRK2 within aggregate structures.  LRRK2-IN-1 will serve as a versatile tool to pharmacol. interrogate LRRK2 biol. and study its role in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwLpGURHqDULVg90H21EOLACvtfcHk0lgNHG7JAbW2Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVKqsL0%253D&md5=9f48f74cad9988e3ea8bb7af280473c1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.538%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DPrescott%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.-D.%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520a%2520selective%2520inhibitor%2520of%2520the%2520Parkinson%25E2%2580%2599s%2520disease%2520kinase%2520LRRK2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D203%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ramsden, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren., Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span> </span><span class="NLM_article-title">Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson’s disease-related toxicity in human neurons</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1028</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb2002413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1021-1028&author=N.+Ramsdenauthor=J.+Perrinauthor=Z.+Ren.author=B.+D.+Leeauthor=N.+Zinnauthor=V.+L.+Dawsonauthor=D.+Tamauthor=M.+Bovaauthor=M.+Langauthor=G.+Drewesauthor=M.+Bantscheffauthor=F.+Bardauthor=T.+M.+Dawsonauthor=C.+Hopf&title=Chemoproteomics-based+design+of+potent+LRRK2-selective+lead+compounds+that+attenuate+Parkinson%E2%80%99s+disease-related+toxicity+in+human+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcb2002413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb2002413%26sid%3Dliteratum%253Aachs%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DPerrin%26aufirst%3DJ.%26aulast%3DRen.%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DB.%2BD.%26aulast%3DZinn%26aufirst%3DN.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DBova%26aufirst%3DM.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DBard%26aufirst%3DF.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DHopf%26aufirst%3DC.%26atitle%3DChemoproteomics-based%2520design%2520of%2520potent%2520LRRK2-selective%2520lead%2520compounds%2520that%2520attenuate%2520Parkinson%25E2%2580%2599s%2520disease-related%2520toxicity%2520in%2520human%2520neurons%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2011%26volume%3D6%26spage%3D1021%26epage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Characterization of TAE684 as a potent LRRK2 kinase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1869</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1864-1869&author=J.+Zhangauthor=X.+Dengauthor=H.+G.+Choiauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Characterization+of+TAE684+as+a+potent+LRRK2+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DCharacterization%2520of%2520TAE684%2520as%2520a%2520potent%2520LRRK2%2520kinase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1864%26epage%3D1869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Kramer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Monte, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goering, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okala Amombo, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title">Small molecule kinase inhibitors for LRRK2 and their application to parkinson’s disease models</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200117j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=151-160&author=T.+Kramerauthor=F.+Lo+Monteauthor=S.+Goeringauthor=G.+M.+Okala+Amomboauthor=B.+Schmidt&title=Small+molecule+kinase+inhibitors+for+LRRK2+and+their+application+to+parkinson%E2%80%99s+disease+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Kinase Inhibitors for LRRK2 and Their Application to Parkinson's Disease Models</span></div><div class="casAuthors">Kramer, Thomas; Lo Monte, Fabio; Goering, Stefan; Okala Amombo, Ghislaine Marlyse; Schmidt, Boris</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">151-160</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) is the second most common neurodegenerative disorder.  Several single gene mutations have been linked to this disease.  Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) indicate LRRK2 as promising therapeutic target for the treatment of PD.  LRRK2 mutations were obsd. in sporadic as well as familial PD patients and have been investigated intensively.  LRRK2 is a large and complex protein, with multiple enzymic and protein-interaction domains, each of which is effected by mutations.  The most common mutation in PD patients is G2019S.  Several LRRK2 inhibitors have been reported already, although the crystal structure of LRRK2 has not yet been detd.  This review provides a summary of known LRRK2 inhibitors and will discuss recent in vitro and in vivo results of these inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqUiu7gx3NxLVg90H21EOLACvtfcHk0lgt2Boo6PME3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFentA%253D%253D&md5=bda078bde5e0b515ca9d6f183d8b06f8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fcn200117j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200117j%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DT.%26aulast%3DLo%2BMonte%26aufirst%3DF.%26aulast%3DGoering%26aufirst%3DS.%26aulast%3DOkala%2BAmombo%26aufirst%3DG.%2BM.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DSmall%2520molecule%2520kinase%2520inhibitors%2520for%2520LRRK2%2520and%2520their%2520application%2520to%2520parkinson%25E2%2580%2599s%2520disease%2520models%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D151%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Lovitt, B</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderporten, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span> </span><span class="NLM_article-title">Differential effects of divalent manganese and magnesium on the kinase activity of leucine-rich repeat kinase 2 (LRRK2)</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3092</span><span class="NLM_x">–</span> <span class="NLM_lpage">3100</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi901726c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=3092-3100&author=B+Lovittauthor=E.+C.+Vanderportenauthor=Z.+Shengauthor=H.+Zhuauthor=J.+Drummondauthor=Y.+Liu&title=Differential+effects+of+divalent+manganese+and+magnesium+on+the+kinase+activity+of+leucine-rich+repeat+kinase+2+%28LRRK2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi901726c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi901726c%26sid%3Dliteratum%253Aachs%26aulast%3DLovitt%26aufirst%3DB%26aulast%3DVanderporten%26aufirst%3DE.%2BC.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DDifferential%2520effects%2520of%2520divalent%2520manganese%2520and%2520magnesium%2520on%2520the%2520kinase%2520activity%2520of%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D3092%26epage%3D3100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lgt2Boo6PME3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZrwZvPWuR1-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgvUgCgKmJxQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Moore, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorarensen, A.</span><span> </span><span class="NLM_article-title">An analysis of the diaminopyrimidine patent estates describing spleen tyrosine kinase inhibitors by Rigel and Portola</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1703</span><span class="NLM_x">–</span> <span class="NLM_lpage">1722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1517%2F13543776.2010.534459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=21073366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1703-1722&author=W.+J.+Mooreauthor=D.+Richardauthor=A.+Thorarensen&title=An+analysis+of+the+diaminopyrimidine+patent+estates+describing+spleen+tyrosine+kinase+inhibitors+by+Rigel+and+Portola"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">An analysis of the diaminopyrimidine patent estates describing spleen tyrosine kinase inhibitors by Rigel and Portola</span></div><div class="casAuthors">Moore, William J.; Richard, David; Thorarensen, Atli</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1703-1722</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Discovery of small mol. inhibitors for treatment of rheumatoid arthritis is a major ongoing effort within the pharmaceutical industry.  Spleen tyrosine kinase (SYK) is one of the leading small mol. targets with regard to clin. developments due to the efforts of Rigel and Portola.Areas covered in this review: Diaminopyrimidines are one of the most prominent structural elements incorporated into the design of kinase inhibitors.  This review provides an extensive overview of the patent estates for the leading discovery programs at Portola and Rigel on diaminopyrimidines and how their patent estates are in relationship with the competition and prior art.What the reader will gain: An overview of the patent landscape for diaminopyrimidines.  In addn., the reader will be updated on what modifications in these scaffolds lead to very potent SYK inhibitors as judged by the applications.  Finally, the authors will provide their best guess on what the structure is of Portola's recently announced clin. candidate.Take home message: The Rigel and the Portola research organizations have filed a series of patent applications on diaminopyrimidines as inhibitors of SYK.  The scope of these applications is broad in a crowded chem. space.  These applications contain very broad claims and the future will tell how much of the generic space claimed will be allowed in granted patents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7wp-QGiNYmrVg90H21EOLACvtfcHk0lgvUgCgKmJxQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7bJ&md5=a594fee4a53660d83042531aaf569eaf</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.534459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.534459%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DW.%2BJ.%26aulast%3DRichard%26aufirst%3DD.%26aulast%3DThorarensen%26aufirst%3DA.%26atitle%3DAn%2520analysis%2520of%2520the%2520diaminopyrimidine%2520patent%2520estates%2520describing%2520spleen%2520tyrosine%2520kinase%2520inhibitors%2520by%2520Rigel%2520and%2520Portola%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D1703%26epage%3D1722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greggio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beilina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cookson, M. R.</span><span> </span><span class="NLM_article-title">Structure of the ROC domain from the Parkinson’s disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1499</span><span class="NLM_x">–</span> <span class="NLM_lpage">1504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=1499-1504&author=J.+Dengauthor=P.+A.+Lewisauthor=E.+Greggioauthor=E.+Sluchauthor=A.+Beilinaauthor=M.+R.+Cookson&title=Structure+of+the+ROC+domain+from+the+Parkinson%E2%80%99s+disease-associated+leucine-rich+repeat+kinase+2+reveals+a+dimeric+GTPase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DP.%2BA.%26aulast%3DGreggio%26aufirst%3DE.%26aulast%3DSluch%26aufirst%3DE.%26aulast%3DBeilina%26aufirst%3DA.%26aulast%3DCookson%26aufirst%3DM.%2BR.%26atitle%3DStructure%2520of%2520the%2520ROC%2520domain%2520from%2520the%2520Parkinson%25E2%2580%2599s%2520disease-associated%2520leucine-rich%2520repeat%2520kinase%25202%2520reveals%2520a%2520dimeric%2520GTPase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D1499%26epage%3D1504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Marín, I.</span><span> </span><span class="NLM_article-title">The Parkinson disease gene LRRK2: evolutionary and structural insights</span> <span class="citation_source-journal">Mol. Biol. Evol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2423</span><span class="NLM_x">–</span> <span class="NLM_lpage">2433</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2006&pages=2423-2433&author=I.+Mar%C3%ADn&title=The+Parkinson+disease+gene+LRRK2%3A+evolutionary+and+structural+insights"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMar%25C3%25ADn%26aufirst%3DI.%26atitle%3DThe%2520Parkinson%2520disease%2520gene%2520LRRK2%253A%2520evolutionary%2520and%2520structural%2520insights%26jtitle%3DMol.%2520Biol.%2520Evol.%26date%3D2006%26volume%3D23%26spage%3D2423%26epage%3D2433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Nichols, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutti, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson’s disease</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">424</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2009&pages=47-60&author=R.+J.+Nicholsauthor=N.+Dzamkoauthor=J.+E.+Huttiauthor=L.+C.+Cantleyauthor=M.+Deakauthor=J.+Moranauthor=P.+Bamboroughauthor=A.+D.+Reithauthor=D.+R.+Alessi&title=Substrate+specificity+and+inhibitors+of+LRRK2%2C+a+protein+kinase+mutated+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNichols%26aufirst%3DR.%2BJ.%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DHutti%26aufirst%3DJ.%2BE.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DDeak%26aufirst%3DM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DSubstrate%2520specificity%2520and%2520inhibitors%2520of%2520LRRK2%252C%2520a%2520protein%2520kinase%2520mutated%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D424%26spage%3D47%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaitsev, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glicksman, M. A.</span><span> </span><span class="NLM_article-title">Kinetic, mechanistic, and structural modeling studies of truncated wild-type leucine-rich repeat kinase 2 and the G2019S mutant</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">9399</span><span class="NLM_x">–</span> <span class="NLM_lpage">9408</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi201173d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=9399-9408&author=M.+Liuauthor=S.+Kangauthor=S.+Rayauthor=J.+Jacksonauthor=A.+D.+Zaitsevauthor=S.+A.+Gerberauthor=G.+D.+Cunyauthor=M.+A.+Glicksman&title=Kinetic%2C+mechanistic%2C+and+structural+modeling+studies+of+truncated+wild-type+leucine-rich+repeat+kinase+2+and+the+G2019S+mutant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fbi201173d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi201173d%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DJ.%26aulast%3DZaitsev%26aufirst%3DA.%2BD.%26aulast%3DGerber%26aufirst%3DS.%2BA.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DGlicksman%26aufirst%3DM.%2BA.%26atitle%3DKinetic%252C%2520mechanistic%252C%2520and%2520structural%2520modeling%2520studies%2520of%2520truncated%2520wild-type%2520leucine-rich%2520repeat%2520kinase%25202%2520and%2520the%2520G2019S%2520mutant%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D9399%26epage%3D9408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Cavasotto, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phatak, S. S.</span><span> </span><span class="NLM_article-title">Homology modeling in drug discovery: current trends and applications</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">676</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1016%2Fj.drudis.2009.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=19422931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFyktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=676-683&author=C.+N.+Cavasottoauthor=S.+S.+Phatak&title=Homology+modeling+in+drug+discovery%3A+current+trends+and+applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Homology modeling in drug discovery: current trends and applications</span></div><div class="casAuthors">Cavasotto, Claudio N.; Phatak, Sharangdhar S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13/14</span>),
    <span class="NLM_cas:pages">676-683</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  As structural genomics (SG) projects continue to deposit representative 3D structures of proteins, homol. modeling methods will play an increasing role in structure-based drug discovery.  Although computational structure prediction methods provide a cost-effective alternative in the absence of exptl. structures, developing accurate enough models still remains a big challenge.  In this contribution, we report the current developments in this field, discuss in silico modeling limitations, and review the successful application of this technique to different stages of the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplkpoeHZH5nrVg90H21EOLACvtfcHk0lh1wVaCHWZ9vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFyktLs%253D&md5=aec3151d1c1adddaedb5d552ad93071c</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DCavasotto%26aufirst%3DC.%2BN.%26aulast%3DPhatak%26aufirst%3DS.%2BS.%26atitle%3DHomology%2520modeling%2520in%2520drug%2520discovery%253A%2520current%2520trends%2520and%2520applications%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D676%26epage%3D683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Grant, M. A.</span><span> </span><span class="NLM_article-title">Protein structure prediction in structure-based ligand design and virtual screening</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">940</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.2174%2F138620709789824718" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=20025561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGqsbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=940-960&author=M.+A.+Grant&title=Protein+structure+prediction+in+structure-based+ligand+design+and+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Protein structure prediction in structure-based ligand design and virtual screening</span></div><div class="casAuthors">Grant, Marianne A.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">940-960</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Advances in protein modeling algorithms and state-of-the-art sequence similarity comparison and fold recognition methods, in combination with growing protein structure information, are facilitating "genome-to-drug lead" approaches in which chems. are virtually screened against computationally-predicted protein targets.  Although the quality of predicted protein structures by homol. modeling methods, and thus their applicability to drug discovery initiatives, predominantly depends on the sequence similarity between the protein of known structure and the protein target to be modeled, recent research underscores that this approach can be used to significant advantage in the identification and optimization of lead compds., as well as for the identification and validation of drug targets.  Rational structure-based drug design cycles begin with an iterative procedure that is dependent on the initial detn. of the structure of the target protein, followed by the prediction of ligands for the target protein from mol. modeling computation.  The structure detn. of all proteins encoded by vast genome sequencing efforts appears to be an unrealistic goal with current technologies.  Therefore, other approaches based on the development of technol. useful for accurately predicting and modeling the structures of proteins have become exceedingly important in certain structure-based drug design efforts.  Here, the author provides an overview of the recent method advancements in protein structure prediction by homol. modeling and includes an assessment of the application of homol. modeling to pharmaceutically relevant questions.  In addn., examples of successful applications of homol. modeling approaches to genome-to-drug lead investigations are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5wlvLv0iXS7Vg90H21EOLACvtfcHk0lh1wVaCHWZ9vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGqsbbM&md5=62d737964bc3a49205786f1c10c2c3e8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.2174%2F138620709789824718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620709789824718%26sid%3Dliteratum%253Aachs%26aulast%3DGrant%26aufirst%3DM.%2BA.%26atitle%3DProtein%2520structure%2520prediction%2520in%2520structure-based%2520ligand%2520design%2520and%2520virtual%2520screening%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2009%26volume%3D12%26spage%3D940%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Cavasotto, C. N.</span><span> </span><span class="NLM_article-title">Homology models in docking and high-throughput docking</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1528</span><span class="NLM_x">–</span> <span class="NLM_lpage">1534</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.2174%2F156802611795860951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=21510834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFOrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=1528-1534&author=C.+N.+Cavasotto&title=Homology+models+in+docking+and+high-throughput+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Homology models in docking and high-throughput docking</span></div><div class="casAuthors">Cavasotto, Claudio N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1528-1534</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The use of homol. models in docking-based drug discovery is already established, and provides an effective and computationally affordable alternative whenever exptl. structures are not available.  Recent methodol. studies have confirmed and benchmarked the feasibility of using structural models in docking.  However, more accurate methods are expected to be developed in the near future, esp. for the model refinement stage.  In this review, the latest developments in homol. modeling in the context of structure-based virtual screening are presented, together with the recent success stories of homol. modeling in actual docking-based drug discovery endeavors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRlZbSdsKo-rVg90H21EOLACvtfcHk0lh1wVaCHWZ9vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFOrtbc%253D&md5=58c45631128d284cc8e829e3e4a50472</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F156802611795860951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611795860951%26sid%3Dliteratum%253Aachs%26aulast%3DCavasotto%26aufirst%3DC.%2BN.%26atitle%3DHomology%2520models%2520in%2520docking%2520and%2520high-throughput%2520docking%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D1528%26epage%3D1534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Bairoch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasteiger, E.</span><span> </span><span class="NLM_article-title">Swiss-Prot: juggling between evolution and stability</span> <span class="citation_source-journal">Briefings Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1093%2Fbib%2F5.1.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=15153305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ahsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=39-55&author=A.+Bairochauthor=B.+Boeckmannauthor=S.+Ferroauthor=E.+Gasteiger&title=Swiss-Prot%3A+juggling+between+evolution+and+stability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Swiss-Prot: juggling between evolution and stability</span></div><div class="casAuthors">Bairoch, Amos; Boeckmann, Brigitte; Ferro, Serenella; Gasteiger, Elisabeth</div><div class="citationInfo"><span class="NLM_cas:title">Briefings in Bioinformatics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-55</span>CODEN:
                <span class="NLM_cas:coden">BBIMFX</span>;
        ISSN:<span class="NLM_cas:issn">1467-5463</span>.
    
            (<span class="NLM_cas:orgname">Henry Stewart Publications</span>)
        </div><div class="casAbstract">Some of the aspects of Swiss-Prot that make it unique are described and the developments that are necessary for the database to continue to play its role as a focal point of protein knowledge are discussed.  Advices pertinent to the development of high-quality knowledge resources on one aspect or the other of the life sciences are provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEgdtQ3E4iD7Vg90H21EOLACvtfcHk0lh1wVaCHWZ9vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ahsbw%253D&md5=20bac4d8d69b26959f71a271299fd233</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1093%2Fbib%2F5.1.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbib%252F5.1.39%26sid%3Dliteratum%253Aachs%26aulast%3DBairoch%26aufirst%3DA.%26aulast%3DBoeckmann%26aufirst%3DB.%26aulast%3DFerro%26aufirst%3DS.%26aulast%3DGasteiger%26aufirst%3DE.%26atitle%3DSwiss-Prot%253A%2520juggling%2520between%2520evolution%2520and%2520stability%26jtitle%3DBriefings%2520Bioinf.%26date%3D2004%26volume%3D5%26spage%3D39%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Altschul, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madden, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäffer, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipman, D. J.</span><span> </span><span class="NLM_article-title">Gapped BLAST and PSI-BLAST: a new generation of protein database search programs</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3389</span><span class="NLM_x">–</span> <span class="NLM_lpage">3402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1093%2Fnar%2F25.17.3389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=9254694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADyaK2sXlvFyhu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1997&pages=3389-3402&author=S.+F.+Altschulauthor=T.+L.+Maddenauthor=A.+A.+Sch%C3%A4fferauthor=J.+Zhangauthor=Z.+Zhangauthor=W.+Millerauthor=D.+J.+Lipman&title=Gapped+BLAST+and+PSI-BLAST%3A+a+new+generation+of+protein+database+search+programs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Gapped BLAST and PSI-BLAST: a new generation of protein database search programs</span></div><div class="casAuthors">Altschul, Stephen F.; Madden, Thomas L.; Schaffer, Alejandro A.; Zhang, Jinghui; Zhang, Zheng; Miller, Webb; Lipman, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3389-3402</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The BLAST programs are widely used tools for searching protein and DNA databases for sequence similarities.  For protein comparisons, a variety of definitional, algorithmic and statistical refinements described here permits the execution time of the BLAST programs to be decreased substantially while enhancing their sensitivity to weak similarities.  A new criterion for triggering the extension of word hits, combined with a new heuristic for generating gapped alignments, yields a gapped BLAST program that runs at approx. three times the speed of the original.  In addn., a method is introduced for automatically combining statistically significant alignments produced by BLAST into a position-specific score matrix, and searching the database using this matrix.  The resulting Position-Specific Iterated BLAST (PSI-BLAST) program runs at approx. the same speed per iteration as gapped BLAST, but in many cases is much more sensitive to weak but biol. relevant sequence similarities.  PSI-BLAST is used to uncover several new and interesting members of the BRCT superfamily.  The source code for the new BLAST programs is available by anonymous ftp from the machine ncbi.nlm.nih.gov, within the directory 'blast', and the programs may be run from NCBIs web site at http://www.ncbi.nlm.nih.gov/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfl-GGLfjeoLVg90H21EOLACvtfcHk0lg0D1D_81AJLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvFyhu7w%253D&md5=4e44123e5984e4aca46a9899d347a176</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F25.17.3389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F25.17.3389%26sid%3Dliteratum%253Aachs%26aulast%3DAltschul%26aufirst%3DS.%2BF.%26aulast%3DMadden%26aufirst%3DT.%2BL.%26aulast%3DSch%25C3%25A4ffer%26aufirst%3DA.%2BA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DMiller%26aufirst%3DW.%26aulast%3DLipman%26aufirst%3DD.%2BJ.%26atitle%3DGapped%2520BLAST%2520and%2520PSI-BLAST%253A%2520a%2520new%2520generation%2520of%2520protein%2520database%2520search%2520programs%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1997%26volume%3D25%26spage%3D3389%26epage%3D3402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span> <span class="citation_source-book">MOE</span>, version <span class="NLM_edition">2009.10</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">Montreal, Canada</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE%2C+version+2009.10%3B+Chemical+Computing+Group+Inc.%3A+Montreal%2C+Canada."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMOE%26pub%3DChemical%2520Computing%2520Group%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuccola, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogan, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jepson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shlyakter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furey, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frantz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauffenbach, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germann, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namchuk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennani, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledeboer, M. W.</span><span> </span><span class="NLM_article-title">Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindole</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7938</span><span class="NLM_x">–</span> <span class="NLM_lpage">7941</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901383u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7938-7941&author=T.+Wangauthor=J.+P.+Duffyauthor=J.+Wangauthor=S.+Halasauthor=F.+G.+Salituroauthor=A.+C.+Pierceauthor=H.+J.+Zuccolaauthor=J.+R.+Blackauthor=J.+K.+Hoganauthor=S.+Jepsonauthor=D.+Shlyakterauthor=S.+Mahajanauthor=Y.+Guauthor=T.+Hoockauthor=M.+Woodauthor=B.+F.+Fureyauthor=J.+D.+Frantzauthor=L.+M.+Dauffenbachauthor=U.+A.+Germannauthor=B.+Fanauthor=M.+Namchukauthor=Y.+L.+Bennaniauthor=M.+W.+Ledeboer&title=Janus+kinase+2+inhibitors.+Synthesis+and+characterization+of+a+novel+polycyclic+azaindole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm901383u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901383u%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DDuffy%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHalas%26aufirst%3DS.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3DZuccola%26aufirst%3DH.%2BJ.%26aulast%3DBlack%26aufirst%3DJ.%2BR.%26aulast%3DHogan%26aufirst%3DJ.%2BK.%26aulast%3DJepson%26aufirst%3DS.%26aulast%3DShlyakter%26aufirst%3DD.%26aulast%3DMahajan%26aufirst%3DS.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHoock%26aufirst%3DT.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DFurey%26aufirst%3DB.%2BF.%26aulast%3DFrantz%26aufirst%3DJ.%2BD.%26aulast%3DDauffenbach%26aufirst%3DL.%2BM.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DFan%26aufirst%3DB.%26aulast%3DNamchuk%26aufirst%3DM.%26aulast%3DBennani%26aufirst%3DY.%2BL.%26aulast%3DLedeboer%26aufirst%3DM.%2BW.%26atitle%3DJanus%2520kinase%25202%2520inhibitors.%2520Synthesis%2520and%2520characterization%2520of%2520a%2520novel%2520polycyclic%2520azaindole%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7938%26epage%3D7941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Covy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giasson, B. I.</span><span> </span><span class="NLM_article-title">Identification of compounds that inhibit the kinase activity of leucine-rich repeat kinase 2</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">378</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2009&pages=473-477&author=J.+P.+Covyauthor=B.+I.+Giasson&title=Identification+of+compounds+that+inhibit+the+kinase+activity+of+leucine-rich+repeat+kinase+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCovy%26aufirst%3DJ.%2BP.%26aulast%3DGiasson%26aufirst%3DB.%2BI.%26atitle%3DIdentification%2520of%2520compounds%2520that%2520inhibit%2520the%2520kinase%2520activity%2520of%2520leucine-rich%2520repeat%2520kinase%25202%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D378%26spage%3D473%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span> <span class="citation_source-book">Maestro</span>; <span class="NLM_publisher-name">Schrödinger, Inc.</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%3B+Schr%C3%B6dinger%2C+Inc.%3A+New+York%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro%26pub%3DSchr%25C3%25B6dinger%252C%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Gould, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C. F.</span><span> </span><span class="NLM_article-title">Designing specific protein kinase inhibitors: insights from computer simulations and comparative sequence/structure analysis</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1016%2FS0163-7258%2802%2900186-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=12191609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD38XksVShtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2002&pages=169-178&author=C.+Gouldauthor=C.+F.+Wong&title=Designing+specific+protein+kinase+inhibitors%3A+insights+from+computer+simulations+and+comparative+sequence%2Fstructure+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Designing specific protein kinase inhibitors: insights from computer simulations and comparative sequence/structure analysis</span></div><div class="casAuthors">Gould, Christine; Wong, Chung F.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">169-178</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Protein kinases are important targets for designing therapeutic drugs.  We describe here a computational approach to extend the usefulness of a single protein-inhibitor structure in aiding the design of protein kinase inhibitors.  This approach is based on using sensitivity anal. to identify the most significant functional groups of a lead compd. in accounting for binding affinity and on using comparative sequence/structure anal. to examine whether these functional groups would present specificity.  A sensitivity anal. study is similar to genetic or chem. modification expts. in which specific features of a lead compd. are modified to examine whether they affect properties such as binding affinity.  In this study, the binding affinity was estd. by using an implicit-solvent model in which the electrostatic contributions were obtained by solving the Poisson equation, and the hydrophobic effects were accounted for by using surface-area-dependent terms.  The comparative sequence/structure anal. involves the study of the amino acid distributions of a large no. of protein kinases (384 in this study) near the ligand-binding sites.  This anal. provides useful guiding principles for designing specific inhibitors targeted towards a particular kinase.  Here, we illustrate the utility of these computational approaches by applying them to identify the determinants of the recognition between the protein kinase A and two of its inhibitors.  One inhibitor, balanol, binds to the ATP-binding pocket.  The other, protein kinase inhibitor, binds to the substrate-binding site.  These analyses have helped to construct pharmacophore models for mining new drug leads from small-mol. libraries and for suggesting how a lead compd. or a peptide inhibitor may be modified to generate selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD4cNyidIWgLVg90H21EOLACvtfcHk0lg0D1D_81AJLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksVShtbc%253D&md5=81c5c5809f3bedad54f9bc0559aca972</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2802%2900186-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252802%252900186-9%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DC.%2BF.%26atitle%3DDesigning%2520specific%2520protein%2520kinase%2520inhibitors%253A%2520insights%2520from%2520computer%2520simulations%2520and%2520comparative%2520sequence%252Fstructure%2520analysis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2002%26volume%3D93%26spage%3D169%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Caffrey, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moshinsky, D. J.</span><span> </span><span class="NLM_article-title">Prediction of specificity-determining residues for small-molecule kinase inhibitors</span> <span class="citation_source-journal">BMC Bioinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1186%2F1471-2105-9-491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=19032760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A280%3ADC%252BD1cjovF2itA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=491-505&author=D.+R.+Caffreyauthor=E.+A.+Lunneyauthor=D.+J.+Moshinsky&title=Prediction+of+specificity-determining+residues+for+small-molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of specificity-determining residues for small-molecule kinase inhibitors</span></div><div class="casAuthors">Caffrey Daniel R; Lunney Elizabeth A; Moshinsky Deborah J</div><div class="citationInfo"><span class="NLM_cas:title">BMC bioinformatics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">491</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Designing small-molecule kinase inhibitors with desirable selectivity profiles is a major challenge in drug discovery.  A high-throughput screen for inhibitors of a given kinase will typically yield many compounds that inhibit more than one kinase.  A series of chemical modifications are usually required before a compound exhibits an acceptable selectivity profile.  Rationalizing the selectivity profile for a small-molecule inhibitor in terms of the specificity-determining kinase residues for that molecule can be an important step toward the goal of developing selective kinase inhibitors.  RESULTS:  Here we describe S-Filter, a method that combines sequence and structural information to predict specificity-determining residues for a small molecule and its kinase selectivity profile.  Analysis was performed on seven selective kinase inhibitors where a structural basis for selectivity is known.  S-Filter correctly predicts specificity determinants that were described by independent groups.  S-Filter also predicts a number of novel specificity determinants that can often be justified by further structural comparison.  CONCLUSION:  S-Filter is a valuable tool for analyzing kinase selectivity profiles.  The method identifies potential specificity determinants that are not readily apparent, and provokes further investigation at the structural level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyqCeJ7_kELOkdrW1FkXG-fW6udTcc2eaWW1ulvHmDv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjovF2itA%253D%253D&md5=46acacc7b2711b7236436b3eac33b443</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1186%2F1471-2105-9-491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2105-9-491%26sid%3Dliteratum%253Aachs%26aulast%3DCaffrey%26aufirst%3DD.%2BR.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26aulast%3DMoshinsky%26aufirst%3DD.%2BJ.%26atitle%3DPrediction%2520of%2520specificity-determining%2520residues%2520for%2520small-molecule%2520kinase%2520inhibitors%26jtitle%3DBMC%2520Bioinf.%26date%3D2008%26volume%3D9%26spage%3D491%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafleur, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevado, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span> </span><span class="NLM_article-title">Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis</span> <span class="citation_source-journal">Bioinformatics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1093%2Fbioinformatics%2Fbtp650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=19942586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=198-204&author=D.+Huangauthor=T.+Zhouauthor=K.+Lafleurauthor=C.+Nevadoauthor=A.+Caflisch&title=Kinase+selectivity+potential+for+inhibitors+targeting+the+ATP+binding+site%3A+a+network+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis</span></div><div class="casAuthors">Huang, Danzhi; Zhou, Ting; Lafleur, Karine; Nevado, Cristina; Caflisch, Amedeo</div><div class="citationInfo"><span class="NLM_cas:title">Bioinformatics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">198-204</span>CODEN:
                <span class="NLM_cas:coden">BOINFP</span>;
        ISSN:<span class="NLM_cas:issn">1367-4803</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Small-mol. inhibitors targeting the ATP binding pocket of the catalytic domain of protein kinases have potential to become drugs devoid of (major) side effects, particularly if they bind selectively.  Here, the sequences of the 518 human kinases are first mapped onto the structural alignment of 116 kinases of known three-dimensional structure.  The multiple structure alignment is then used to encode the known strategies for developing selective inhibitors into a fingerprint.  Finally, a network anal. is used to partition the kinases into clusters according to similarity of their fingerprints, i.e., physico-chem. characteristics of the residues responsible for selective binding.  For each kinase the network anal. reveals the likelihood to find selective inhibitors targeting the ATP binding site.  Systematic guidelines are proposed to develop selective inhibitors.  Importantly, the network anal. suggests that the tyrosine kinase EphB4 has high selectivity potential, which is consistent with the selectivity profile of two novel EphB4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQVQsrpqB_ILVg90H21EOLACvtfcHk0lhqg0ycqjB70A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlGkug%253D%253D&md5=b6c63ccd4654219a56752f9cfc1356a3</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1093%2Fbioinformatics%2Fbtp650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbioinformatics%252Fbtp650%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DLafleur%26aufirst%3DK.%26aulast%3DNevado%26aufirst%3DC.%26aulast%3DCaflisch%26aufirst%3DA.%26atitle%3DKinase%2520selectivity%2520potential%2520for%2520inhibitors%2520targeting%2520the%2520ATP%2520binding%2520site%253A%2520a%2520network%2520analysis%26jtitle%3DBioinformatics%26date%3D2010%26volume%3D26%26spage%3D198%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Posy, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermsmeier, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todderud, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippy, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trainor, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loughney, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span> </span><span class="NLM_article-title">Trends in kinase selectivity: insights for target class-focused library screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101195a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFSms7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=54-66&author=S.+L.+Posyauthor=M.+A.+Hermsmeierauthor=W.+Vaccaroauthor=K.+H.+Ottauthor=G.+Todderudauthor=J.+S.+Lippyauthor=G.+L.+Trainorauthor=D.+A.+Loughneyauthor=S.+R.+Johnson&title=Trends+in+kinase+selectivity%3A+insights+for+target+class-focused+library+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Trends in Kinase Selectivity: Insights for Target Class-Focused Library Screening</span></div><div class="casAuthors">Posy, Shana L.; Hermsmeier, Mark A.; Vaccaro, Wayne; Ott, Karl-Heinz; Todderud, Gordon; Lippy, Jonathan S.; Trainor, George L.; Loughney, Deborah A.; Johnson, Stephen R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-66</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A kinome-wide selectivity screen of >20000 compds. with a rich representation of many structural classes has been completed.  Anal. of the selectivity patterns for each class shows that a broad spectrum of structural scaffolds can achieve specificity for many kinase families.  Kinase selectivity and potency are inversely correlated, a trend that is also found in a large set of kinase functional data.  Although selective and nonselective compds. are mostly similar in their physicochem. characteristics, we identify specific features that are present more frequently in compds. that bind to many kinases.  Our results support a scaffold-oriented approach for building compd. collections to screen kinase targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJlqg1ZszRmLVg90H21EOLACvtfcHk0lhqg0ycqjB70A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFSms7jJ&md5=f824b454904fb99d1ddd1ac6396cb784</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm101195a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101195a%26sid%3Dliteratum%253Aachs%26aulast%3DPosy%26aufirst%3DS.%2BL.%26aulast%3DHermsmeier%26aufirst%3DM.%2BA.%26aulast%3DVaccaro%26aufirst%3DW.%26aulast%3DOtt%26aufirst%3DK.%2BH.%26aulast%3DTodderud%26aufirst%3DG.%26aulast%3DLippy%26aufirst%3DJ.%2BS.%26aulast%3DTrainor%26aufirst%3DG.%2BL.%26aulast%3DLoughney%26aufirst%3DD.%2BA.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26atitle%3DTrends%2520in%2520kinase%2520selectivity%253A%2520insights%2520for%2520target%2520class-focused%2520library%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D54%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, J.</span><span> </span><span class="NLM_article-title">Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1942</span><span class="NLM_x">–</span> <span class="NLM_lpage">1956</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci1005004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVSrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=1942-1956&author=E.+Martinauthor=P.+Mukherjeeauthor=D.+Sullivanauthor=J.+Jansen&title=Profile-QSAR%3A+a+novel+meta-QSAR+method+that+combines+activities+across+the+kinase+family+to+accurately+predict+affinity%2C+selectivity%2C+and+cellular+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Profile-QSAR: A Novel meta-QSAR Method that Combines Activities across the Kinase Family To Accurately Predict Affinity, Selectivity, and Cellular Activity</span></div><div class="casAuthors">Martin, Eric; Mukherjee, Prasenjit; Sullivan, David; Jansen, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1942-1956</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Profile-QSAR is a novel 2D predictive model building method for kinases.  This "meta-QSAR" method models the activity of each compd. against a new kinase target as a linear combination of its predicted activities against a large panel of 92 previously studied kinases comprised from 115 assays.  Profile-QSAR starts with a sparse incomplete kinase by compd. (KxC) activity matrix, used to generate Bayesian QSAR models for the 92 "basis-set" kinases.  These Bayesian QSARs generate a complete "synthetic" KxC activity matrix of predictions.  These synthetic activities are used as "chem. descriptors" to train partial-least squares (PLS) models, from modest amts. of medium-throughput screening data, for predicting activity against new kinases.  The Profile-QSAR predictions for the 92 kinases (115 assays) gave a median external R2ext = 0.59 on 25% held-out test sets.  The method has proven accurate enough to predict pairwise kinase selectivities with a median correlation of R2ext = 0.61 for 958 kinase pairs with at least 600 common compds.  It has been further expanded by adding a "CkXC" cellular activity matrix to the KxC matrix to predict cellular activity for 42 kinase driven cellular assays with median R2ext = 0.58 for 24 target modulation assays and R2ext = 0.41 for 18 cell proliferation assays.  The 2D Profile-QSAR, along with the 3D Surrogate AutoShim, are the foundations of an internally developed iterative medium-throughput screening (IMTS) methodol. for virtual screening (VS) of compd. archives as an alternative to exptl. high-throughput screening (HTS).  The method has been applied to 20 actual prospective kinase projects.  Biol. results have so far been obtained in eight of them.  Q2 values ranged from 0.3 to 0.7.  Hit-rates at 10 uM for exptl. tested compds. varied from 25% to 80%, except in K5, which was a special case aimed specifically at finding "type II" binders, where none of the compds. were predicted to be active at 10 μM.  These overall results are particularly striking as chem. novelty was an important criterion in selecting compds. for testing.  The method is completely automated.  Predicted activities for nearly 4 million internal and com. compds. across 115 kinase assays and 42 cellular assays are stored in the corporate database.  Like computed phys. properties, this predicted kinase activity profile can be computed and stored as each compd. is registered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjTg6KqlgEyLVg90H21EOLACvtfcHk0lg-Stqlxvtmlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVSrsrw%253D&md5=49422d01fd686a4befc9db7c123cfcce</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fci1005004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci1005004%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DMukherjee%26aufirst%3DP.%26aulast%3DSullivan%26aufirst%3DD.%26aulast%3DJansen%26aufirst%3DJ.%26atitle%3DProfile-QSAR%253A%2520a%2520novel%2520meta-QSAR%2520method%2520that%2520combines%2520activities%2520across%2520the%2520kinase%2520family%2520to%2520accurately%2520predict%2520affinity%252C%2520selectivity%252C%2520and%2520cellular%2520activity%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D1942%26epage%3D1956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Anderson, P. C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Sapio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmer, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoeniger, J. S.</span><span> </span><span class="NLM_article-title">Identification of binding specificity-determining features in protein families</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1926</span><span class="NLM_x">–</span> <span class="NLM_lpage">1939</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200979x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1926-1939&author=P.+C+Andersonauthor=V.+De+Sapioauthor=K.+B.+Turnerauthor=S.+P.+Elmerauthor=D.+C.+Roeauthor=J.+S.+Schoeniger&title=Identification+of+binding+specificity-determining+features+in+protein+families"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm200979x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200979x%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DP.%2BC%26aulast%3DDe%2BSapio%26aufirst%3DV.%26aulast%3DTurner%26aufirst%3DK.%2BB.%26aulast%3DElmer%26aufirst%3DS.%2BP.%26aulast%3DRoe%26aufirst%3DD.%2BC.%26aulast%3DSchoeniger%26aufirst%3DJ.%2BS.%26atitle%3DIdentification%2520of%2520binding%2520specificity-determining%2520features%2520in%2520protein%2520families%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1926%26epage%3D1939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0lg-Stqlxvtmlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Korr, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toschi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohlenz, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreft, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, B.</span><span> </span><span class="NLM_article-title">LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">910</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1016%2Fj.cellsig.2005.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=16243488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=910-920&author=D.+Korrauthor=L.+Toschiauthor=P.+Donnerauthor=H.+D.+Pohlenzauthor=B.+Kreftauthor=B.+Weiss&title=LRRK1+protein+kinase+activity+is+stimulated+upon+binding+of+GTP+to+its+Roc+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain</span></div><div class="casAuthors">Korr, Daniel; Toschi, Luisella; Donner, Peter; Pohlenz, Hans-Dieter; Kreft, Bertolt; Weiss, Bertram</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">910-920</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human leucine-rich repeat kinase 1 (LRRK1) is a multi-domain protein of unknown function belonging to the ROCO family of complex proteins.  Here, we report the mol. characterization of human LRRK1 and show, for the first time, that LRRK1 is both a functional protein kinase and a GDP/GTP-binding protein.  Binding of GTP to LRRK1 is specific, requires the GTPase-like Roc domain, and leads to a stimulation of LRRK1 kinase activity.  LRRK1 is the first example of a GTP-regulated protein kinase harboring both the kinase effector domain and the GTP-binding regulatory domain.  Hence, we propose a model in which LRRK1 cycles between a GTP-bound active and a GDP-bound inactive state.  Moreover, we mutated LRRK1 to mimic mutations previously identified in LRRK2/dardarin, the only human paralogue of LRRK1, that have been linked to autosomal-dominant parkinsonism.  We demonstrate that three of four mutations analyzed significantly downregulate LRRK1 kinase activity.  Ultimately, the results presented for LRRK1 may contribute to the elucidation of LRRK2's role in the pathogenesis of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy_2JwaZskS7Vg90H21EOLACvtfcHk0lg-Stqlxvtmlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlakurc%253D&md5=52b70550b230dc8be509aa3767a1f2f5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2005.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2005.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DKorr%26aufirst%3DD.%26aulast%3DToschi%26aufirst%3DL.%26aulast%3DDonner%26aufirst%3DP.%26aulast%3DPohlenz%26aufirst%3DH.%2BD.%26aulast%3DKreft%26aufirst%3DB.%26aulast%3DWeiss%26aufirst%3DB.%26atitle%3DLRRK1%2520protein%2520kinase%2520activity%2520is%2520stimulated%2520upon%2520binding%2520of%2520GTP%2520to%2520its%2520Roc%2520domain%26jtitle%3DCell.%2520Signalling%26date%3D2006%26volume%3D18%26spage%3D910%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48a"><span><span class="NLM_contrib-group">Galkin, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steensma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span> </span><span class="NLM_article-title">Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=270-275&author=A.+V.+Galkinauthor=J.+S.+Melnickauthor=S.+Kimauthor=T.+L.+Hoodauthor=N.+Liauthor=L.+Liauthor=G.+Xiaauthor=R.+Steensmaauthor=G.+Chopiukauthor=J.+Jiangauthor=Y.+Wanauthor=P.+Dingauthor=Y.+Liuauthor=F.+Sunauthor=P.+G.+Schultzauthor=N.+S.+Grayauthor=M.+Warmuth&title=Identification+of+NVP-TAE684%2C+a+potent%2C+selective%2C+and+efficacious+inhibitor+of+NPM-ALK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalkin%26aufirst%3DA.%2BV.%26aulast%3DMelnick%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DHood%26aufirst%3DT.%2BL.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DWarmuth%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520NVP-TAE684%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520inhibitor%2520of%2520NPM-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D270%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit48b"><span>Erratum in  <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">2025</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Erratum+in+Proc.+Natl.+Acad.+Sci.+U.S.A.+2007%2C+104%2C+2025."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D2025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernier, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahoney, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poda, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourey, R. J.</span><span> </span><span class="NLM_article-title">Pyrrolopyridine inhibitors of mitogen-activated protein kinase activated protein kinase 2 (MK-2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2647</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0611004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2647-2654&author=D.+R.+Andersonauthor=M.+J.+Meyersauthor=W.+F.+Vernierauthor=M.+W.+Mahoneyauthor=R.+G.+Kurumbailauthor=N.+Caspersauthor=G.+I.+Podaauthor=J.+F.+Schindlerauthor=D.+B.+Reitzauthor=R.+J.+Mourey&title=Pyrrolopyridine+inhibitors+of+mitogen-activated+protein+kinase+activated+protein+kinase+2+%28MK-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm0611004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611004%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DMeyers%26aufirst%3DM.%2BJ.%26aulast%3DVernier%26aufirst%3DW.%2BF.%26aulast%3DMahoney%26aufirst%3DM.%2BW.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DCaspers%26aufirst%3DN.%26aulast%3DPoda%26aufirst%3DG.%2BI.%26aulast%3DSchindler%26aufirst%3DJ.%2BF.%26aulast%3DReitz%26aufirst%3DD.%2BB.%26aulast%3DMourey%26aufirst%3DR.%2BJ.%26atitle%3DPyrrolopyridine%2520inhibitors%2520of%2520mitogen-activated%2520protein%2520kinase%2520activated%2520protein%2520kinase%25202%2520%2528MK-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2647%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Huggins, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidor, B.</span><span> </span><span class="NLM_article-title">Rational approaches to improving selectivity in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1424</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2010332" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1424-1444&author=D.+J.+Hugginsauthor=W.+Shermanauthor=B.+Tidor&title=Rational+approaches+to+improving+selectivity+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Approaches to Improving Selectivity in Drug Design</span></div><div class="casAuthors">Huggins, David J.; Sherman, Woody; Tidor, Bruce</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1424-1444</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Rational Approaches to improving selectivity in Drug Design are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJv9AbW-c3TbVg90H21EOLACvtfcHk0lhWnlVQq7un8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFWktg%253D%253D&md5=5b7bf49f9f96a05adad4d42f63739252</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm2010332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2010332%26sid%3Dliteratum%253Aachs%26aulast%3DHuggins%26aufirst%3DD.%2BJ.%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DTidor%26aufirst%3DB.%26atitle%3DRational%2520approaches%2520to%2520improving%2520selectivity%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1424%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosgrove, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruston, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFaul, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colclough, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, B.</span><span> </span><span class="NLM_article-title">Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6672</span><span class="NLM_x">–</span> <span class="NLM_lpage">6682</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0605233" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6672-6682&author=A.+G.+Leachauthor=H.+D.+Jonesauthor=D.+A.+Cosgroveauthor=P.+W.+Kennyauthor=L.+Rustonauthor=P.+MacFaulauthor=J.+M.+Woodauthor=N.+Colcloughauthor=B.+Law&title=Matched+molecular+pairs+as+a+guide+in+the+optimization+of+pharmaceutical+properties%3B+a+study+of+aqueous+solubility%2C+plasma+protein+binding+and+oral+exposure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Guide in the Optimization of Pharmaceutical Properties; a Study of Aqueous Solubility, Plasma Protein Binding and Oral Exposure</span></div><div class="casAuthors">Leach, Andrew G.; Jones, Huw D.; Cosgrove, David A.; Kenny, Peter W.; Ruston, Linette; MacFaul, Philip; Wood, J. Matthew; Colclough, Nicola; Law, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6672-6682</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By identifying every pair of mols. that differ only by a particular, well-defined, structural transformation in a database of measured properties and computing the corresponding change in property, we obtain an overview of the effect that structural change has upon the property and set an expectation for what will happen when that transformation is applied elsewhere.  The mean change indicates the expected magnitude of the change in the property and the no. of cases in which the property increases give the probability that the structural transformation will cause the property to increase.  Outliers indicate potential ways of avoiding the general trend.  Comparing to changes in lipophilicity highlights structural transformations that have unusual effects, some of which can be explained by conformational changes.  In this paper, we focus upon the effects on aq. soly., plasma protein binding and oral exposure of adding substituents to arom. rings and methylating heteroatoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcyrloR79Oq7Vg90H21EOLACvtfcHk0lhWnlVQq7un8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtV2gtLnO&md5=2c143b424aee3ddb6c34616aff699ee0</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm0605233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605233%26sid%3Dliteratum%253Aachs%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DJones%26aufirst%3DH.%2BD.%26aulast%3DCosgrove%26aufirst%3DD.%2BA.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DRuston%26aufirst%3DL.%26aulast%3DMacFaul%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DColclough%26aufirst%3DN.%26aulast%3DLaw%26aufirst%3DB.%26atitle%3DMatched%2520molecular%2520pairs%2520as%2520a%2520guide%2520in%2520the%2520optimization%2520of%2520pharmaceutical%2520properties%253B%2520a%2520study%2520of%2520aqueous%2520solubility%252C%2520plasma%2520protein%2520binding%2520and%2520oral%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6672%26epage%3D6682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Peltason, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">SAR index: quantifying the nature of structure–activity relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5571</span><span class="NLM_x">–</span> <span class="NLM_lpage">5578</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0705713" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5571-5578&author=L.+Peltasonauthor=J.+Bajorath&title=SAR+index%3A+quantifying+the+nature+of+structure%E2%80%93activity+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm0705713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0705713%26sid%3Dliteratum%253Aachs%26aulast%3DPeltason%26aufirst%3DL.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DSAR%2520index%253A%2520quantifying%2520the%2520nature%2520of%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5571%26epage%3D5578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Wassermann, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Chemical substitutions that introduce activity cliffs across different compound classes and biological targets</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1248</span><span class="NLM_x">–</span> <span class="NLM_lpage">1256</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci1001845" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVGhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=1248-1256&author=A.+M.+Wassermannauthor=J.+Bajorath&title=Chemical+substitutions+that+introduce+activity+cliffs+across+different+compound+classes+and+biological+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Substitutions That Introduce Activity Cliffs Across Different Compound Classes and Biological Targets</span></div><div class="casAuthors">Wassermann, Anne Mai; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1248-1256</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Applying the concept of matched mol. pairs, the authors have systematically analyzed the ability of defined chem. changes to introduce activity cliffs.  Public domain compd. data were systematically screened for matched mol. pairs that were then organized according to chem. transformations they represent and assocd. potency changes.  From vast available chem. transformation space, including both R-group and core substructure changes, ∼250 nonredundant substitutions were identified that displayed a general tendency to form activity cliffs.  These substitutions introduced activity cliffs in the structural context of diverse scaffolds and in compds. active against many different targets.  Activity cliff-forming transformations were often rather simple, including replacements of small functional groups.  Moreover, in many instances, chem. very similar transformations were identified that had a much lower propensity to form activity cliffs or no detectable cliff potential.  Thus, clear preferences emerged for specific transformations.  A compendium of substitutions with general activity cliff-forming potential is provided to aid in compd. optimization efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUSS8Tj-rk8bVg90H21EOLACvtfcHk0ljd-QdWFgnK8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVGhtrY%253D&md5=381262f83abb19d326dbf95ddc367565</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fci1001845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci1001845%26sid%3Dliteratum%253Aachs%26aulast%3DWassermann%26aufirst%3DA.%2BM.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DChemical%2520substitutions%2520that%2520introduce%2520activity%2520cliffs%2520across%2520different%2520compound%2520classes%2520and%2520biological%2520targets%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D1248%26epage%3D1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Peltason, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajorath, J.</span><span> </span><span class="NLM_article-title">Computational analysis of activity and selectivity cliffs</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">672</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1007%2F978-1-60761-839-3_4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=20838966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlaqu7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=672&publication_year=2011&pages=119-132&author=L.+Peltasonauthor=J.+Bajorath&title=Computational+analysis+of+activity+and+selectivity+cliffs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Computational analysis of activity and selectivity cliffs</span></div><div class="casAuthors">Peltason, Lisa; Bajorath, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">672</span>
        (<span class="NLM_cas:issue">Chemoinformatics and Computational Chemical Biology</span>),
    <span class="NLM_cas:pages">119-132</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The exploration of structure-activity relationships (SARs) is a major challenge in medicinal chem. and usually focuses on compd. potency for individual targets.  However, selectivity of small mols. that are active against related targets is another crit. parameter in chem. lead optimization.  Here, an integrative approach for the systematic anal. of SARs and structure-selectivity relationships (SSRs) of small mols. is presented.  The computational methodol. is described and a cathepsin inhibitor set is used to discuss key aspects of the anal.  Combining a numerical scoring scheme and graphical visualization of mol. networks, the approach enables the identification of different local SAR and SSR environments.  Comparative anal. of these environments reveals variable relationships between mol. structure, potency, and selectivity.  Furthermore, key compds. are identified that are involved in the formation of activity and/or selectivity cliffs and often display structural features that det. compd. selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1gw1jY9CO97Vg90H21EOLACvtfcHk0ljd-QdWFgnK8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlaqu7fF&md5=76cdbdc87385c145a0b4cd08a22039cc</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2F978-1-60761-839-3_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-60761-839-3_4%26sid%3Dliteratum%253Aachs%26aulast%3DPeltason%26aufirst%3DL.%26aulast%3DBajorath%26aufirst%3DJ.%26atitle%3DComputational%2520analysis%2520of%2520activity%2520and%2520selectivity%2520cliffs%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2011%26volume%3D672%26spage%3D119%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Griffen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. J.</span><span> </span><span class="NLM_article-title">Matched molecular pairs as a medicinal chemistry tool</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7739</span><span class="NLM_x">–</span> <span class="NLM_lpage">7750</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200452d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7739-7750&author=E.+Griffenauthor=A.+G.+Leachauthor=G.+R.+Robbauthor=D.+J.+Warner&title=Matched+molecular+pairs+as+a+medicinal+chemistry+tool"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Matched Molecular Pairs as a Medicinal Chemistry Tool</span></div><div class="casAuthors">Griffen, Ed; Leach, Andrew G.; Robb, Graeme R.; Warner, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7739-7750</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">At the very heart of the role of a medicinal chemist or drug designer is the ability to link chem. structure to mol. properties.  This is the structure-activity relationship(SAR) or structure-property relationship(SPR).  Drug discovery projects often discover that a particular structural change causes a change to a property of interest.  The authors of this paper have been involved in developing and implementing some variations on the original theme of MMPA (matched mol. pairs anal.) and felt this to be the time to highlight some of these and to point toward future developments.  All of them are involved in the process of drug design, and it is within this context that they will set their comments.  In outline, they introduce matched mol. pair anal. and highlight why it fits so well with the kind of problem solving that is required in the process of drug design.  This will be followed by some comments concerning when the application of the methodol. is appropriate.  Then in a section intended for those with more computational interests, the authors describe the various ways that have been devised for identifying such matched pairs.  Throughout the paper, the authors have elected to use a publicly available data set to illustrate some of the comments: the ChEMBL database of inhibitors of the epidermal growth factor receptor tyrosine kinase (EGFR).  This consists of 2899 measurements of an IC50 annotated as a binding measurement on 2348 unique compds.  These measurements are drawn from a no. of sources, having been abstracted from the scientific literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMGFfO8Flm5bVg90H21EOLACvtfcHk0ljd-QdWFgnK8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Wks7jK&md5=fab3344d790d1c0ae688ec65830d9143</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fjm200452d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200452d%26sid%3Dliteratum%253Aachs%26aulast%3DGriffen%26aufirst%3DE.%26aulast%3DLeach%26aufirst%3DA.%2BG.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DWarner%26aufirst%3DD.%2BJ.%26atitle%3DMatched%2520molecular%2520pairs%2520as%2520a%2520medicinal%2520chemistry%2520tool%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7739%26epage%3D7750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Seebeck, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagener, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rarey, M.</span><span> </span><span class="NLM_article-title">From activity cliffs to target-specific scoring models and pharmacophore hypotheses</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1639</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1630-1639&author=B.+Seebeckauthor=M.+Wagenerauthor=M.+Rarey&title=From+activity+cliffs+to+target-specific+scoring+models+and+pharmacophore+hypotheses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeebeck%26aufirst%3DB.%26aulast%3DWagener%26aufirst%3DM.%26aulast%3DRarey%26aufirst%3DM.%26atitle%3DFrom%2520activity%2520cliffs%2520to%2520target-specific%2520scoring%2520models%2520and%2520pharmacophore%2520hypotheses%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1630%26epage%3D1639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Scherrmann, J. M.</span><span> </span><span class="NLM_article-title">Expression and function of multidrug resistance transporters at the blood–brain barriers</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1517%2F17425255.1.2.233" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm300452p&amp;key=16922639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKltLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=233-246&author=J.+M.+Scherrmann&title=Expression+and+function+of+multidrug+resistance+transporters+at+the+blood%E2%80%93brain+barriers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and function of multidrug resistance transporters at the blood-brain barriers</span></div><div class="casAuthors">Scherrmann, Jean-Michel</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-246</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  The presence of active carrier-mediated transport of substrates from the brain to the blood is a major feature of the barrier properties of the blood-brain barrier (BBB).  These proteins lie in the luminal or abluminal membranes of the endothelial cells that form the BBB.  Some are ATP-binding cassette proteins (ABC) and many amphipathic cationic drugs are carried by P-glyco-protein (ABCB1) or ABCG2, which lie at the luminal pole of the BBB.  Several multidrug resistance-assocd. proteins (MRPs, ABCCs) are also present on the membranes of brain microvessels; these are mainly involved in the efflux of anionic compds.  All these ABC proteins help to protect the brain and form a crit. target for CNS Pharmaceuticals, influencing the clin. variability of responses to, and the design of, these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCALgzku018LVg90H21EOLACvtfcHk0lg8-UUfPyjmJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKltLfM&md5=90d19490f886b3dcf00c9b71246409f9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1517%2F17425255.1.2.233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.1.2.233%26sid%3Dliteratum%253Aachs%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26atitle%3DExpression%2520and%2520function%2520of%2520multidrug%2520resistance%2520transporters%2520at%2520the%2520blood%25E2%2580%2593brain%2520barriers%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2005%26volume%3D1%26spage%3D233%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Schinkel, A. H.</span><span> </span><span class="NLM_article-title">P-Glycoprotein, a gatekeeper in the blood–brain barrier</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1999&pages=179-194&author=A.+H.+Schinkel&title=P-Glycoprotein%2C+a+gatekeeper+in+the+blood%E2%80%93brain+barrier"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DP-Glycoprotein%252C%2520a%2520gatekeeper%2520in%2520the%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1999%26volume%3D36%26spage%3D179%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieplak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1074</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm300452p&amp;key=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=1049-1074&author=J.+Wangauthor=P.+Cieplakauthor=P.+A.+Kollman&title=How+well+does+a+restrained+electrostatic+potential+%28RESP%29+model+perform+in+calculating+conformational+energies+of+organic+and+biological+molecules%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span></div><div class="casAuthors">Wang, Junmei; Cieplak, Piotr; Kollman, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1049-1074</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The authors present conformational energies for a mol. mech. model (Parm99) developed for org. and biol. mols. using the restrained electrostatic potential (RESP) approach to derive the partial charges.  This approach uses the simple generic force field model (Parm94), and attempts to add a minimal no. of extra Fourier components to the torsional energies, but doing so only when there is a phys. justification.  The results are quite encouraging, not only for the 34-mol. set that was studied by both the highest level ab initio model (GVB/LMP2) and expt., but also for the 55-mol. set for which high-quality exptl. data are available.  Considering the 55 mols. studied by all the force field models for which there are exptl. data, the av. abs. errors (AAEs) are 0.28 (this model), 0.52 (MM3), 0.57 (CHARMm [MSI]), and 0.43 kcal/mol (MMFF).  For the 34-mol. set, the AAEs of this model vs. expt. and ab initio are 0.28 and 0.27 kcal/mol, resp.  This is a lower error than found with MM3 and CHARMm, and is comparable to that found with MMFF (0.31 and 0.22 kcal/mol).  The authors also present 2 examples of how well the torsional parameters are transferred from the training set to the test set.  The abs. errors of mols. in the test set are only slightly larger than in the training set (differences of <0.1 kcal/mol).  Therefore, a simple generic force field with a limited no. of specific torsional parameters can describe intra- and intermol. interactions, although all comparison mols. were selected from 82-compd. training set.  Also this effective 2-body model can be extended for use with a nonadditive force field (NAFF), both with and without lone pairs.  Without changing the torsional parameters, the use of more accurate charges and polarization increases av. abs. error compared with expt., but adjustment of the parameters restores the level of agreement found with the additive model.  After reoptimizing the Ψ, Φ torsional parameters in peptides using alanine dipeptide (6 conformational pairs) and alanine tetrapeptide (11 conformational pairs), the new model gives better energies than the Cornell et al. force field.  The av. abs. error of this model for high-level ab initio calcn. is 0.82 kcal/mol for alanine dipeptide and tetrapeptide as compared with 1.80 kcal/mol for the Cornell et al. model.  For nucleosides, the new model also gives improved energies compared with the Cornell et al. model.  To optimize force field parameters, the authors developed a program called parmscan, which can iteratively scan the torsional parameters in a systematic manner and finally obtain the vest torsional potentials.  Besides the org. mols. in test set, parmscan was also successful in optimizing the Ψ, Φ torsional parameters in peptides to significantly improve agreement between mol. mech. and high-level ab initio energies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0dHME9_PfT7Vg90H21EOLACvtfcHk0lg8-UUfPyjmJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D&md5=c81631289cf58f63917e2a9fa9547ab6</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-987X%2528200009%252921%253A12%253C1049%253A%253AAID-JCC3%253E3.0.CO%253B2-F%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DHow%2520well%2520does%2520a%2520restrained%2520electrostatic%2520potential%2520%2528RESP%2529%2520model%2520perform%2520in%2520calculating%2520conformational%2520energies%2520of%2520organic%2520and%2520biological%2520molecules%253F%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2000%26volume%3D21%26spage%3D1049%26epage%3D1074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Thompson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, T. J.</span><span> </span><span class="NLM_article-title">CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4673</span><span class="NLM_x">–</span> <span class="NLM_lpage">4680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1994&pages=4673-4680&author=J.+D.+Thompsonauthor=D.+G.+Higginsauthor=T.+J.+Gibson&title=CLUSTAL+W%3A+improving+the+sensitivity+of+progressive+multiple+sequence+alignment+through+sequence+weighting%2C+position+specific+gap+penalties+and+weight+matrix+choice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DJ.%2BD.%26aulast%3DHiggins%26aufirst%3DD.%2BG.%26aulast%3DGibson%26aufirst%3DT.%2BJ.%26atitle%3DCLUSTAL%2520W%253A%2520improving%2520the%2520sensitivity%2520of%2520progressive%2520multiple%2520sequence%2520alignment%2520through%2520sequence%2520weighting%252C%2520position%2520specific%2520gap%2520penalties%2520and%2520weight%2520matrix%2520choice%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1994%26volume%3D22%26spage%3D4673%26epage%3D4680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span> <span class="citation_source-book">Pipeline Pilot</span>, version <span class="NLM_edition">7.5</span>; <span class="NLM_publisher-name">Accelrys Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pipeline+Pilot%2C+version+7.5%3B+Accelrys+Inc.%3A+San+Diego%2C+CA."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DPipeline%2520Pilot%26pub%3DAccelrys%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Rogers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, M.</span><span> </span><span class="NLM_article-title">Extended-connectivity fingerprints</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci100050t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm300452p&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=742-754&author=D.+Rogersauthor=M.+Hahn&title=Extended-connectivity+fingerprints"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-Connectivity Fingerprints</span></div><div class="casAuthors">Rogers, David; Hahn, Mathew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">742-754</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Extended-connectivity fingerprints (ECFPs) are a novel class of topol. fingerprints for mol. characterization.  Historically, topol. fingerprints were developed for substructure and similarity searching.  ECFPs were developed specifically for structure-activity modeling.  ECFPs are circular fingerprints with a no. of useful qualities: they can be very rapidly calcd.; they are not predefined and can represent an essentially infinite no. of different mol. features (including stereochem. information); their features represent the presence of particular substructures, allowing easier interpretation of anal. results; and the ECFP algorithm can be tailored to generate different types of circular fingerprints, optimized for different uses.  While the use of ECFPs has been widely adopted and validated, a description of their implementation has not previously been presented in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra43orI-Y7lbVg90H21EOLACvtfcHk0lg8-UUfPyjmJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D&md5=cd6c736cd7a3d280b67f5316acce8006</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fci100050t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100050t%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DD.%26aulast%3DHahn%26aufirst%3DM.%26atitle%3DExtended-connectivity%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D742%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JY9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JY9','PDB','3JY9'); return false;">PDB: 3JY9</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i41"><a href="/doi/suppl/10.1021/jm300452p">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_47553"></div></div></div></div></div><hr /></hr><p class="last">Table 1 listing Invitrogen kinase selectivity profiling data. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm300452p/suppl_file/jm300452p_si_001.pdf">jm300452p_si_001.pdf (82.34 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm300452p&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm300452p%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-11%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm300452p" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679938ca2f333cdc","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
